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ABSTRACT 
Michael A. T. Maughan 
Ph.D December 2003 
This thesis describes the development of methodology for the synthesis of cyclic 
imine-sugars, and their use in the synthesis of aza-sugars as potential sugar-processing 
enzyme inhibitors. Our goals include the synthesis of cyclic imines of L-rhamnose, 
D-glucose, and L-idose stereochemistry, and the introduction of functionality via 
nucleophilic addition reactions. 
Work on the synthesis of cyclic imines commenced with the use of the simple model 
systems piperidine and 2-methylpiperidine. N-Chlorination of these systems was 
performed, and the products converted into their cyclic imine derivatives through 
elimination of HCl. Nucleophilic addition reactions to these systems were attempted, 
but the low stability and reactivity of the imines led to the isolation of only one 
adduct. 
The synthesis of novel cyclic pyrrolidine imine-sugars of L-rhamnose stereochemistry 
was performed by a Staudinger aza-Wittig reaction. The aza-Wittig reaction of a 
known L-rhamnose derived azido-sugar gave a novel cyclic L-rharnnopyrrolidine 
aldimine. A novel synthesis of this azido-sugar was also devised. Successful 
nucleophilic additions to the cyclic L-rhamnopyrrolidine aldimine were performed 
with a range of Grignard reagents giving novel protected aza-sugars in good yields 
and with excellent diastereoselectivities. A novel cyclic L-rhamnopyrrolidine 
ketimine was also synthesised via a Staudinger aza-Wittig from a novel azido-sugar, 
although time constraints prevented screening this system with nucleophiles. 
The synthesis of novel cyclic piperidine imine-sugars of D-glucose, and L-idose 
stereochemistry was performed, both via N-chlorination/elimination of the protected 
parent aza-sugars, and via the Staudinger aza-Wittig reaction of novel azido-sugars. 
The elimination of HCl from six-membered N-chloro aza-sugars of D-glucose and L-
idose stereochemistry was investigated, and methodology developed in the case of D-
glucose system for the regioselective elimination of HCl to give either the aldimine or 
the ketimine derivative. Comparison of elimination reactions of the N-chloro aza-
sugars of D-glucose, and L-idose stereochemistry allowed rationalisation of the 
observed regiocontrol. 
Screening of the cyclic imines of D-glucose and L-idose stereochemistry with 
nucleophiles, followed by deprotection of the adducts, allowed the synthesis of novel 
aza-sugars via late-stage introduction of functionality. Low yields were obtained for 
these additions, but diastereocontrol was generally good, and could be rationalised by 
accepted stereoelectronic and steric approach control factors. 
The formation of cyclic piperidine imines of L-idose, and D-glucose stereochemistry 
was also performed via the Staudinger aza-Wittig reaction. These systems were found 
to be identical to those synthesised by the N-chlorination/elimination protocol. We 
also performed the first synthesis of the enantiomer of the natural product ( + )-
adenophorine thereby allowing assignment of the absolute configuration of the natural 
product (+)-adenophorine. The key synthetic step in this synthesis was stereoselective 
reduction of a novel intermediate cyclic piperidine ketimine-sugar of L-idose 
stereochemistry. 
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Chapter 1. Introduction 
1.1 Introduction 
Polyhydroxylated piperidines and pyrrolidines, loosely classed as aza-sugars (sugars 
where the ring oxygen has been replaced by nitrogen), have long been recognised for 
their, sometimes highly potent, inhibition of sugar-processing enzymes. 1•2 Indeed 
alpha substituted piperidine and pyrrolidine alkaloids also have many applications in 
the treatment of disease. 3 There are countless syntheses of a wide variety of aza-
sugars, and often, simple modification of aza-sugar scaffolds can dramatically change 
the specificity or potency of inhibition. 1 Nojirimycin (NJ) (1.01) (Figure 1 ),4 an aza-
sugar analogue of D-glucopyranose, first isolated from Streptomyces 
roseochromogenes R-468 is the archetypal aza-sugar, and many structural variants 
have been synthesised. NJ itself is a potent specific inhibitor of several glucose-
processing enzymes,4•5 which may be expected due to the simple stereochemical 
similarity between NJ and the pyranse form of D-glucose itself (1.02) (Figure 1 ). 
OH OH OH 
OH OH OH 
(1.01) (1.03) (1.02) 
Figure 1. Comparison between NJ, DNJ and D-glucopyranose. 
1-Deoxynojirimycin (DNJ) (1.03) is another glucose analogue found in nature (Figure 
1).6 It has also been found to inhibit specifically several glucose processing enzymes, 
although often with lower potency than NJ (1.01) itselr.? As a general rule, aza-sugars 
mimicking the conformation of the sugar-processing enzyme substrate may show 
inhibitory activity toward that enzyme. This is not always the case, however, and 
inhibitory activity can be very sensitive to structure. 1 There are often many variants of 
a particular sugar-processing enzyme present in a given organism, and indeed such 
variations occur between species. These isoenzymes can often show markedly 
different responses to a specific inhibitor, and this can allow the design of very 
enzyme specific inhibors as potential therapeutics. 1 
The introduction of hydrophobic functionality to an aza-sugar can not only potentially 
increase the inhibitory activity of an aza-sugar in vitro, but also increase the 
bioavailability of the inhibitor, and therefore its in vivo activity. 8 This is most likely to 
be due to the hydrophobic group improving the aza-sugar's ability to pass through cell 
walls. 
In order to optimise the activity of enzyme inhibitors, and change their 
pharmacokinetic properties, it is important to have convenient access to large numbers 
of compounds with designed structural variations. The ideal situation is late-
synthetic-stage introduction of functionality, allowing either the modification of 
existing inhibitors, or the facile synthesis of arrays or libraries of compounds from a 
single precursor in few chemical steps. In the case of aza-sugars late-stage 
introduction of functionality can be conveniently achieved through N-substitution 
(Scheme 1) by means of, for example reductive amination,9 SN2 reaction with suitable 
electrophiles, 10 condensation reactions11 etc. This has allowed many N-substituted 
aza-sugars to be synthesised as potential inhibitors and mechanistic probes. 
H 
RO~N) 
(~OR 
R 
I 
RO~N) 
(~OR 
Scheme 1. N-fuctionalisation of aza-sugars. 
Late-stage introduction of functionality at the a- nitrogen positions would be a 
valuable tool to the synthetic chemist in the synthesis of libraries of compounds for 
mechanistic studies and as potential therapeutics. 
Dransfield et al. 12 reported the introduction of functionality to aza-sugars a- to 
nitrogen at an early synthetic stage by the use of SN' additions to imino-glucal (1.04). 
2 
The addition reactions gave fair to good yields of C-1 functionalised unsaturated aza-
sugars, with only moderate diasterocontrol (58 - 72 % de). Conversion into the 
peracetylated aza-sugar was also performed in the case of the ethyl adduct. 
OAc OAc 
R R 
(i) (ii)-(iv) 
- -
OAc OAc 
(1.04) R =Et (1.05) 
(i)Et2Zn, BF30Et2, DCM,- 20 °C; (ii) Os04 (cat.), N-methylmorpholine N-oxide, acetone/H20; 
(iii) Ac20, Py; (iv) piperidine, DCM, R =Et, 62% from (1.04) ( IR: IS 43 : 19). 
Scheme 2. Early-synthetic stage introduction of functionality to aza-sugar 
scaffo lds. 12 
Y okoyama et al. 13 describe a convenient sysnthesis of C-1 substituted aza-nuleosides 
by the addition of organometallic reagents to the aldehyde function of a protected D-
ribofuranose system (1.06 (Scheme 3). Subsequent oxidation to the dicarbonyl sugar, 
then a double reductive amination with ammonium formate gave the protected aza-
sugars. Only one diastereoisomer was observed, but the stereocontrol of the reductive 
amination was not fully understood. The chemistry was performed with a range of 
aryllithium reagents. 
3 
[Si)O~OH [Si)O~H R 
(i) 
OH 
. . . . 
(i) 2-Aryllithium, THF, 71-94 %; (ii) DMSO, TFAA, Et3N, DCM, 
- 78 °C, 80-86 %; (iii) HC03NH4, NaBH3CN, MeOH, 75-98 %. 
Scheme 3. Synthesis of a-substituted aza-sugars. 13 
Here we atm to address the necessity for convenient late-stage introduction of 
functionality at the a-nitrogen positions in the synthesis of aza-sugars, by the use of 
cyclic imines as substrates for addition reactions. We envisaged the conversion of 
existing aza-sugars into cyclic imine-sugars, and subsequent reaction with suitable 
nucleophiles (Scheme 4 ), and the synthesis of cyclic imines from chiral pool starting 
materials. This methodology also lends itself to the synthesis of C-1 branched aza-
sugars, which may have applications as three component glycosyltransferase 
inhibitors? Applications for this methodology will be investigated toward the 
synthesis of such three component transition-state mimics as potential 
rhamnosyltransferase inhibitors (see Section 1.6.2), and in the synthesis of piperidine 
aza-sugars of D-glucose and L-idose stereochemistry (see Section 1.6.3). Cyclic 
imine-sugars have previously been used as intermediates in the synthesis of aza-
sugars, however they are relatively rare in the literature (see Section 1.5.3). 
4 
RO~~)~ RO~N~ 
(~OR (~OR 
H 
RO~N'::rR 
(~OR 
Scheme 4. Proposed introduction of functionality via irreversible additions to cyclic 
1mme sugars. 
In order to rationalise the structure-activity relationship of aza-sugar enzyme 
inhibitors, it is necessary to understand the mechanism of the target enzymes. 
1.2 Sugar-Processing Enzymes 
1.2.1 Background 
Enzymes are biological catalysts, in that they have the ability to increase the rate of a 
given reaction, sometimes in a highly specific manner. Enzymes are proteins, made 
up of one or more chains of amino acids linked by covalent peptide bonds. Intra- and 
inter-chain bonding, both covalent and polar, hold the structure in the correct 
conformation. 14 
The site of catalysis, or active site, is shaped in order to accept the substrate(s), with 
which it interacts, exerting strong non-covalent attractive forces, such as 
hydrophobic/hydrophilic, hydrogen bonding, Van der Waals, ionic and dipolar 
interactions. 15 The specificity of many enzymes led to the lock-and-key theory of 
enzyme action, which compares the specificity of enzyme/substrate interaction to the 
interaction of a key with a lock. 16•17 This theory has been superseded by the concept of 
transition-state stabilisation, 17 whereby the enzyme is shaped so as to make 
maximum contact, and maximum stabilisation at the transition-state. 
The micro-environment within the active site is optimised for the specific action of 
the enzyme, and contributions can be made by micro-pH change within the active site 
(general acid/base catalysis), 17 conformational changes, proximity of reactive groups 
on the protein surface, or proximity of other reactants held within the active site. 18 
After the reaction is complete, the enzyme releases the product(s), and is ready to 
accept a new substrate(s). 
5 
If binding of the enzyme to the substrate or product is too favourable energetically, 
the action of the enzyme may be impaired, either due to slow product release, or 
product inhibition. This leads us to Pauling's suggestion that the enzyme must elicit 
tightest binding during the transition-state. 19 This theory has been supported by 
numerous examples of potent enzyme inhibitors synthesised as transition-state 
analogues, as well as crystal structures of enzyme/inhibitor complexes. Such 
transition-state analogues can be powerful mechanistic tools, as well as potential 
therapeutics? 
The catalytic process for a single substrate enzyme can be shown in terms of the two 
stages of the process, shown below in Equation 1. 
1. Formation of the enzyme-substrate, or Michaelis complex ([ES]). 
2. Reaction of [ES] to give free enzyme E, and product(s) P. 
E+S [ES] 
k.} 
Equation 1 
The rate of the forward reaction can be seen to depend on [ES], which in turn is 
defined by the equilibrium constant for the binding of E to S, assuming that this 
equilibrium is not affected by the breakdown of [ES] toP, an assumption that is more 
accurate in the case ofk.,>>k2. 
1.2.2 Enzyme Inhibitors 
Our target is the synthesis of compounds that effectively inhibit enzyme action. The 
mode of action of an enzyme inhibitor can be described by the use of the above 
model, and fall into four main classes; 
1. Competitive 
2. Non-competitive 
6 
3. Mixed 
4. Uncompetitive 
In general there is an interaction between the enzyme and inhibitor to form a 
catalytically inactive enzyme-inhibitor complex ([El]) (Equation 2). 17 Competitive 
inhibitors slow the catalysis of an enzyme by interacting with the active site, and as 
such both substrate and inhibitor cannot both bind simultaneously to the same 
enzyme. Such inhibitors compete with the substrate for the active site, and the 
efficiency of inhibition will be influenced by the concentration of substrate. 
Competitive inhibitors often share structural characteristics with the substrate as they 
usually both bind to the same site on the enzyme surface. 
Non-competitive inhibitors can bind to the enzyme in conjunction with the substrate, 
and may bind specifically at a position removed from the active site, termed an 
allosteric site. The action of binding prevents catalytic turnover, possibly by causing 
a change in conformation of the enzyme. Such inhibitors do not need to compete for 
the active site, and can be very different structurally to the substrate. In some cases 
the action of the inhibitor (I) binding to the enzyme (E) can alter the equilibrium of 
binding of E to S (KM, Equation 1 ), as well as reducing catalytic turnover (k2, 
Equation 1 ), this is termed mixed inhibition. 
Uncompetitive inhibitors bind to the enzyme only in association with the substrate, 
and inhibition is therefore dependent on both substrate and inhibitor concentration. 
Uncompetitive inhibitors are less common than the other types of inhibitor mentioned 
above. 
In both the case of competitive and non-competitive inhibitors, there is some form of 
interaction between the inhibitor and enzyme; in many cases this is merely non-
covalent bonding, and the enzyme can simply release the inhibitor, which is termed 
reversible inhibition. In certain cases, however, the enzyme may bind to the inhibitor, 
creating the inactive enzyme-inhibitor complex (El), which may react further to form 
irreversibly a covalently bonded system El (Equation 2), thereby rendering the 
enzyme permenantly inactive, this is termed irreversible inhibition, as both the 
inhibitor and the enzyme are rendered inactive. 
7 
E+S El [El] [ES] E+ S+I ----
-----
----
--
Equation 2 
Simplistically, competitive reversible inhibitors of enzymes can be designed in order 
to mimic the substrate, thereby increasing the possibility of tight binding to the 
inhibitor. This substrate-like inhibitor design is based around the lock-and-key theory 
of enzyme activity (see Section 1.2.1), in that the enzyme is specifically shaped to 
accept the substrate in its most stable conformation. Although this can be an effective 
method of inhibitor design, the lock-and-key theory over-simplifies the enzyme's 
activity. 
Whilst in the active site, the micro-environment is very different for the substrate and 
non-bonding interactions can cause a change in preferred conformation. It is also 
postulated that enzymes elicit tightest binding during the transition-state (see Section 
1.2.1 ). Much success has been achieved in the synthesis of transition-state mimics, 
compounds that mimic the shape and distribution of charge/bonding groups at the 
enzyme-transition state. Such inhibitor design not only has applications in the 
development of therapeutics, but can also be used to probe the mechanism of the 
enzyme? 
In order to describe the design of transition-state mimics, it is necessary to understand 
the mechanism of the enzyme in question. The two main classes of sugar-processing 
enzymes in which we are interested are glycosylhydrolases and glycosyltransferases. 
The general mechanism of action of glycosylhydrolase enzymes has been established 
by means of site-directed mutagenisis,20 kinetic studies21 and enzyme crystal 
structures. 21 '22 
1.2.3 Glycosylhydrolases 
Glycosylhydrolase, or glycosidase, enzymes are catalysts for the, often highly 
8 
specific, cleavage of glycosidic bonds?1 There are two mam classes of 
glycosylhydrolase enzymes, termed retaining, and inverting, referring to the 
stereochemical transformation at the anomeric carbon where the hydrolysis takes 
place. 
Retaining glycosylhydrolases hydrolyse the glycosidic bond, with the product 
retaining the original stereochemistry, whereas inverting glycosylhydrolases cause an 
inversion of stereochemistry at the anomeric centre. 
Retaining Glycosylhydrolases 
The retention of configuration at the point of glycolysis has been postulated to be due 
to a double displacement at the anomeric centre, initially by an enzyme-bound 
nucleophile.23 Crystal structures and sequencing of many glycosylhydrolases has 
shown that the active site of inverting glycosylhydrolases generally contain two 
carboxylate groups, and these are implicated in the catalytic activity of such enzymes. 
It is postulated that, upon binding of the substrate, the aglycon substituent is displaced 
by one of the enzyme carboxylates to form a covalently-enzyme-bound intermediate. 
Figure 2 shows schematic representations of the mechanisms of retaining and 
inverting glycosylhydrolase enzymes.24 The presence of the second carboxylate was 
initially thought to be involved in the protonation of the anomeric substituent, 
increasing the !ability of the glycosidic bond. However, there is some debate about 
the role of the second carboxylate, due to the ability of such enzymes to catalyse 
efficiently the hydrolysis of, for example, non-protonatable glycosylpyridinium ions.25 
It may be that the second carboxylate, in its deprotonated form, merely stabilises the 
developing positive charge during the hydrolysis. The active site of such enzymes 
have been likened to 'super-solvents' ,21 allowing the finite existence of this otherwise 
very unstable intermediate species. 
9 
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Figure 2. Schematic representation of the mechanism of inverting and retaining 
glycosylhydrolase enzymes. 
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The resulting enzyme-bound sugar is subsequently hydrolysed by water present in the 
active site. The overall transformation, via two SN2 displacements, is replacement of 
the anomeric substituent with a hydroxyl group with retention of stereochemistry. 
The transition-states of the reaction can therefore be simplified to a flattened system 
where positive charge develops both at the anomeric centre, and to some extent on the 
ring oxygen through conjugative stabilisation, and design of inhibitors based around 
structural mimics of such a transition-state has had much success (Figure 2). 2 
Inverting Glycosylhydrolases 
Inverting glycosylhydrolases act in a similar manner to retaining glycosylhydrolases 
(see above), but lack the participation of the second carboxylate group in the active 
site, the cleavage of the anomeric linkage being performed by a water molecule?1 As 
there is only one inversion the hydrolysis product has the opposite anomeric 
stereochemistry to the substrate. Again, a transition-state can be envisaged with 
flattening of the sugar ring, and developing positive charge at the anomeric centre and 
ring oxygen (Figure 2). Transition-state mimics for both inverting and retaining 
glycosylhydrolases may therefore be very similar. 
1.2.4 Glycosyltransferases 
Glycosyltransferases are catalysts for the formation of glycosidic bonds to molecules 
other than water. They have many and varied roles in nature, and are involved in the 
synthesis of all glycoconjugates, including glycosylation of proteins, lipids, and 
bacterial cell wall biosynthesis. 2 Inhibitors of such enzymes have applications as 
antibiotics, antiviral agents, anti-inflammatory agents, and may be important in 
enzyme folding, and activitiy, and biological encoding for processes such as 
metastasis, immune response and intercellular recognition?,26,27 
In general, glycosyltranferases are less well studied than their glycosylhydrolase 
counterparts, mainly due to the fact that the transferases are less stable, and usually 
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immobilised on the cell wall, making their handling and characterisation more 
difficult.21 
Glycosyltransferase enzymes generally process either a glycosyl phosphonucleotide 
(Leloir type) or a glycosyl phosphate (non-Leloir type) as the glycosyl donor,28•29 and 
form a new glycosidic bond selectively to another moiety. Leloir type 
glycosyltransferases, which we will be targeting, are responsible for glycosylation of 
proteins and formation of glycoconjugates in most mammalian systems. There are 
glycosyltransferases, which transfer to both 0, and N-acceptors, and can be retaining 
or inverting, as discussed for glycosyl hydrolases above. 
A proposed transition-state for a Leloir type glycosyltransferase (Figure 3), again 
involves the displacement of the anomeric substituent, with associated flattening of 
the sugar ring, and the development of a partial positive charge. 30 
Design of transition-state mimics as potential inhibitors of such enzymes can, once 
again again be based around incorporation of the develoment of positive charge on the 
ring oxygen, and flattening of the sugar ring. Due to the similarity in structure of the 
sugar ring during the transition-state of the glycosyltransferase to that of the 
glycosylhydrolase discussed above, inhibitors of such systems may have much in 
common with each other. Incorporation of structural features of both the donor and 
the acceptor, both of which are postulated to be present in the active site in the case of 
inverting glycosyltransferases, may increase potency or specificity of inhibition? 
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Figure 3. Proposed mechanism of a Leloir-type glycosyl transferase. 30 
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1.3 Potential Sugar-Processing Enzyme Inhibitors 
The discussion of the mechanism of glycoprocessing enzymes explains the inhibitory 
activity shown by many aza-sugars. The ring nitrogen, protonated at physiological 
pH/1 is able to mimic the developing charge on the pyranose ring oxygen. 
It has been observed that the 1,4-imino- (furanose) forms of aza-sugars can be more 
potent inhibitors of the corresponding pyrano-glycosylhydrolases32•33•34 than their 1,5-
imino (pyranose) forms. This inhibitory activity has been attributed to the similarity 
between the envelope conformation of the five-membered aza-sugar, and the proposed 
half-chair conformation of the pyranose sugar substrate in the glycosylhydrolase 
transition-state?1 For example, rhamnopyrrolidine aza-sugar DRAM (1.07) (Figure 
4), a furano-aza-sugar analogue of L-rhamnose, has been found to be a potent 
inhibitor of naringinase, an a-L-rhamnosidase/5 whereas the pyranose aza-sugar 
analogue RNJ (1.08) has very low inhibitory activity. 36 
HO 
~ ~\~ ~ 
. 
~ .. ·· ..... ~ 
~ ~ HO' DH 
(1.07) 
H 
''''''•····( N l HO~ ''"'"OH 
OH 
(1.08) 
Figure 4. DRAM (1.07), and RNJ (1.08), both potential rhamnosidase inhibitors. 
The increase in positive charge postulated at the transition-state has prompted the 
synthesis of many C-1 aza-analogues of sugars.' Such systems have, in many cases, 
been found to be good inhibitors of the corresponding glycosylhydrolase enzyme, 
further reinforcing the accepted glycosylhydrolase mechanism. 
Selectivity in enzyme inhibition may be increased by the introduction of functionality 
that mimics not only the central ring of the transition state, but also features of the 
donor/acceptor. Wong et al. 37 have synthesised an array of functionalised three-
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component aza-sugars as potential transition-state mimics of a fucosyltransferase, 
incorporating features of the donor and acceptor (Figure 5). 
~ 
OH (1.09) 
''''''•· O:N 
·:: ..• ,,,1111--0H 
HO''''''' ! OH 
OH (1.10) 
,,,,,,, 
'·· 
,,,,,,,, 
• .. 
HN~ 
: OH 
. .•• ,,,111--oH :. NH2 
(1.11) (1.12) 
Figure 5. Three-component potential fucosyltransferase inhibitors?7 
Kim et al. 38 describe the rational design, synthesis and biological testing of several 
compounds as potential inhibitors of human a-1 ,3-galactosyltransferase. The a-1 ,3-
galactosyltransferase is a retaining glycosyltransferase utilising UDP-galactose as the 
glycosyl donor (Figure 6). The mechanism is expected to proceed via an enzyme-
bound intermediate as discussed above for glycosylhydrolases. 
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OH 
HO OH 
UDP-Galactose 
Figure 6. UDP-Galactose substrate for human a-1 ,3-galactosyltransferase. 38 
Potential inhibitors designed both around the aza-sugar analogues of the galactose 
segment (Figure 7) and the UDP segment (Figure 8) were synthesised. ICso values in 
the micromolar region were obtained for these compounds. 38 
HO 
HO 
.. ,,, 
''''oH 
HO 
··,,, 
''''oH 
HO 
OH OH OH 
(1.13) (1.14) (1.15) 
Figure 7. Aza-sugar analogues of the galactose segment of a-1,3-
galactosyltransferase donor substrate.38 
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R= OH (1.16) 
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OH 
lFigure 8. UDP-segment mimics as potential glycosyltransferase inhibitors.38 
The moderate inhibitory activity of these substrates indicates that the enzyme binds to 
both the sugar and the nucleotide segment of the donor. 
1.4 Irreversible Nucleophilic Addition to !mines 
1.4.1 Imines as §ubstrates for Irreversible Nucleophillic AdditioJrn Reactions 
The structure of an imine has a great effect on its reactivity to nucleophiles.49•50 
Enolisable imines (see Figure 9), can be sensitive to basic nucleophiles, and may well 
form the aza-enolate in a competing reaction (B, Figure 9). !mines with a proton a- to 
the nitrogen may be susceptible to deprotonation, again competing with the addition 
reaction (C, Figure 9). The generally low electrophilicity of the imine carbon in such 
systems can mean these systems often favour deprotonation over addition. 
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R1H2C, 
NH Nuc 
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R2H2C H 
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Non-enolisable aldimine 
R2 = aryl/ terl alkyl 
R1H2C, 
N 
R2H2C~H 
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R1H2C, 
w 
/ R2H2CAH 
~ R1HC 'N 
R2H2C~H 
Non-enolisable ketimine 
R2 =aryl/ tert. alkyl 
R3 = aryl/ tert alkyl 
B 
c 
Figure 9. Types of imines and possible reactions with basic organometallics. 
Many methods of increasing the electrophilicity of the imine carbon are possible. N-
functionalisation can give more reactive species (Figure 1 0), such as highly reactive 
iminium ions, N-acyl iminium ions, nitrones, and N-sulfonyl imines, amongst 
others. 49•50 Although members of the general class of iminium ions are more reactive 
than their uncharged imine counterparts,49 the N-substituent may be difficult to 
remove, and their formation and conversion back into the amine can add, possibly 
unnecessary, synthetic steps. Use of Lewis acids to increase the electrophilicity of the 
azomethine carbon can also be beneficial in nucleophilic addition reactions to imines. 
'R R" Ac'-....._+ /R. /S02R' 0 
'---..+/ +N/ N N N )I )I )I )I 
R R R R 
Iminium ion Acyl iminium N-Sulfonyl Nitrone ion imine 
Figure 10. Examples of N-functionalised imines and iminiums. 
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The level of substitution of the azomethine carbon also has an effect on the reactivity 
of the imine bond towards nucleophiles. The less hindered aldimines (derived from 
an aldehyde) are, in general, more susceptible to nucleophilic attack than their 
ketimine equivalents (imines derived from a ketone), possibly due to a combination of 
lower steric hindrance and greater reactivity of the aldimine.49•50 
The problems of acidity of enolisable imines can be overcome with the use of less 
basic nucleophiles. Metals such as zinc,39•40 copper,39.41•42•43 lead,44 and cerium45.46 are 
known to form less basic organometallics than their Grignard or alkyllithium 
counterparts. Recently Hou and co-workers40 reported the addition of diethylzinc, in 
the presence of a trimethylsilyl Lewis acid, to both enolisable and non-enolisible 
aldimines. Hou observed an increased yield for non-enolisable aldimines, in 
particular those with an electron-withdrawing group present, consistent with both the 
generally poor electrophilicity of imines and side reactions associated with basic 
conditions. 
Organocerium(III) reagents were first used due to their low basicity, for the addition 
of carbon nucleophiles to enolisable aldehydes and ketones,47 but it was some years 
before they were used in addition to enolisable imines. Working independently, two 
groups began investigating the addition of organocerium reagents to enolisable 
aldimines45•46 with good results. The author knows of no examples to date of the use 
of alkylcerium reagents with enolisible ketimines. 
More recently, Oppolzer et al. 48 used organocerium(III) reagents derived from 
organolithiums and Grignard reagents in nucleophilic additions to simple five- and 
six-membered cyclic aldimines (Scheme 6, page 26). Slightly lower yields were 
obtained with organocerium reagents derived from Grignard reagents. This is in 
agreement with results observed within our group on the effect of magnesium based 
lewis acids on enolisable cyclic imines (see Chapter 2, Section 2.2). 
1.4.2 Stereochemistry of Additions to Acyclic sp2 Systems 
Nucleophilic addition to acyclic imines in the synthesis of primary and secondary 
amines is well documented, and has been reviewed in the literature.49•50 Additions to 
cyclic imine systems are less common. 
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Irreversible addition to such sp2 systems is well understood, the nucleophile 
approaching at the Biirgi-Dunitz angle of around 105°.51 Stereochemical induction in 
irreversible addition to aldehydes and ketones with an a-chiral centre has been the 
subject of much research, and can be predicted by use of Felkin-Anh52 or Cram-
chelate53 models, often giving good correlation with experimental results. 
In the case of the Felkin-Anh model, the likely stereochemical outcome of any given 
addition is determined by the steric size and orientation of the substituents adjacent to 
the carbonyl group. It is necessary to distinguish between each of the three 
substituents a- to the carbonyl in terms of their size, for example L, M, and S being 
the large, medium and small substituents respectively (Figure 11).54 The analysis 
depends on the assumption that the most sterically demanding group (L) is 
perpendicular to the plane of the carbonyl. This leads us to two possible lowest 
energy conformations, A, and B (Figure 11 ). If we further assume that A and B are of 
similar energy, i.e. that there is no stereochemical preference for the position of S and 
M relative to the carbonyl group, we can see that the course of reaction is determined 
by steric interaction with the approaching nucleophile. In Figure 11 the more reactive 
conformation is A, where the nucleophile is in closest proximity to S. 
A B 
Figure 11. Felkin-Anh analysis of irreversible addition to a carbonyl compound. 
There are notable exceptions to the Felkin-Anh model as it is described above. It has 
been observed that the presence of an electron-withdrawing group (EWG) a- to the 
carbonyl group can dictate the observed stereochemistry, giving the opposite 
stereochemistry from that expected by simple steric analysis when M is the EWG.55 
Strong EWGs (er-acceptors) can interact with the carbonyl group, lowering the energy 
of the LUMO (n*), and reducing the energy gap between the HOMO of the 
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nucleophile and the LUMO of the carbonyl, thereby favouring the addition. Such an 
interaction can only occur if the EWG lies perpendicular to the carbonyl group, and 
this leads us to two new favoured reactive conformations C, and D (Figure 12). Again 
interaction of the nucleophile, approaching from Bi.irgi-Duntiz angle, with the a-
substituents, leads us to the most reactive conformation C. 
~EWG 
Nuc-$ 
R 
c 
EWG_AK 
~Nuc· 
R 
D 
Figure 12. a* -n *-Dominated Felhin-Anh analysis of irreversible addition to a 
carbonyl compound. 
One further exception to the Felkin-Anh model as it is described above is in the case 
of systems containing a group a- to the carbonyl carbon capable of forming a cyclic 
chelate in the presence of a suitable Lewis acid. In this case the favoured reactive 
conformation of the carbonyl compound may be defmed by the chelation, rather than 
simple steric considerations, as in the case of the Felkin-Anh model, or 
stereoelectronic considerations as in the case of the a* -n *-dominated F elkin-Anh 
model. This chelation control can be accounted for by the Cram-chelate model, 53 and 
Figure 13 shows the formation of a five-membered chelate between a Lewis basic 
group (B:), a Lewis acid (LA), and the carbonyl oxygen. The stereochemistry of 
addition is predicted by consideration of the interactions between the approaching 
nucleophile and the non-chelating groups adjacent to the carbonyl group, indicating 
that in this case F is the favoured trajectory for the nucleophile. 
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Figure 13. Chelation control in addition to carbonyl compounds. 
The above considerations can easily be extended to imines with chiral centres a- to 
the azomethine carbon (derived from chiral aldehydes), and such analysis has given 
good agreement with experiment.49•56 There is also the presence of a substituent on 
nitrogen, which may have an effect on the course of the addition. Y amamoto et al. 57 
propose a further model to account for the presence of a chiral substituent at nitrogen 
(imines derived from chiral amines) (Figure 14). The model can be further extended 
to account for chelation contolled reactions (Figure 15).49 Good diasterocontrol is 
often observed in chelation-controlled addition to acyclic imines due high Lewis 
basicity of nitrogen. There are relatively few examples of nonchelation-controlled 
additions to chiral imines. 
s 
A B 
Figure 14. Stereocontrol of addition to non-chelation controlled addition to acyclic 
imines. 57 
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Figure 15. Stereocontrol of chelation controlled addition to acyclic imines.49 
In the case of imines derived from chiral amines and chiral aldehydes, double 
induction reactions are possible and matched processes can lead to excellent 
diastereoselectivities.49 
1.4.3 Stereochemistry of Additions to 6-Membered Cyclic sp2 Systems 
In irreversible additions to cyclic 6-membered sp2 systems, steric approach 
considerations must be combined with the tortional and conformational energy 
barriers associated with possible cyclic transition-states. 58 In the case of six 
membered cyclic sp2 systems, such as the example of 1,2,3,4-tetrahydropyridine 
(1.18) (Figure 16), the lowest energy conformation is that of the half-chair, as shown. 
Path b + 
Nuc-eq Path a 
* ~ > ~ A H 
v6 
Nuc o- ()"" 
(/ (1.18) Nuc 0-' / ' Nuc-.q G/ Nuc-ax ~ Path b 
Path a B o-
Figure 16. Proposed transtiton-states for addition reactions of 2,3,4,5-
tetrahydropyridine (1.18). 
Addition of a nucleophile to such an imine could occur from either above or below the 
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ring, giving two possible transition-states, which allow for the development of the 
tetrahedral sp3 centre at the azomethine carbon, and maintain orbital overlap between 
the attacking nucleophile and the developing lone pair on nitrogen. 
The chair-like transition-state (A, Figure 16) is energetically favoured over the boat-
like transition-state (B, Figure 16); therefore, addition should proceed via Path a with 
pseudo-axial attack of the nucleophile. In the case of (1.18), Path a, and Path b lead 
to enantiomers of the same product, and determining transition-state of the reaction is 
not possible by analysis of the products. The introduction of functionality to the ring 
will allow us to observe the diastereocontrol of addition to such a system, and indeed 
prediction of diastereocontrol of additions to these systems by such stereoelectronic 
analysis is often in good agreement with experimental results. 58 
In the case of the cyclic iminium (1.19) for example, Bohlman et al. 59 observed 
reduction with borohydride to occur via a Path a reaction (Figure 17). Axial attack of 
hydride via chair-like transition-state A gave (1.20) as the only diastereoisomer 
(Figure 17). 
Path a 
(1.19) § 
:\~~ 
. 1 ~R 
~eq 
Path b 
~ 
Path a 
~ 
Path b 
- R~.-t 
R R R~ 
.S+ R R 
A (1.20) 
*"~~ R H 
(1.21) 
Figure 17. Reduction of cyclic iminium (1.19) with axial attack of hydride. 59 
Steric approach constraints may also influence the course of any addition reaction to 
such a system. In the case of the cyclic piperidine iminiums (1.22), and (1.23) 
(Scheme 5), Stevens and Lee observed nucleophilic addition of hydride to (1.22) (R' 
= H, Scheme 5, NaBH3CN)60 or a Grignard reagent to (1.23) (R' = Me, Scheme 5, 
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MeMgBr)61 occurs to give a single diastereoisomer. 
R = H (1.23) 
R= Me (1.22) 
(i) 
'R 
NJ 
::;. 
n.:Su 
R = H, R' =Me (1.25) 
R =Me, R' = H (1.26) 
(i) R' = H, NaBH3CN; R' =Me, MeMgBr. 
Scheme 5. Nucleophilic additions to cyclic piperidine iminium systems (1.22) and 
(1.23).60,61 
Addition to such a system can occur to either of two half-chair conformers (conformer 
1 and conformer 2, Figure 18), leading to proposed transition-states A, B, C, and D 
(Figure 18). Preffered addition is expected to occur via chair-like transition-states A, 
or C. In the case of C, however, unfavourable steric interactions of the incoming 
nucleophile with the hydrogen atom at C-8 are thought to disfavour this approach, and 
Stevens and Lee were thus able to rationalise the observed diastereocontrol, and 
synthesise stereoselectively (+/-)-monomorine (1.26), and the epimer (1.25). 
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Figure 18. Possible nucleophilic additions of to cyclic piperidine iminium systems 
(1.23), and (1.34).60•61 
In the case of five-membered imine systems, stereochemistry of addition reactions is 
often defined by simple steric approach considerations. There are relatively few 
examples of additions to cyclic five membered imines. Oppolzer et al. 48 reported 
addition of organocerium(III) reagents to cyclic pyrrolidine imines (1.27) and (1.28) 
(Scheme 6). Excellent diastereoselectivity (up to 98 % de) was attributed to steric 
approach control defined by large alkyl substituents a- to the imine nitrogen. The 
cyclic imines were generated in-situ from acylsultam precursors, and overall yields 
were moderate to fair (48- 60 %). 
n = I, R' = C7H15 (1.27) 
n = 2, R' = CllH23 (1.28) 
(i) 
n =I; R= C7H15, R' = n-butyl (1.29) 
n = I, R = C7H15, R' = 3-butenyl (1.30) 
n = 2; R = C 11H23 , R' =Me (1.31) 
(i) R'CeCI2. 
Scheme 6. Addition of organocerium(III) reagents to cyclic pyrrolidine imines. 48 
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Horenstein et al. 62 describe the addition of Grignard reagents to a bicyclic five-
membered imine-sugar (Scheme 12, page 33). The fused cup-like structure defines 
the stereochemistry of addition, the nucleophile approaching from the least-hindered 
face. 
Bosco et al. 63 describe the addition of an organic phosphonate anion to a five-
membered cyclic imine-sugar (1.32). Only one diastereoisomer was observed 
consistent with steric approach contol defined by the substituent a- to the azomethine 
carbon (Figure 19) (see Section 1.5.3). 
BnO 
BnO OBn BnO 
(i) 
-BnO 
R 
(1.32) E 
(i) Nuc-. 
Figure 19. Steric approach control of addition to five-membered cyclic imine-sugar 
(1.32).63 
Interestingly, Ryu and Kim64 achieved organotin additions to the cyclic iminium 
(1.33) (Scheme 7), generated in-situ from the a-acetoxylactam (1.34), with steric 
control attributed to anchimeric delivery of the organometallic by the adjacent tert-
butyldimethylsilyl ether, rather than steric approach control. Excellent yields and 
diastereoselectivities were observed for allyl-, propargyl- and allenyltin reagents (up 
to 100 % de, 97 %yield). 
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Scheme 7. Stereocontrol in addition to cyclic iminium (1.33) via anchimeric delivery 
of nucleophile. 64 
1.5 Synthesis of Cyclic Imines 
1.5.1 N-Chlorination/Elimination Strategy 
Our syntheses of cyclic imine-sugars are to be performed both from existing aza-
sugars, and by synthesis from chiral pool starting materials. The conversion of 
existing aza-sugars into cyclic imine sugars can be achieved by the introduction of a 
suitable leaving group at nitrogen. Similar transformations are well known for N-
chloro compounds, which can give the corresponding imines when treated with a 
suitable base. 
Early examples of cyclic piperidine and pyrrolidine imines such as 2,3,4,5-
tetrahydropyridine (1.18) (Scheme 8) have been synthesised from the corresponding 
N-chloro derivatives.65 
Cl 
I 
o~o 
(1.35) (1.18) 
(i) KOH, EtOH. 
Scheme 8. Synthesis of a simple cyclic imine from N-chloropiperidine. 65 
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Elimination reactions of N-chloro compounds with alkoxide bases are generally 
accepted to proceed via an E2 mechanism, and products are obtained according to 
Saytzev's rule.66'67 Orbital alignment of the C-H and N-Cl bond being broken is 
required for the elimination to occur. To the best of the author's knowledge there has 
been no account of the regiochemistry of elimination of heterocyclic N-chloro 
compounds to give the corresponding cyclic imine. However, similar elimination 
reactions of cyclic haloalkanes have been studied. 68 
Alkyl halides with a /)-hydrogen are, in general, expected to react with base to give 
the olefin with a concerted E2 mechanism.68 This E2 mechanism dictates that there is 
some double bond character at the transition-state, which can be stabilised by the 
presence of alkyl substituents at the /)-position. This stabilisation generally leads to 
Saytzev-rule products, i.e. the most substituted, or most stabile product is formed. 
Studies involving cyclic haloalkanes, in particular six-membered rings, have indicated 
that the elimination occurs with an anti-periplanar C-H, C-Cl conformation. 68 
(1.37) 
Cl 
(1.36) 
Base 
(1.38) 
He 
Base 
(1.39) 
Scheme 9. Elimination reactions of menthyl chloride (1.36) and neomenthyl chloride 
(1.37). 69,70 
Investigations into the elimination reactions of menthyl chloride (1.36), and 
neomenthyl chloride (1.37) have shown the preference for anti-periplanar elimination 
of HCI to give the olefin (Scheme 9).69,7° In the case of menthyl chloride (1.36) the 
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Saytzev-rule product 3-menthene (1.38) is preffered (78 %) with loss of He and 
chloride via an E2 elimination. In the case of the neomenthyl chloride (1.37) 2-
menthene (1.39) is the sole product obtained. Again the mechanism was determined 
as E2. The formation of a conformation that allows anti-periplanar elimination of H8 , 
and chloride is possible via a ring-flip to the alternative chair form with both alkyl 
groups axial. Due to the cis-configuration of He and Cl, in neomenthyl chloride, the 
elimination of He, and chloride is not possible via an anti-periplanar conformation. 
These two systems can be directly compared to a N-chloropiperidine system where 
inversion at nitrogen can allow chlorine to adopt either configuration. 
The configurational !ability of N-chloro compounds71 •72 dictates that elimination in 
similar six-membered ring systems should give the Saytzev-rule product in situations 
where there is a choice of two axial ,8-hydrogens (A, Figure 20). We can further 
speculate that in situations where there is only one axial ,8-hydrogen available, 
elimination by loss of this axial proton will occur (B, Figure 20). This situation may 
occur if the conformation of the ring is locked so as to disfavour ring-flip to the 
alternative chair form. This is as might be expected in A and B (Figure 20) due to the 
all-equatorial configuration of ring substituents. 
Figure 20. Proposed elimination reactions of six membered N-chloro piperidines of 
locked conformation. 
By analogy to cyclic haloalkanes, the Saytzev-rule product should predominate in N-
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chlorpiperidine systems where such a ring flip is energetically more favourable. 
Swain and Thorn ton 73 postulated that the use of stronger bases in such E2 
eliminations makes the transition-state less product-like, moving the mechanism 
toward E 1 cB. Partial development of negative charge on carbon at the transition-state 
favours the formation of the less stable Hoffman-rule, or least substituted product in 
such situations. 
A functionalised sugar-imine system (1.40) has been synthesised by Horenstein et 
al. 62 from the N-chloro aza-sugar precursor. Elimination of HCl was performed with 
lithium 2,2,6,6-tetramethylpiperidide (LiTMP) at - 78 °C (Scheme 1 0). Only the 
aldimine was observed. The formation of the less stable aldimine (1.41), or Hoffman-
rule product, is as would be expected in the case of an elimination of HCl with more 
ElcB character. 
Cl 
TBDMSO I 
l{J 
>< 
TBDMSO 
(i) ~ 
~ ; 
X 
(1.40) (1.41) 
(i) Lithium tetramethyl piperidide, THF, -78°C, 30 min. 
Scheme 10. Synthesis of cyclic pyrrolidine imine (1.41). 62 
Pyrimidal inversion in chloramines is slowed due to the presence of unshared electons 
on chlorine.72 At low temperatures this inversion may be slowed or effectively halted, 
introducing a new factor, which may govern the regiochemistry of elimination. Our 
aim is to investigate elimination reactions of aza-sugars in order to develop 
methodology allowing the regioselective elimination of N-chlorinated aza-sugars. 
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1.5.2 The §taudlinger Aza-WJittig Reaction. 
Imines are conveniently synthesised by the Staudinger aza-Wittig reaction between an 
azide and carbonyl with a suitable phosphine (Scheme 11).74 The intramolecular 
Staudinger reaction has rarely been performed in the synthesis of cyclic imine-sugars, 
and two examples are given in section 1.5.3 (see Scheme 14 and Scheme 16). 
(i) 
-
§cheme 11. Imine formation via the Staudinger aza-Wittig reaction. 
The synthesis of the azido-sugars required as cyclic imine-sugar precursors will be 
approached via the introduction of azide by an SN2 displacement of a suitable leaving 
group, such as a sulfonate ester. Such azido-sugars are well known in the literature. 
1.5.3 Examples of Cyclic Imine-§ugars as Intermediates in the §ynthesis of Aza-
§ugars 
Horenstein and co-workers62 used an elaborate cyclic pyrrolidine imine-sugar (1.41) 
as a substrate for addition reactions. Excellent diastereocontrol was achieved in the 
addition of phenyl Grignard, attributed to steric approach control, in this case defined 
by the 'cup-like' shape of the bicyclic imine (Scheme 12). The imine was formed 
from the chloramine of the parent pyrrolidine, by treatment with the strong base 
lithium tetramethylpiperidide (LiTMP) (see Scheme 10, p 31 ). Further 
organometallic additions to this system have been reported in 20 - 66 % yield with the 
same observed diastereocontrol. 75•76•77 The resultant aza-sugars were designed as 
transition-state probes for protozoan nucleoside hydrolase and transferase enzymes. 
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Cl 
TBDMSO I 
l{) TBDMSO Ol ~ 
><% X 
(1.40) (1.41) (1.42) 
(i) Lithium tetramethyl piperidide, THF, -78°C, 30 min; (ii) 2 eq. PhMgBr, Et20, -78°C, 30 min. 
Scheme 12. Nucleophilic addition to cyclic pyrrolidine imine (1.40).62 
Bosco et al. 63 describe the synthesis of another pyrrolidine cyclic-sugar imine (1.43) 
as a substrate for the addition of an organic phosphonate anion (Scheme 13). The 
imine was synthesised by the hydrolysis of the trifluoroacetamide (1.44), then 
subsequent elimination of water from the cyclic hemi-aminal. Addition of lithiated 
dimethylmethylphosphate gave the adduct (1.45) in 32 % yield with only one 
diastereoisomer observed, consistent with steric approach control defined by the 
adjacent benzyloxy group. 
OBn 
(1.44) 
OH 
(i) 
(1.43) 
BnO 
(ii) 
(1.45) 
Scheme 13. Synthesis and addition to a cyclic pyrrolidine imine (1.43).63 
Martin et al. 78 describe the total synthesis of 1-deoxycastanospermine (1.46) via the 
Staudinger reaction of a polyhydroxylated azido-sugar (1.47) (Scheme 14). The imine 
(1.48) was formed with triphenylphosphine in toluene at 70 °C and reduced to the 
amine with lithium aluminium hydride and a Lewis acid, without isolation. The 
desired 8aR diasteroisomer (1.49) was obtained in a 4.4 : 1 ratio with the the 8aS 
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isomer (1.50). No discussion of the stereocontrol was given, other than the fact that 
8aS isomer was obtained as the sole product when hydrogenation of the imine was 
performed. 
OMe 
"'""')< "''")< 
0 (i) 0 (ii) 
- -
(1.47) (1.48) 
OMe 
OH 
OH l·deoxycastanospermine (1.46) 
(i) PPh3, benzene, 70 °C; (ii) LAH, TiC14, Et3N, DCM, 69% over two steps; (iii) HCI, 
THF/H20, then Hz, Pd/C, MeOH, 81%. 
BaR (1.49) 
SaS (1.50) 
Scheme 14. Synthesis of 1-deoxycastanospermine (1.46) via a Staudinger aza-Wittig 
reaction. 78 
Pearson and Hembre79 describe a synthesis of a similar fused aza-sugar as an analogue 
of the mannosidase ll inhibitor swainsonine (1.51) (Scheme 15). The intermediate 
imine (1.52) was synthesised by hydrogenolysis of the azido-ketone (1.53). 
Subsequent reduction of the imine (1.52) with sodium borohydride in methanol, 
followed by cyclisation of the alkyl chloride, gave the desired 9aR isomer (1.53). The 
imine was not purified, and no account of the diastereocontrol of reduction was given. 
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rn ~Bn rBDMS 
BnO 
(i) (ii), (iii) 
- -OTBDMS 
Cl BnO BnO 
N3 (1.53) (1.52) Cl (1.54) 
HO swainsonine (1.51) 
(i) H2, Pd(OH)2/C; (ii) NaB~, MeOH; (iii) K2C03, EtOH, 70 °C. 
Scheme 15. Synthesis of a swainsonine analogue via an intermediate cyclic imine.79 
Bruce et al. 80 describe the synthesis of a-homomannojirimycin (1.55) via 
stereoselective reduction of an intermediate cyclic imine (1.56) synthesised by an aza-
Wittig cyclisation of the azide-sugar precursor (1.57) (Scheme 16). Reduction of the 
imine function of (1.56) with lithium bore hydride gave good diasterocontrol (23 : 1, 
isolated, 48 % overall yield). The lactone was also reduced under these conditions. 
Stereochemistry of reduction was attributed to reduction of the imine predominantly 
in the bicyclic form, prior to the lactone, from the least hindered face. 
0 
[Si]O 0 
(i) 
-
(1.56) (1.55) 
(i) (Et0)3P, THF, 89 %; (ii) LiB~, THF,- 78 °C, 48% (dr 23 : 1); (iii) CF3COOH, H20, 92 %. 
Scheme 16. Synthesis of a-homomannojirimycin (1.55) via intermediate cyclic 
imine-sugar (1.56). 80 
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Wong et al. 81 describe the enzymatic synthesis of azido-sugars as cyclic imine-sugar 
precursors. The enzymatic condensation of azido-aldehyde (1.58) with 
dihydroxyacetone phosphate gave azido-sugar (1.59) (Scheme 17). Reduction of the 
azide functionality gave the sugar-amine (1.60), which was in equilibrium with the 
imine (1.61). The synthesis of the branched aza-sugar (1.62) is also described via 
addition of cyanide to intermediate cyclic imine (1.61), followed by reduction of the 
resultant cyano-sugar (1.63). No discussion of the observed stereocontrol of addition 
of cyanide was given. The observed stereocontrol is consistent with axial attack of 
cyanide on the half-chair conformer of (1.61). However, such Strecker-type reactions 
are reversible, and the product stereochemistry may be thermodynamically 
controlled. 82 The resultant branched aza-sugar (1.62) was later used in the synthesis of 
transition-state mimics by simple N-functionalisation (see Figure 5, page 15).37 
w3 
~CHO~ 
OH 
(1.58) 
,,,,,,,, 
'·· 
(1.62) 
(iv) 
(1.59) 
(ii) 
OH-
H CN OH '""''"(""{.~.,/ ~ 
Ho•'""~oH 
OH (1.63) 
OH 
OH 
(1.60) 
11 
11111''•···cc~ OH 
,,, .. · 
HO''x i OH 
OH (1.61) 
(i) Dl-IAP, rabbit muscle aldolase, pH 6.7, 25 °C, then acid phosphatase, pH 5.0, 37 °C, 78 %; (ii) H2, Pd/C, 
HCl, H20, 100 %; (iii) KCN, dioxane/H20, 77 %; ((iv) H2, Pt02, HCl, EtOH, 99%. 
Scheme 17. Synthesis of branched aza-sugar (1.62) via intermediate cyclic imine-
sugar (1.61). 81 
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1.6 Proposed Cyclic Imine Systems 
1.6.1 Model Simple Cyclic !mines 
Investigation into the synthesis and irreversible addition reactions of cyclic imines 
will start with the use of simple piperidine imines as model systems. N-Chlorination 
and elimination of HCl is expected to give the desired imines (see Section 1.5.1). 
The synthesis and evaluation of such simple piperidine systems are discussed in 
Chapter 2. 
Cl 
H I N R er~ er~ er, 
(i) "Cl+"; (ii) Base. 
Scheme 19. Proposed synthesis of simple piperidine imines. 
1.6.2 Cyclic Imine-Sugars of L-Rhamnofuranose Stereochemistry 
L-Rhamnose is a non-mammalian sugar residue that has been identified in the 
peptidoglycan region of the cell wall of certain mycobacteria, including 
Mycobacterium tuberculosis (Figure 21 ). 83 An L-rhamnopyranose unit is thought to 
be incorporated into the developing cell wall by a postulated rharnnosyltransferase 
enzyme. Selective inhibitors of such a non-mammalian biosynthetic pathway would 
present a novel therapeutic strategy for the treatment of diseases such as tuberculosis, 
and as such are a valuable synthetic target. 
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D-Galactose 
(Gal) 
Figure 21. Postulated L-rhamnose unit present in the cell wall of Mycobacterium 
tuberculosis. 83 
The furanose form of an aza-sugar can, in many cases, show higher inhibitory activity 
towards the corresponding pyrano-glycosylhydrolase (see Section 1.3) than the 
pyranose form ofthe aza-sugar.21 
The synthesis of a protected L-rhamnofuranose cyclic imine-sugar presents us with 
the possiblitiy of introduction of functionality at the C-1, pseudoanomeric position 
that mimics the shape of a proposed transition-state for the postulated L-rhamnosyl 
transferase enzyme (Figure 22). 
OH 
HO_....i._n f"-HO~O 
NHAc 
RHAMNOSYL ACCEPTOR 
- 0 'I 1 NH 
o,R/o, 11 l ..... L 
cf' r-o'to,]~ 
_OQ ~ 
OH 
Figure 22. Proposed mechanism for the postulated rhamnosyltransferase enzyme 
(Mycobacterim tuberculosis). 
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Chapter 3 discusses the synthesis and nucleophilic addition reactions of such 
rhamnofuranose cyclic imine-sugars via a Staudinger aza-Wittig reaction. 
1.6.3 Cyclic Imine-Sugars of DNJ (D-Glucopyranose) and DINJ (L-Idopyranose) 
Stereochemistry 
DNJ (1.03) (Figure 23) is a potent inhibitor of several glucose processing enzymes 
(see Section 1.1). N-Butyl DNJ (1.64) (Zavesca) (Figure 23) is a potent inhibitor of 
glucosylceramide synthase, and is approved for the treatement of Gaucher's disease, a 
glycolipid-storage disorder. 84 The introduction of hydrophobic functionality can 
increase the activity and improve the bioavailability of such systems. 8 The late stage 
introduction of functionality at the 1- and 5- positions of DNJ, as may be achieved by 
addition to 1-N, or 5-N dehydro derivatives, would therefore be of high potential 
utility in the generation of libraries of potentially biologically active compounds 
(Scheme 20). 
1-Deoxyidonojirimycin (DINJ) (1.65), an L-idose analogue, is an isomer (C-5 epimer) 
of DNJ. It forms the central ring structure in the recently isolated natural product 
adenophorine (1.66) (Figure 23),85 and as such is an interesting target skeleton. The 
use of systems with DINJ stereochemistry also allows a direct comparison of the 
effect of the C-5 stereochemistry on the regiochemistry of elimination of their N-
chloro derivatives. 
OH OH 
I 
'lt,,,,, 
'·. 
OH 
I ,,,,,,, 
'·. 
OH 
I ,,,,,,, 
'·· 
... ,, 
'''
1oH 
OH OH OH 
(1.03) (1.64) (1.65) (1.66) 
Figure 23. DNJ (1.03), N-butyl-DNJ (1.64), DINJ (1.65) and the natural product 
adenophorine (1.66). 
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[P]O (i) [P]O 
-... 
'''''to[PJ 
O[P] O[P] 
R 
[P]O [P]O (i) 
-
,,,.· .. ,,, 
[PJO'''' '''1o[PJ 
,\, .. 
[PJO'''' 
O[P] O[P] 
(i)RM. 
Scheme 20. Proposed late-stage introduction of functionality to DNJ and INJ aza-
sugar systems. 
Chapter 4 discusses the synthesis of cyclic imine sugars of DNJ CD-glucopyranose), 
and DINJ (L-idopyranose) stereochemistry by both Staudinger aza-Wittig 
methodology, and N-chlorination/elimination reactions. 
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Chapter 2. Synthesis and :Evaluation of Simple Cyclic limi:nes as 
Substrates for Addition Reactions 
In this chapter we discuss the synthesis, isolation, and nucleophilic addition reactions 
of simple cyclic piperidine imines. These systems are intended to model the cyclic 
imine sugars we will discuss in Chapters 3 and 4. Simple pyrrolidine imines were not 
studied due to time constraints and their reported low stability. 86 
2,3,4,5-Tetrahydropyridine (.Ll1piperideine) (2.01),87 and 6-methyl-2,3,4,5-
tetrahydropyridine (2-methyl-.Ll1piperideine) (2.02)88 are proposed as model cyclic 
imine systems. The syntheses have been based upon the N-chlorination of simple 
piperidines, followed by elimination of HCl to give the desired imine. Scheme 20 
shows a simple retrosynthetic analysis revealing piperidine (2.03) and 2-
methylpiperidine (2.04) as readily available starting materials. 
Cl 
I H 
u~u~u· 
(2.01) R = H 
(2.02) R=Me 
(2.03) R = H 
(2.04) R=Me 
Scheme 20. Retrosynthetic analysis of simple piperidine imines (2.01), and (2.02). 
Following the successful synthesis and isolation of imines (2.01), and (2.02), we will 
investigate their irreversible addition reactions with organometallic reagents. 
N R cr-(i) 
(2.01) R = H 
(2.02) R= Me 
(i)R'M. 
Scheme 21. Proposed addition reactions of imines (2.01), and (2.02). 
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The work in this chapter is divided into two main sections: 
2.1 Synthesis of Simple Cyclic Imines 
2.2 Nucleophilic Addition to Simple Cyclic Imines 
2.1 Synthesis of Simple Cyclic lmines 
2.1.1 N-Chlorination of Piperidines 
Aqueous sodium hypochlorite has been used for N-chlorination of such piperidines. 
However, our requirement for anhydrous conditions prompted us to use a different 
chlorinating agent. N-chlorosuccinimide (NCS) was chosen as the chlorinating agent 
in forming the chloramines, as it is a convenient, solid source of electophilic chlorine. 
Formation of the desired chloramines (2.05), and (2.06) from the relevant piperidines 
proceeded smoothly in diethyl ether, following the procedure of Grundon and 
Reynolds for the chlorination of 2-butyl piperidine. 88 The use of diethyl ether as a 
solvent, however, proved quite inefficient with regards to reaction volume, due to the 
low solubility of NCS in diethyl ether. DCM was used as an alternative solvent, 
which overcame this problem. 
(i) er~ R ----
(2.03) R= H 
(2.04) R= Me 
Cl 
I ()" 
(2.05) R = H 
(2.06) R= Me 
(i) NCS, Et20, 70% for (2.05), or NCS, DCM, 75 % for (2.06). 
Scheme 22. Synthesis of imine precursors N-chloropiperidine (2.05) and N-chloro-2-
methylpiperidine (2.06). 
N-Chloro derivatives (2.05) and (2.06) were isolated as colourless oils by vacuum 
distillation in up to 70 % and 75 % yields, respectively (Scheme 22). N-
Chloropiperidine (2.05) was found to be fairly stable, and can be stored for periods of 
weeks under nitrogen at - 18 °C without decomposition. The corresponding N-chloro-
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2-methylpiperidine (2.06) is unstable and decomposes at- 18 °C under nitrogen in the 
dark over a period of days. 
2.1.2 Elimination Reactions of N-Chloropiperidines 
Synthesis of simple imine 2,3,4,5-tetrahydropyridine (2.01) was attempted by the 
treatment of N-chloropiperidine (2.05) with ethanolic potassium hydroxide followed 
by aqueous acid extraction then basification and re-extraction into diethyl ether, 
similar to a reported synthesis of the same compound. 65 Conversion of the starting 
material was observed by TLC, but formation of a further product was also observed. 
This was isolated as an off-white crystalline material in low yield. NMR analysis of 
the product suggested it may be a mixture of isomers of the trimerised 1mme, 
tripiperideine (2.07) (Figure 24). 87 
Attempts made to isolate imine (2.01) were largely unsuccessful. Continuous 
extraction of a basic aqueous solution of imine with both diethyl ether and THF, even 
over periods of days, resulted in negligible yields after drying and concentrating the 
solutions. The imine was observable by 1H-NMR (CDCh, s, br, 7.8 ppm). However, 
the imine proton was observed to reduce in intensity over a period of hours, 
apparently forming the trimer (2.07). 
Figure 24. Two possible isomers oftripiperideine (2.07). 
Whether the low yields were due to the inefficiency of the described continuous 
extraction methodology, or the formation of tripiperideine, is unclear. The 
investigation was, therefore, moved to the synthesis of the 2-methyl-L11piperideine 
(2.02) system, which should show less tendency to trimerise due to the unfavourable 
steric interactions ofthe azomethine substituent in the trimer. 56 
The elimination of HCl from N-chloro-2-methylpiperidine (2.06) was attempted, as 
for (2.05) above. Again continuous extraction over a period of days gave 
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disappointing results, much of the imine formed remained in the aqueous layer (TLC), 
and problems were encountered removing the solvent by distillation - no distinct 
fraction was obtained as the imine azeotroped with diethyl ether. 
Due to the need for the imine to be dry and free from protic solvents, and the 
difficulties encountered in isolation, the organic bases lithium diisopropylamide 
(LDA) and 1,8,diazabicyclo[5.4.0]undec-7-ene (DBU) were chosen as alternatives, 
and the reactions performed in dry THF. 
It was anticipated that the elimination of HCl from chloramine (2.06) should form the 
most-substituted ketimine (2.02), rather than the aldimine (2.08) (Scheme 23). N-
Chloro compounds are expected to give the most stable, most substituted imine when 
treated with base (see Chapter 1, Section 1.5.1). 
Cl 
I 
(NYcH3<i) 
V ~ 
(2.06) (2.02) (2.08) 
(i) Base. 
Scheme 23. Possible formation of cyclic imines from N-chloro-2-methylpiperidine 
(2.06). 
Treatment of N-chloro-2-methylpiperidine with LDA (1.1 eq.) at room temperature in 
THF gave a distinct change by TLC, but streaking of the products made ascertaining 
the extent of reaction difficult. A sample of the reaction mixture was concentrated. 
Crude NMR studies showed the presence of 2-methylpiperidine (2.04), and 
chloramine starting material (2.06), in the reaction mixture. The presence of the 
piperidine starting material suggests a possible metal-halogen exchange occurring 
instead of the desired elimination; no evidence of the desired imine was observed. 
Treatment of chloramine (2.06) with DBU (1.1 eq) at room temperature in THF 
showed rapid consumption of starting material. A precipitate was observed to form, 
which could be isolated by filtration and was found to be the DBU hydrochloride salt. 
The product was found to azeotrope with THF, and the resultant THF solution was 
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analysed by GCMS, giving a single peak corresponding to the desired product (El+, 
rnlz 97, [M]l. 
In an attempt to isolate imine (2.02) the elimination reaction was performed in DCM 
with DBU (1.3 eq.). The product was purified by distillation, and could be isolated in 
77 % yield from 2-methylpiperidine (2.04) with no problems associated with 
azeotropes, which had been encountered with THF. Analysis of the product revealed 
exclusive formation of the expected 6-methyl-2,3,4,5-tetrahydropyridine (2.02) 
(Scheme 24). 
(~Y ("Y V (i) 0 
(2.04) (2.02) 
(i) NCS, DCM, then DBU, DCM, 77% over two steps. 
Scheme 24. Formation ofketimine (2.02). 
2.2 Nucleophilic Addition to Simple Cyclic Imines. 
Initially, two types of nucleophilic addition reactions were used, Type A, and Type B. 
In a Type A reaction, the simple cyclic imine was synthesised from the chloramine, 
using DBU as a base to eliminate HCl, and was not isolated from THF solution. The 
HCl salt of DBU precipitated and was removed by filtration. Organometallic reagents 
were added to the resultant imine solution, assuming 1 00 % conversion of the 
chloramine to the imine (Scheme 25). 
Cl 
l R ~ R (··y (i) etR· V --------
R = H (2.05) 
R =Me (2.06) 
(i) DBU, THF, filter, then R'M, THF. 
Scheme 25. Proposed Type A addition to simple imines. 
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In an attempt to reduce trimerisation, in the case of cyclic aldimine (2.01), and the 
effects of residual base, a second method of forming the imine was employed. Excess 
of the organometallic reagent was added directly to the chloramine in an attempt to 
form the imine in-situ. This in-situ formation of the imine was termed a Type B 
addition (Scheme 26). 
Cl 
I H R 
()" __ (il __ ~ et· 
R= H (2.05) 
R=Me (2.06) 
(i)R'M. 
Scheme 26. Proposed Type B addition to simple cylic imines. 
Screening of 2-methyl-~ 1piperideine with Type A reactions of alkyllithium and 
Grignard reagents (MeLi, n-BuLi, TMSCH2Li, MeMgBr, EtMgBr and BnMgCl) was 
performed. Crude 1H-NMR studies generally indicated the reaction had not followed 
the desired course and the expected methyl singlet at 8- 1.0 ppm due to addition 
products was not seen in the crude reaction mixture, in fact the methyl peak generally 
stayed as a singlet and moved up from 8 = 1.8 ppm to 1.9 ppm. Both this, and the 
appearance of another multiplet peak at 8 = 5.6 ppm indicated the presence of an 
unsaturated compound, consistent with enamine formation through base catalysed 
tautomerisation (Scheme 27). 
o-1 ppm 
(2.02) 
(i)RM. 
(fm 
Scheme 27. Proposed base-catalysed tautomerisation ofketimine (2.02). 
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Purification of the products from Type A reactions of simple imines (2.01 ), and (2.02) 
was attempted initially by column chromatography. However this was not successful 
due to lack of separation and the large numbers of products formed. The presence of 
free amines would hamper attempts to separate by chromatography, and therefore in 
some cases an excess acetylating mixture of acetic anhydride and pyridine was added 
to completed reactions to form the corresponding amides. Column chromatography 
of these gave no isolable products. The final method of purification attempted was 
vacuum distillation. However this is difficult to achieve efficiently on the relatively 
small scales used, and with the large number of compounds formed. 
Simple nucleophilic addition was not observed for ketimine (2.02) with any Grignard 
or alkyllithium employed under Type A conditions. GCMS and 1H-NMR analysis 
indicated that aldol-type dimerisation and trimerisation reactions were occurring. 
The proposed mechanism for the dimerisation of ketimine (2.02) with such basic 
nucleophiles is shown in Scheme 28 below, for the reaction with TMSCH2Li, 
followed by per-acetylation of the reaction mixture to aid purification. 
The presence of the condensation product of this reaction was established by a 
combination of GCMS and 1H-NMR data. This product, although not isolated from 
the reaction mixture, is very similar to condensation products observed later for 
additions using dialkylmagnesium reagents (Scheme 29, page 48). 
B~ B~ 
H H 
mlz= 278.4 
-
Scheme 28. Proposed dimerisation ofketimine (2.02) with TMSCH2Li. 
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Treatment of ketimine (2.02) with Grignard reagents invariably led to intractable 
mixtures of many products. This was attributed to the high basicity of the Grignard 
reagent RMgX. The organomagnesium halide is in equilibrium with, amongst other 
components, the magnesium halide and a diorganomagnesium species, which are 
known to be less basic than the Grignards.89 This equilibrium is known as the 
Schlenk equilibrium, and a simplified version is shown in Equation 3 below. 
Addition of dioxane to diethyl ether or THF solutions of Grignard reagents causes the 
magnesium halide/dioxane complex to precipitate, forcing the equilibrium infavour of 
diorganomagnesium R2Mg. 89 
1 ,4-dioxane 
2RMgX R2Mg + MgX2 ~ MgX2.dioxane t 
Equation 3. The Schlenk equilibrium is displaced by the presence of dioxane. 
Methyl, ethyl, phenyl, and benzyl Grignard, in the presence of 1,4-dioxane (1.1 eq.) 
were used. Solutions of (2.02), isolated by distillation, were added slowly to the 
freshly prepared dialkylmagnesium solutions in diethyl ether solution at room 
temperature. In all cases the imine (2.02) dimerised (Scheme 29 below). 
Where 1.1 eq. of Grignard reagent were used, between 50 and 60 % formation of 
dimer was consistently observed throughout the range of Grignards. Where an excess 
of Grignard reagent (1.5 eq.) was used with 1 ,4-dioxane (1.1 eq.), varying quantities 
of condensation products were observed, depending on the Grignard reagent. 
(NY 0 _ Ol 
(2.02) 
(f 
(2.09) (2.10) 
(i) BnMgCI, 1,4-dioxane, Et20, 39 %of (2.09) (7 % isolated), 52 %of (2.10). 
Scheme 29. Addition to ketimine (2.02). 
Only in the case of benzyl Grignard was any addition addition product seen, both with 
1.1 eq. and 1.5 eq. of the reagent (Scheme 29). In the case of addition of 1.5 eq. of 
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BnMgCl with 1.1 eq. 1 ,4-dioxane, the mass recovery was good, being a mixture of 3 9 
%benzyl adduct (2.09), and 52% dimer (2.10) as determined by 1H-NMR and GCMS 
analysis. The adduct was purified by flash chromatography. 
Further investigation was made into the effect of such magnesium reagents on 
ketimine (2.02). It was found that similar condensation was observed for the 
treatment of (2.02) with magnesium bromide.dioxane complex in diethyl ether 
(Scheme 30). This indicates that, in this system, it is the Lewis acidity of magnesium 
that causes the dimerisation. This observation is supported by the formation of the 
dimer with the use of organocerium(Ill) reagents derived from Grignard reagents, as 
opposed to those derived from organolithium reagents, as described below. 
Br~ 
(2.02) (2.10) 
§cJIJ.eme 30. Formation of dimer (2.10) ofketimine (2.03) with magnesium bromide. 
In the absence of problems associated with Lewis acidity, the use of less basic 
organometallic reagents should reduce enolisation as a side reaction. 
Organocerium(III) reagents, made by transmetallation from Grignard or organo-
lithium reagents,90 were chosen due to their success in additions to enolisable acyclic 
and cyclic aldimines.45'46 
Use of organocerium(III) reagents derived from Grignard reagents led to dimerisation 
to give (2.10), similar to that observed for reactions performed with Grignards in the 
presence of 1 ,4-dioxane (see above). The transmetallation reaction of cerium(III) 
chloride in the presence of a Grignard reagent should yield a solution of the 
organocerium(III) reagent with a suspension of magnesium halide.90 Again, this 
magnesium halide is likely to be the cause of the dimerisation observed in this case. 
The use of methylcerium(Ill) dichloride, derived from methyllithium, for 12 h at 
ambient temperature gave very pure recovered starting material in low yield after 
aqueous work-up.91 This result suggests that the organometallic is less basic, or less 
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Lewis acidic, but may also be less nucleophilic than the alkyllithium from which it is 
derived. The reaction may require longer, or the use of a Lewis acid to activate the 
C=N double bond. 
Aldimine (2.01) has been reported to undergo nucleophilic addition of certain 
alkyllithium reagents.92 Our investigations confirmed this with n-butyllithium, in a 
direct Type B reaction of N-chloropiperidine (2.05) with n-butyllithium, giving both 
addition and condensation products isolated by distillation (Scheme 31 ). 
GCMS analysis of the product fractions obtained indicated that 2-n-butylpiperidine 
(2.11) had been formed (lower boiling point), together with dimer products (higher 
boiling point fraction) similar to that shown above (Scheme 29 above) with one 
notable exception: not only was the simple dimer (2.12) formed (mle = 168), but the 
dimer butyl adduct (2.13) (m/e = 224). The proposed reaction scheme is shown below 
(Scheme 31 ). 
Cl 
I 
ON 
(2.05) 
[ 
N l / (2.12) 
___;___;..,.. 0 dim":";'" H ""' I 6i 
~ N n-Bu 
(i) 
(i) n-BuLi 
Addition a 
(2.11) 
m/z 141 
Addition 
-
(2.13) 
mlz224 
Scheme 31. Type B reaction of N-chloropiperidine (2.05) with n-butyllithium. 
The addition of butyllithium to the dimer (2.12) suggests that the absence of any 2-
substituent on the imine makes the azomethine carbon more susceptible to 
nucleophilic attack, as might be expected due to simple steric effects. 
The range of alkyl and aryl organometallics was chosen for their availability, 
simplicity and relevance to the future work of this project. The trimethylsilyl group 
introduced by TMSCH2Li could, for example be cleaved oxidatively to introduce a 
hydroxyl group.93 This is similar to the use of methoxymethylmethyllithium 
(MOMCH2Li) to introduce oxygen functionality into furanose ring systems.94 
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2.3 Summary and conclusions. 
The simple cyclic imine systems studied in this chapter were intended to model the 
proposed use of functionalised cyclic imine-sugars as intermediates in the synthesis of 
functionalised aza-sugars (see Chapters 3 and 4). The methodology for the formation 
of N-chloro-compounds, and the successful use of DBU in the formation of cyclic 
imines, is transferable to the sugar systems (see Chapter 4, Section 4.3, and Section 
4.5). Isolation of the imines by vacuum distillation, however, will not be possible for 
the higher molecular weight sugar-imines. 
Addition reactions to the simple imines studied were largely unsuccessful, due to the 
tendency for dimerisation, and the low reactivity to nucleophiles. The reactions of the 
simple imines have, in general been uncontrolled and have in many cases give 
intractable mixtures of many products, probably oligomeric or polymeric aldol-like 
products. These simple imines themselves are not activated by the electron-
withdrawing effect of oxygen ring functionality, as we might expect for cyclic imine-
sugars, and enolisation of such systems will also no doubt be affected by substituents 
adjacent to the azomethine carbon. The methodology developed in this chapter does 
not present a convenient synthesis of 2- and 6- functionalised simple piperidines. 
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2.4 Experimental Section 
N-Chloropiperidine (2.06) (Ref 87): 
Cl 
I 
0 
NCS (1.1 eq., 55.8 mmol, 7.57 g) was stirred in dry diethyl ether (250 mL) under 
nitrogen. Piperidine (2.03) (1 eq., 50.4 mmol, 4.31 g, 5.0 mL) was added, and the 
reaction followed by TLC. After 4.5 h, TLC revealed complete conversion of starting 
material to a single product. The reaction was washed with water (3 x 50 mL) and the 
organic layer retained and concentrated in vacuo. The resultant colourless oil was 
purified by vacuum distillation, giving N-chloropiperidine (2.05) as a colourless liquid 
(4.25g, 70 %): bp 64 °C at 61 mb (lit. 87 62-64 °C at 41 mmHg/62 mb); Vmax (film)/cm· 
1 2941, 2850, 2830 cm"1 (aliphatic C-H stretch); ~ (CDCh, 300 MHz) 1.39 (br, s, 
2H), 1.63 (br, s, 4H), 2.6- 3.6 (br, 4H); ~ (CDCh, 125.7 MHz), 22.9 (C-4), 27.5 (C-
3, C-5), 63.8 (C-2, C-6). 
N-Chloro-2-methylpiperidine (2.06): 
Cl 
I 
C) 
NCS (1.1 eq., 55.5 mmol, 7.50 g) was stirred with dry diethyl ether (250 mL), under 
nitrogen. 2-Methylpiperidine (2.04) (1.0 eq., 51.1 mmol, 5.06 g, 6.0 mL) was added 
and the reaction followed by TLC. After 20 h TLC showed complete consumption of 
starting material and formation of a new product. The reaction mixture was washed 
with water (3 x 50 mL) and the organic layer dried (MgS04), and concentrated in 
vacuo. The resultant yellow oil was distilled at reduced pressure to give N-chloro-2-
methylpiperidine (5.09 g, 75 %) as a pale yellow oil; bp 74-79 oc at 62 mb; Vmax 
(film)/cm-1: 2986, 2967, 2937, 2854, 2832 (aliphatic C-H stretch); ~ (CDCh, 250 
MHz), 1.22 (d, 1H, CH3), 1.35 (m, br, 2H, CH2), 1.65 (m, 4H, CH2), 2.69 (s, br, lH, 
H-6), 2.9 (m, br, 1H, H-6'), 3.50 (m, lH, H-2); ~ (CDCh, 62.9 MHz, DEPT) 21.6 (q, 
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CH3), 23.9 (t, CH2) 27.7, 35.3, 64.3 (3 x t, br, 3 x CH2), 66.4 (d, br, C-2). 
6-Methyl-2,3,4,5-tetrahydropyridine (2.02) (Ref 88): 
NCS (1.1 eq., 55.5 mmol, 7.50 g) was stirred with dry DCM (150 mL), under 
nitrogen. 2-Methylpiperidine (2.04) (1.0 eq., 51.1 mmol, 5.06 g, 6.0 mL) was added 
and the reaction followed by TLC. After 20 h TLC showed complete consumption of 
starting material and formation of a new product. The reaction mixture was washed 
with water (4 x 50 mL). The aqueous layer was washed with DCM (2 x 50 mL) and 
the organic extracts combined dried (MgS04), and concentrated in vacuo. The 
resultant yellow oil (5.81 g) was dissolved in dry DCM (150 mL) under nitrogen. 
DBU (1.3 eq., 55.7 mmol, 8.50 g, 8.34 mL) was added with stirring. After 6.5 hours 
the solvent was removed and the residue distilled at reduced pressure yielding 6-
methyl-2,3,4,5-tetrahydropyridine (2.02) (3.8 g, 77 %) as a colourless oil: (bp= 57 °C 
at 76 mb (lit.,88 78 oc at 222 Torr (295 mbar); mlz 99 (El, GCMS, 273 seconds, 
[M+Ht, 60 %, THF); Vmax (film)/cm"1: 1664 (C=N stretch), 2987, 2932, 2852 
(aliphatic C-H stretch); ~ (CDCh, 500 MHz, COSY, gHSQC) 1.50 (m, 2H), 1.58 (m, 
2H), 1.82 (s, br, 3H, H-9, CH3), 2.04 (t, br, 2H, H-1,2, H-5, H-5'), 3.44 (s, br, 2H, H-
2, H-2'); ~ (CDCh, 125.7 MHz, DEPT, gHSQC), 19.8 (t, C-3), 21.8 (t, C-4), 27.7 (q, 
CH3), 30.4 (t, C-5), 49.4 (t, C-2), 168.2 (s, C-6). 
2-Benzyl-2-methylpiperidine (2.09): 
6-Methyl-2,3,4,5-tetrahydropyridine (2.02) (1.0 eq., 1.86 mmol, 0.204 mL) in dry 
diethyl ether (10 mL), was added by cannular (nitrogen pressure) to a solution of 
benzylmagnesium chloride (1.1 eq., 2.02 mmol, 2.02 mL, 1 M solution in diethyl 
ether), dry 1,4-dioxane (1.1 eq., 2.02 mmol, 0.172 mL), and dry diethyl ether (2.8 
mL). The mixture was stirred under nitrogen for 4.5 hours before quenching with 
methanol (1 mL). The reaction mixture was diluted with diethyl ether (20 mL), and 
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washed with HCl (3 M, aq., 2 x 20 mL). The aqueous layers were combined and 
basified with NaOH (3 M, aq.) to pH 13. The resultant cloudy solution was extracted 
with DCM (2 x 30 mL), and the organic layers combined, dried (Na2S04), filtered and 
the solvent removed to yield a pale orange oil (191 mg) containing 39% 2-benzyl-2-
methylpiperidine (2.09) (1H-NMR integration). The mixture was purified by column 
chromatography (5 : 95 - 1 : 9, methanol : CHCh, eluent) giving 2-benzyl-2-methyl 
piperidine (2.09) as an orange oil (19 mg, 7% isolated): mlz 190 (ES, [M+Ht, 100%, 
MeOH); Vmax (film)/cm-1: 2861, 2930 (aliphatic C-H stretch), 3027, 3062, 3090, 
(aromatic C-H stretch), 3305 (br, N-H stretch); 4r (CDCh, 500 MHz, gHSQC) 0.95 
(s, 3H, Cfu), 1.3 - 1.6 (m, 6H, 3 x C.fu), 2.57 (d, 1H, 1 of C.fuPh, JHH 12.9 Hz), 2.70 
(m, lH, H-6), 2.77 (d, 1H, 1 of C.fuPh, JHH 12.9 Hz), 2.86 (ddd, H-6', h,6· 12.7, JHH 
4.28 Hz, JHH 5.86 Hz), 7.10- 7.22 (m, 5H, aromatic CH); &:; (CDCh, 125.7 MHz, 
DEPT, gHSQC) 24.7 (q, br, CH3), 20.7, 26.3, 36.7, 41.3 (4 x t, C-3, C-4, C-5, C-6), 
46.5 (t, br, CH2Ph) 52.2 (s, C-2), 126.1, 128.0, 130.6 (3 x d, 3 x aromatic CH), 138.0 
(s, quartemary aromatic); HRMS found 190.1601 (C13H2oN ([M+Ht) requires 
190.1596). 
Type A nucleophilic addition to (4.02) (typical): 
To a stirred solution of 6-methyl-2,3,4,5-tetrahydropyridine (4.02) in dry THF under 
nitrogen was added a solution of the required organometallic (2 eq.) over 5 - 15 
minutes. The reaction was followed by TLC (1 : 9 : 90, triethylamine : methanol : 
CHCh eluent) and the consumption of starting imine observed. Upon completion the 
reaction mixture was either acetylated (a) or an aqueous work-up employed (b). 
(a) Acetylation: An excess of acetic anhydride : pyridine (1 : 1) was added carefully 
to the reaction mixture. The resultant slurry was stirred for 1 h before washing with 
dilute HCl (0.1 M, aq.). The organic layer was separated and dried (MgS04), then 
concentrated. The resultant mixture was subjected to 1H-NMR analysis then column 
chromatography, gas chromatography, GCMS analysis, distillation or a combination 
of these techniques. 
(b) Aqueous work-up: The reaction mixture was quenched cautiously with water, 
diluted (diethyl ether), acidified (HCl, aq.) to pH 1, and the aqueous phase retained. 
The aqueous phase was basified (pH 13) and washed with diethyl ether. The organic 
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phases were combined, dried (Na2S04), and the solvent removed. The resultant 
mixture was subjected to 1H-NMR analysis then column chromatography, gas 
chromatography, GCMS analysis, distillation or a combination of these techniques. 
Type B elimination then addition to (2.01) and (2.02), (typical): 
To a stirred solution of an N-chloropiperidine ((2.01) or (2.02)) in dry THF under 
nitrogen, a solution of the relevant organometallic (3 eq.) was added over 10 - 15 
minutes. The solution was stirred and the reactions analysed by tlc. When complete, 
the reaction mixtures were subjected to the same analyses and work-up procedures as 
described above ((a) or (b)). 
Reaction of cyclic imines with organocerium reagents (general): 
Anhydrous cerium(III) chloride (1.1 eq. approx. 0.2 mmol) was stirred in dry diethyl 
ether (15 mL) under nitrogen. A solution ofGrignard reagent was added (1.1 eq., 1-3 
M in diethyl ether) with stirring. The suspension was stirred under nitrogen for 2.5 h 
before adding the imine reagent (1.0 eq.). The mixture was stirred for 16 h before 
diluting with diethyl ether (20 mL), and washing with sodium hydroxide (aq., 3 M, 2 
x 20 mL). The organic layer was washed with HCl (aq., 3 M, 2 x 20 mL) and the 
aqeous extracts adjusted to pH 13 with sodium hydroxide (aq., 3 M). The resultant 
suspension was extracted with DCM (3 x 20 mL), dried (Na2S03), filtered and the 
solvent removed in vacuo. 
Reactions of cyclic imines with diorganomagnesium reagents (general): 
A solution of the cyclic imine (1.0 eq., approx 2 mmol) in dry diethyl ether (1 0 mL), 
was added by cannular (nitrogen pressure) to a solution of Grignard reagent (1.1 eq., 
1-3 M solution in diethyl ether), dry 1,4-dioxane (1.1 eq.), and dry diethyl ether (2.8 
mL). The mixture was stirred under nitrogen for 4.5 hours before quenching with 
methanol (1 mL). The reaction mixture was diluted with diethyl ether (20 mL), and 
washed with HCl (3 M, aq., 2 x 20 mL). The aqueous layers were combined and 
basified with NaOH (3 M, aq.) to pH 13. The resultant cloudy solution was extracted 
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with DCM (2 x 30 mL), and the organic layers combined, dried (Na2S04), filtered and 
the solvent removed in vacuo. 
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Chapter 3. Synthesis and Evaluation of Rhamnopyrrolidine !mines 
as Substrates for Addition Reactions 
Our target enzyme, inspiring the synthesis of aza-sugars of rharnno-stereochemistry, 
is a postulated rhamnosyl transferase enzyme in Mycobacterium tuberculosis (see 
Chapter 1, Section 1.6.2),83 that incorporates an L-rhamnopyranose unit into the 
developing peptidoglycan region of the bacterial cell wall. Aza-sugars, sugar mimics 
with the ring oxygen replaced by nitrogen (see Introduction, Section 1.3), can be 
potent and specific inhibitors of sugar-processing enzymes. 95 
In this chapter we investigate the synthesis of cyclic imines of 1,4-dideoxy-1,4-imino-
L-rhamnitol (L-rhamnofuranose) stereochemistry (Scheme 32), synthetic precursors 
of potential rhamnose-processing enzyme inhibitors (see Chapter 1, Section 1.6.2). 
The synthesis of novel rharnnopyrrolidine aza-sugars is to be based around the 
addition of nucleophiles to such cyclic imine sugars (Scheme 32). In the case of 
cyclic aldimines, potential access to 'two-component' aza-sugars is available (Scheme 
32, R =H), where R' forms the second component). 
O[P] [PJg, 
1 ~N (-(_)<~ ,~~ R' R ..-'' . (i) .• ,,,,, 
-----~ R 
! ~ j \ ~ ~ ~ ~ [P]O' U[P) [P]O O[P] 
R = H, alkyl, aryl 
(i)W. 
R = H, alkyl, aryl 
R' = H, alkyl, aryl 
Scheme 32. Proposed nucleophilic addition to cyclic rharnnopyrrolidine imines. 
The synthesis of cyclic aldimines of the type shown above (Scheme 32) is to be 
approached from the known azido-sugar (3.01), the enantiomer of which is known. 
An intramolecular Staudinger aza-Wittig reaction 74 of the open chain aldehyde should 
afford the previously unknown cyclic imine (3.02) (Scheme 33) via the 
iminophosphorane intermediate, and elimination oftriphenyphosphine oxide. 
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'"XX'' 0 OH (') H~ '''·· I "; 
. .. ------------- ~···''''N~ 
N3 
1+'''''''o , H - s , 
5 X 
(3.01) (i) PPh3, DCM. (3.02) 
Scheme 33. Proposed formation of cyclic aldimine (3.02) via an intramolecular 
Staudinger aza-Wittig reaction. 
The 2,3-0-ispopropylidine ketal protection of the cis-diol is ideally suited to our 
strategy, being stable to the reaction conditions employed, and conveniently removed 
by acidic hydrolysis.96 A tert-butyldimethylsilyl ether is proposed to protect the free 
hydroxyl group of imine (3.02), again for the stability of such ethers to the reaction 
conditions used, and their ease of removal by acidic hydrolysis.96 This should allow 
global deprotection ofthe final aza-sugar in one synthetic step. 
Addition of suitable nucleophiles to imine (3.03) (Scheme 34) should afford the 
desired functionalised aza-sugar, with diastereoselectivity expected to be defined by 
steric approach control, often observed in such rigid bicyclic structures (see Chapter 
1, Section 1.4 ). This methodology would allow the fast, convenient synthesis of 
libraries of compounds limited only by the availability of nucleophiles. 
OH QTBDMS 
;: 
~.·•''''N~ 
.. (i), (ii) : \___) 
~+ ~ 
TBDMSQ. 
;: H 
~ \,N R 
' . 
(iii) 
I ~ X 
(3.01) (3.03) 
(i) PPh3, DCM; (ii) TBDMSOTf, py; (iii) RMgX, Et20. TBDMS =SiMe2t-Bu 
Scheme 34. Proposed formation of functionalised cyclic imine (3.03), and 
subsequent nucleophilic addition. 
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Use of a suitable hydroxymethyl anion equivalent such as, allyloxymethylmagnesium 
chloride97 or benzyloxymethylmagnesium chloride98 could also afford homologated, 
orthogonally protected aza-sugar products, allowing further functionalisation (Scheme 
34, R = CH20Bn, CH20allyl). 
In the case of addition to cyclic pyrrolidine ketimines (R :f. H, Scheme 32, above), 
access to 'three-component' aza-sugars is available. A generalised retrosynthetic 
analysis for a potential rhamnosyltransferase inhibitor is shown below (Scheme 35), 
revealing the utility of such additions, the key synthetic step being nucleophilic 
addition to an intermediate cyclic ketimine (3.05). Stereochemistry of irreversible 
addition is again expected to be defined by steric approach control. 
TBDMSO TBDMSO 
'% H R 'S 
. N :=:::=:>~~ ,,,,,N 
11111"-.,. ··' ~ O[P] 
O[P] 
.$~· ';~ .:/ '-::;. x (3.05)x 
R= 
~ ~ 0 rto 
... ,,, R'= o/i'''-o/I""-.0~-~NrNH 
~1/N[Ph ~ OH OH u 
'V'V'V'V , ... 
I ~ 0 
[P]d' 
[P]O 
Scheme 35. Retrosynthetic analysis of a target inhibitor (3.04), showing the 
application of intermediate ketimine (3.05). 
Two synthetic approaches to such cyclic ketimines are suggested, and the 
retrosyntheses are shown below. Aza-sugars formed by addition to aldimine (3.03) 
adducts (Scheme 34) could beN-chlorinated and elimination of HCl from these N-
chloro compounds under basic conditions should afford a cyclic ketimine (Scheme 
36) (cf. Chapter 2, and Chapter 4), although regiocontrol of elimination may be an 
issue (see Chapter 1, Section 1.5.1). 
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TBDMSO Cl ~ TBDMS~ I ~·=====>~· 
>< X 
Scheme 36. Retrosynthetic analysis of cyclic ketimines, via a 
chlorination/elimination method. 
A second approach to the synthesis of cyclic pyrrolidine ketimines is via the 
Staudinger aza-Wittig reaction of masked azido ketones (Scheme 37), analogous to 
that discussed for pyrrolidine aldimine (3.02) (Scheme 33). The synthesis depends 
upon the previously unknown nucleophilic addition to the known99 azido lactone 
(3.06) to give the masked azido ketone. 
TBDMSO 
)-, .. ''""y" /u 
.·.· .. Staudinger 
. , 
~ ~ 
X 
.,,,,,/, 
"o ~+ 
il 
0 
+ K 
..•• ,,,,to 
(3.06) !+ 
Scheme 37. Retrosynthetic analysis of cyclic ketimines via a Staudinger aza Wittig 
reaction of masked azido ketones. 
Scheme 38 shows the retrosynthetic analysis for the common intermediate azide-
sugar (3.01), following the work of Fleet et al. ([P] =Me). 10° Commercially available 
L-rhamnose (3.07) is a convenient chiral pool starting material. 
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OH 
HO 
(3.07) OH 
Scheme 40. Retrosynthetic analysis of azido lactol (3.01) (cf. Ref. 1 00). 
The work performed in this chapter can be separated into five main sections: 
3.1 The synthesis of 4-azido-4-deoxy-2,3-0-isopropylidene-a,,B-L-rhamnose (3.01). 
3.2 Alternative synthesis of 4-azido-4-deoxy-2,3-0-isopropylidene-a,,B-L-rhamnose 
(3.01). 
3.3 Synthesis of protected pyrrolidine aldimine (3.03) via an intramolecular 
Staudinger aza-Wittig reaction. 
3.4 Nucleophilic addition to pyrrolidine aldimine (3.03). 
3.5 Synthesis of a cyclic pyrrolidine ketimine via an intramolecular Staudinger aza-
Wittig reaction. 
3.1 The Synthesis of 4-Azido-4-Deoxy-2,3-0-Isopropylidene-L-Rhamnose (3.03) 
We have synthesised the known 4-azido-4-deoxy-2,3-0-isopropylidene-a,,B-L-
rhamnose (3.03) from L-rhamnose (3.07) by two separate synthetic routes. A known 
synthetic route (38 %, 7 steps)100 to the deprotected azido lactol (3.08) was followed 
initially (Scheme 24, page 50), anomeric protection being afforded by the robust 
methyl glycoside. 
Fischer glycosidation of L-rhamnose with methanol and acetyl chloride, as a source of 
acidic methanol, gave the a-methyl glycoside. Treatment of the methyl glycoside 
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with 2,2-dimethoxypropane and catalytic camphor-1 0-sulfonic acid (CSA) in acetone 
afforded methyl 2,3-0-isopropylidene-a-L-rhamopyranoside (3.09) in 85 % yield 
after chromatography (Scheme 41 ), according to literature methods, 100 on an 11 g 
scale. 
OH 
(i) 
HO 
.. ,,, 
''''oH 
OH 
(3.07) 
(i) AcCI, methanol, then Me2C(OMeh, CSA, acetone, 85 %over two steps. 
Scheme 41. Formation of protected rhamnose derivative (3.09). 
Oxidation of the free hydroxyl function with pyridinium chlorochromate (PCC) in 
DCM gave the intermediate ketone (Scheme 41 ), which was purified by passing 
through a silica plug, and immediately reduced with sodium borohydride in 
ethanol/water. Attack of hydride occurred, as expected, from the least hindered face to 
yield exclusively the L-talo-diastereoisomer, methyl 6-deoxy-2,3-0-isopropylidene-
a-L-talopyranoside (3.10), in 75 % yield over two steps, on an 11 g scale, according 
to the literature method. 100 
Formation of the corresponding 4-trifluoromethylsulfonate (triflate) was achieved 
with trifluoromethanesulfonic anhydride and pyridine. After aqueous work-up, the 
resultant crude sugar triflate was treated with sodium azide in DMF. SN2 
displacement of the 4-triflate group gave methyl 4-azido-4-deoxy-2,3-0-
isopropylidene-a-L-rhamnopyranoside (3.11) in 58 % yield over two steps. Side 
products with 1H-NMR signals in the olefinic region were also obtained, 
corresponding to elimination occurring as a competing process. 
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OMe """• .. CXOMo OMe (1), (il) (iii), (iv) 
I> 
HO 
··.,,,,, HO''''''··· . . •• ,,,110 ..• ,,,,,0 ~+ ~+ ~+ 
(3.09) (3.10) (3.11) 
(i) PCC, sieves, DCM; (ii) NaBH4, EtOH/H20, 75% (two steps); (iii) Tf20, Py, DCM; (iv) NaN3, DMF, 58% 
over two steps. 
Scheme 42. Synthesis of methyl 4-azido-4-deoxy-2,3-0-isopropylidene-a-L-
rhamnopyranoside. 
Hydrolysis of the methyl glycoside cannot be performed selectively in the presence of 
an isopropylidene-protected diol, 101 and it was therefore necessary to remove both 
protecting groups in one step, and then selectively reintroduce the 2,3-0-
isopropylidene group. Acid-catalysed hydrolysis of the 2,3-0-isopropylidene and the 
methyl glycoside was achieved with degassed trifluoroacetic acid (TF A) and water (1 
: 1) at 80 °C giving the fully deprotected 4-deoxy-4-azido-L-rhamnose (3.08) in up to 
84% yield. 
(i) (ii) 
OH 
(3.11) (3.08) (3.01) 
(i) TFA: water (1 : 1), 80 °C, 84 %; (ii) CuS04(anhyd.), H2S04, 94 %. 
Scheme 43. Synthesis of protected azido-sugar (3.01). 
Selective formation of the protected 4-azido-4-deoxy-2,3-0-isopropylidene-L-
rhamnose (3.01) proceeded in high yield (94 %), by treatment with acetone, copper 
(II) sulfate, and catalytic sulfuric acid over molecular sieves. An overall yield of 3 5 % 
was obtained in the synthesis of the desired azido-sugar (3.01) from L-rhamnose, 
comparing well to the 38% obtained in the literature preparation. 100 
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3.2 Alternative Synthesis of 4\-Azido-4\-Deoxy-2,3-Isopropylidlene-a,fJ-L-
Rhamnose (3.01) 
In order to synthesise larger quantities of the desired azido-lactol (3.01) a new 
synthesis was devised, which removes the need for global deprotection, then 2,3-
reprotection at the stage of cleavage of the anomeric protecting group. Orthogonality 
at this stage was introduced by the use of an allyl glycoside. Simple isomerisation 
with a suitable catalyst or strong base/02•103 followed by iodine-assisted cleavage of 
the resultant vinyl ether should allow selective cleavage of only the anomeric 
protecting group. The synthetic strategy followed that discussed in Section 3 .1. 
Fischer glycosidation to form the a-allyl glycoside was achieved in allyl alcohol, with 
catalytic cone. sulfuric acid. The crude allyl a-L-rhamnopyranoside was isolated then 
treated with 2,2-dimethoxypropane in acetone, again with catalytic cone. sulfuric acid, 
giving the known104 allyl 2,3-0-isopropylidene-a-L-rhamnopyranoside (3.12) as a 
colourless oil in 88% yield (Scheme 44). 
''XX"' 0 OH 
'''• .. 
-.,,, 
HO ~ 11110H 
(i) 
OH 
(3.07) 
Scheme 44. Synthesis of allyl 2,3-0-isopropylidene-a-L-rhamnopyranoside (3.12). 
Oxidation of the 4-hydroxyl group in allyl 2,3-0-isopropylidene-a-L-
rhamnopyranoside (3.12) was achieved with PCC in DCM, as for the analogous 
compound (3.09) (Scheme 42) and the resultant ketone purified by passing through a 
silica plug. The ketone was immediately reduced with sodium borohydride in 
ethanol/water, giving the expected L-talo-diastereoisomer (3.13) in 93 % yield over 
two steps (cf. compound (3.10), p 46). This is a marked improvement over the 
parallel 2 step synthesis of (3.10) which was achieved in only 75% yield. 
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"'"'··:ex .... OAIIyl 
,,,,,, '''''" 
HO ~+ 
(I), (ii) (iii), (iv) 
I> 
(3.12) (3.13) (3.14) 
(i) PCC, sieves, DCM; (ii) NaBH4, EtOH/H20, 93% (two steps); (iii) Tf20 Py, DCM; (iv) NaN 3, DMF, 37 %. 
Scheme 45. Synthesis of allyl 4-azido-4-deoxy-2,3-0-isopropyilidine-a-L-
rharnnopyranoside (3.14). 
Introduction of nitrogen with inversion of configuration at C-4 was achieved by 
conversion of the free 4-hydroxyl into the corresponding triflate with triflic anhydride 
and pyridine in DCM, followed by aqueous work-up. Subsequent treatment with 
sodium azide in DMF, giving the desired azide (3.14) in 37 % yield (Scheme 45). 
The low yield is attributed to competing elimination of the triflate group, and 
impurities with additional 1H-NMR signals in the olefinic region were obtained. 
Removal of the allyl glycoside proved slightly problematic. Standard102 use of 
Wilkinson's catalyst, with catalytic 1,4-diazabicyclo[2.2.2]octane (DABCO) in 
ethanol or THF gave, at best, only partial isomerisation (as judged by 1H-NMR) even 
with extended reaction times at reflux. Variation of solvent, base and temperature 
gave no reproducible results. After several attempts, the use of the method of Corey 
and Suggs, 103 employing Wilkinson's catalyst, pre-treated with n-BuLi, at reflux in 
THF, gave reliable, reproducible results. 
OH 
(i) 
•• ,,,1. 
~+ 
(3.14) (3.01) 
(i) (PPh3hRhCI, BuLi, THF, reflux, then 12, THF/water, rt, 76 %. 
Scheme 46. Cleavage of the anomeric allyl ether with Wilkinson's catalyst and n-
BuLi, and subsequent hydrolysis. 
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Pre-treatment of the Wilkinson's catalyst is thought to give the rhodium hydride 
species. The rhodium hydride species, synthesised separately, has also been found to 
isomerise allyl ethers. 102 Treatment of the intermediate vinyl glycoside with iodine in 
THF/water, gave the desired azido-sugar (3.01) in 76% yield from the allyl glycoside 
(3.14) (Scheme 46). 
3.6 Synthesis of Protected Pyrrolidine Aldimine (3.03) via an Intramolecular 
Staudinger Aza-Wittig Reaction 
Staudinger aza-Wittig reaction of the azido-sugar (3.01) with triphenylphosphine gave 
the crystalline cyclic imine (3.02) in excellent yield (96 %) (Scheme 47). The 
resultant imine was stable enough to be purified by flash column chromatography on 
silica. Protection of the free hydroxyl group was achieved in DCM with either tert-
butylchlorodimethylsilane/imidazole, or with tert-butyldimethylsilyltriflate/pyridine 
in good yield, giving protected imine (3.03) as a colourless liquid after 
chromatography (79 %, and 84 % respectively). 
~ .• N·~~. 
(i) ~ \_/ 
.. · -:. 
'" ~ &X 
(3.01) (3.02) (3.03) 
(i) PPh3, DCM (96 %); (ii) TBDMSOTf, py, DCM (84 %), or TBDMSCI, imid, DCM (79 %). 
Scheme 47. Intramolecular Staudinger reaction of azido sugar (3.01), and subsequent 
0-silylation. 
Interestingly, attempts to recrystallise the protected imine (3.03) from ethyl 
acetate/hexane gave a mixture of compounds, including the trimer of (3.15) (c.f. 
tripiperidein Chapter 2, page 43), and the monomeric imine, which could be separated 
by flash chromatography giving the trimer and monomer in 29 % and 21 % yield 
respectively (Scheme 48 below). The trimer and monomer are apparently in 
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equilibrium in ethyl acetate solution at room temperature. Attempts to recrystallise 
the pure trimer from ethyl acetate failed. However, upon purification of initially pure 
trimer by column chromatography, a proportion of monomeric imine (3.03) was 
obtained, proving the equilibrium is active. Such equilibration was not observed in 
DCM, or deuterated chloroform . 
. fTBDMS 
~ Ethyl acetate 
H 
(3.03) TBDMSOIIIu ... 
(3.15) 
Scheme 48. Reversible trimerisation of 5-0-tert-butyldimethylsilyl-l,N-dehydro-
1 ,4-dideoxy-1 ,4-imino-2,3-0-isopropylidene-L-rhamnitol (3.03). 
Trimer (3.15) was identified by mass spectroscopy (m/z 898, (ES, MeOH, [M+Ht, 50 
%), 921 ([M+Nat, 100 %). The trimer lacks a 13C-NMR signal for the C-1 
azomethine carbon, observed in (3.03) at 167 ppm. Three new major peaks at 110, 
111, and 114 ppm may correspond to the C-1 geminal amines. Both the 1H and 13C 
NMR spectra are very complex, and it is possible that it may exist in more than one 
form. The stereochemistry shown is arbitrarily based on simple molecular model 
analysis. 
Imine (3.03) was screened with a variety of commercial Grignard reagents (see 
Section 3.4, below). 
3.4 Nucleophilic Addition to Pyrrolidine Aldimine (3.03) 
Protected pyrrolidine imine (3.03) was treated with Grignard reagents in diethyl ether. 
Initially addition reactions were performed by addition of a solution of the appropriate 
Grignard (1.1 eq. in diethyl ether) to a diethyl ether solution of the imine at room 
temperature. Under these conditions an addition product was only isolated with 
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phenyl magnesium bromide (60 %yield, 37 % unreacted imine); Methyl and benzyl 
Grignard only gave unreacted starting material after 4.5 h under the same conditions. 
Using an alternative reverse addition strategy developed within our group, 105 a diethyl 
ether solution of the imine was added to the Grignard reagent (3.0 M in ether), and 
stirred at room temperature. This alternative strategy used an excess of the Grignard 
(15.0 eq.) and gave good to excellent yields of adducts (up to 100 %), with only one 
diasteroisomer observed in each the case of phenyl and ethyl Grignards. In the case 
of methyl Grignard a ratio of 69 : 2 was observed (NMR) with an overall yield of 86 
%. The major diastereoisomer (3.18) could be isolated by flash chromatography. 
Stereochemistry was consistent with steric approach control due to the 'cup-like' 
shape of the fused system, with the smaller methyl nucleophile also able to access the 
opposite face. 
TBDMSO_ 
::: H )--/''''N~R 
___ : \_j R=Ph,(3.16) (i) 
./ ·::;_ R =Et, (3.17) X R ~ Mo, (3.18) 
(3.03) 
(i) RMgBr, Et20, (R =Ph, 69 %, R =Et, 100%, R =Me, 86 %, (dr 69:2)) 
Scheme 49. Nucleophilic addition to cyclic imine (3.03). 
The stereochemistry of each adduct was established by NMR using nOesy 
experiments. The key interactions observed were as shown in Figure 25 below. 
H 
~· ~ ..... -:... X ..:- -;.: X X 
(3.16) (3.17) (3.18) 
Figure 25. Stereochemical assignment of adducts by nOesy interactions. 
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3.5 Synthesis of a Pyrrolidine Ketimine via Nucleophilic Addition to L-
Rhamnolactone (3.06) 
For the formation of azido-lactone (3.06), protected azido-sugar (3.01) was treated 
with PCC in retluxing 1 ,2-dichloroethane (DCE), giving the desired lactone (3.06) in 
up to 76% yield after chromatography (Scheme 50). The reaction was found to stop 
before completion at room temperature in DCM. 
(i) 
(3.01) (3.06) 
(i) PCC, DCE, reflux, 76 %. 
Scheme 50. Formation ofazido-lactone (3.06). 
4-Azido-4-deoxy-2,3-0-isopropylidene-L-rharnno-1 ,5-lactone (3.06) was treated with 
ethyl magnesium bromide at room temperature to form the azidocarbonyl-sugar 
(3.19), which exists as a mixture of anomers in 85 %crude yield. Azido-sugar (3.19) 
could be purified by flash chromatography, to give a single cyclic ketal anomer (17 
% ), however considerable decomposition was observed, and mixtures of several 
products with NMR signals in the olefinic region were obtained, together with the 
unanticipated spontaneous formation of cyclic ketimine (3.20), which was isolated in 
26% yield. 
The absence of a reducing agent in the mixture suggests a, thermally allowed, [3+2] 
dipolar cycloaddition, possibly catalysed by silica, followed by spontaneous loss of 
N20, thereby forming the imine. Such cycloadditions are well known for nitriles with 
azides, and are a common way of forming cyclic tetrazoles. Indeed a similar 
cycloaddition has been observed in the formation of cyclic oxatriazoles106 through a 
tandem substitution/cycloaddition reaction of 4-bromoalkyl aldehydes (Scheme 53). 
A suggested mechanism for the formation of imine (3.20) is shown in Scheme 50. 
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(i) 
(3.06) (3.19) (3.20) 
(i) EtMBr, Et20, rt; (ii) PPh3, DCM, rt, 64% from (3.06) over 2 steps. 
Scheme 49. Synthesis of pyrrolidine ketimine (3.20) from azido lactone (3.06). 
The crude addition product, when treated with triphenylphosphine in DCM at room 
temperature gave the same imine in 64 % yield from the lactone (Scheme 49), and this 
is the preferred method. 
OH 
:;; 
(3.19) 
Et 
~Et 
;: -:. 
8~ 
(3.20) 
h'N+ 
OH // 
;;: /N ) 
--\ ... ,.-".,;,: ;l 
\__/ ~Et 
.:: ~ 
X 
1~ silica 
.QH N=N 
f I \ 
~.··'''''N~O 
\__/ ·v\Et 
E ;. 8x 
Scheme 50. Proposed mechanism for the formation of cyclic imine (3.20) upon 
chromatography. 
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(i) Br~o __ _ 
(i) NaN3, solvent temperature 
Scheme 53. Synthesis of oxatriazoles from azido-aldehydes· 106 
3.6 Summary and Future Directions 
The successful synthesis of the previously unknown cyclic ketimine (3.20), and 
aldimine (3.03), via the common intermediate azido-sugar (3.01) presents us with our 
target enantiomerically pure cyclic imine sugar scaffolds as precursors to potential 
sugar-processing enzyme inhibitors. Both imines are synthesised from commercially 
available L-rhamnose in 28 % overall yield (9 steps, compound (3.03)), and 17 % 
overall yield (10 steps, compound (3.20)). 
Successful irreversible addition of carbon nucleophiles to aldimine (3.03) in excellent 
yields and diastereoselectivities presents us with the possibility of the synthesis of 
arrays of aza-sugars, with late-stage introduction of functionality at the 
pseudoanomeric position. 
The synthesis of pyrrolidine ketimine (3.20), via addition to the azido lactone (3.06) 
presents the possibility of the formation of three component aza-sugars. Protection of 
the free hydroxyl group as the tert-butyldimethylsilyl ether, followed by addition of a 
range of nucleophiles could lead to the synthesis of libraries of novel potentially 
biologically interesting compounds. 
Use of hydroxymethyl anion equivalents, such as allyloxymethylmagnesium halides 
allows the introduction of new, orthogonally protected hydroxyl functionality. 
Deprotection and biological screening of these new compounds using both 
glycosylhydrolase and transferase assays could provide insight into enzyme 
mechanism, and possibly lead to novel therapeutic target compounds. 
Reduction of cyclic ketimines with a suitable hydride source may also provide access 
to the C-1 epimers of adducts to the cyclic aldimine (3.03) as synthesised above, 
allowing the chemist to probe further the effect of stereochemistry on biological 
activity (Scheme 52). 
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(i) RMgX, Et20; (ii) LiAIH4, Et20. 
Scheme 52. Proposed synthesis of C-1 functionalised epimers with cyclic imine 
sugars as intermediates. 
The work presented above demonstates the synthetic utility of cyclic imine sugars as 
versitile intermediates in the synthesis of potential therapeutic compounds and 
mechanistic probes. 
3. 7 Experimental Section 
Methyl 2, 3-0-isopropylidene-a-L-rhamnopyranoside (3. 09) (Ref 1 09): 
Acetyl chloride (0.8 eq., 49.2 mmol, 3.86 g, 3.50 mL) was added to a solution of a-L-
rhamnose monohydrate (3.07) (1.0 eq., 62.1 mmol, 11.31 g,) in methanol (anhydrous, 
150 mL) and refluxed under nitrogen. After 45 h, TLC showed consumption of 
starting material, and formation of a major product. The reaction solution was cooled, 
neutralised with sodium bicarbonate and the solvent removed. The residue was 
dissolved in ethyl acetate, passed through a silica plug (ethyl acetate eluent), the 
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solvent removed and the residue dissolved in dry acetone (250 mL) under nitrogen. 
To the resulting solution, camphor-10-sulfonic acid (CSA) (0.2 g) and then 2,2-
dimethoxypropane ( 40 mL) were added. After 22 h, TLC showed the formation of a 
major product, and consumption of starting material. The reaction solution was 
neutralised with concentrated aqueous ammonia solution, and the solvent removed. 
The residue was dissolved in CHCh (200 mL) and washed with distilled water (50 
rnL). The aqueous layer was re-extracted (2 x 50 rnL), the organic fractions 
combined, dried (MgS04), filtered and the solvent removed. The residue was purified 
by flash chromatography (1 : 3, ethyl acetate : hexane eluent) to give methyl 2,3-0-
isopropylidene-a-L-rhamnopyranoside (3.09) (11.5 g, 85 %) as a pale yellow oil: 
25.0 . 107 23 [a]0 - 12.0 (c = 1.00, H20) (Ltt., [a]0 -10.65 (c = 1.88, H20); ~ (CDCh, 500 
MHz, gCOSY) 1.30 (d, 3H, H-6, H-6', H-6", J5,6 6.4 Hz), 1.35, 1.52 (2 x s, 2 x 3H, 
(CH3)2C), 2.34 (s br, 1H, OH), 3.38 (m, 1H, H-4), 3.38 (s, 3H, OCH3), 3.63 (lH, dq, 
H-5, J4,s 0.7 Hz, Js,6 6.4 Hz), 4.06 (dd, 1H, H-3, h_3 5.8 Hz, J3,4 7.1 Hz), 4.12 (d, lH, 
H-2, h_3 5.8 Hz), 4.84 (s, lH, H-1); ~ (CDCh, 100.6 MHz, DEPT) 17.6 (q, C-6), 
26.2, 28.1 (2 X q, (CH3)2C), 55.1 (q, CH30), 65.9, 74.6, 75.9, 78.5 (4 X d, C-2, C-3, C-
4, C-5), 98.3 (d, C-1), 109.6 (s, (CH3)2C). 
Methyl 6-deoxy-2, 3-0-isopropylidene-a-L-talopyranoside (3.1 0) (Ref 1 09): 
Methyl 2,3-0-isopropylidene-a-L-rharnnopyranoside (3.09) (1.0 eq., 52.7 mmol, 11.5 
g), dried powdered molecular sieve (50.0 g) and pyridinium chlorochromate (3.7 eq., 
195 mmol, 42.0 g) were stirred in dry DCM (500 mL) under nitrogen at room 
temperature for 20 h. At this point TLC showed complete conversion of starting 
material to a single product. The reaction mixture was triturated with diethyl ether 
(500 mL), and filtered through a silica plug topped with celite (diethyl ether eluent). 
The solvent was then removed to leave crude methyl 2,3-0-isopropylidene-a-L-
rhamnopyran-4-uloside (3.21) (10.3 g): [a]0 25·9 -110 (c = 1.00, CHCh) (lit. 108 [a]0 20 
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- 107 (c = 3.5, EtOH)); mlz 271.1 (ES, MeOH, [M+MeOH+Nat, 100 %), 239.1 
([M+Nat, 23 %); Vmax (film)/cm"1: 1742 (C=O stretch), 2836, 2912, 2939, 2989 
(aliphatic C-H stretch); 41 (CDCh, 400 MHz, gCOSY, gHSQC) 1.36, 1.48 (2 x s, 2 x 
3H, (CH3)2C), 1.40 (d, 3H, H-6, H-6', H-6", 1s,6 6.8 Hz), 3.45 (s, 3H, CH30), 4.24 (q, 
1H, H-5, 15,6 6.8 Hz), 4.42 (m, 2H, H-2, H-3), 4.84 (s, 1H, H-1); 4: (CDCh, 100.6 
MHz, DEPT) 16.0 (q, C-6), 25.6, 26.9 (2 x q, (CH3)2C), 56.0 (q, CH30), 69.9, 76.0, 
78.8 (3 x d, C-2, C-3, C-4), 98.3 (d, C-1), 111.6 (s, (CH3)2C), 204.8 (s, C-4). (3.21) 
was immediately dissolved in ethanol : water (9 : 1, 600 mL) and cooled to 0 °C. 
Sodium borohydride (2.0 eq., 0.11 mmol, 4.0 g) was added and the solution stirred at 
0 °C until TLC indicated the complete consumption of starting material, and 
formation of a single product. The reaction was quenched after 2 h by careful addition 
of solid ammonium chloride with stirring until effervescence ceased. The solvent was 
removed and the residue dissolved in CHCh (350 mL), washed with distilled water (2 
x 100 mL), brine (satd., 100 mL), then the organic layer dried (MgS04), filtered and 
the solvent removed in vacuo to yield methyl 6-deoxy-2,3-0-isopropylidene-a-L-
26.0 
talopyranoside (3.10) (8.65 g, 75 % over two steps) as a pale yellow oil: [a]0 -
. 109 20 -1 37.6 (c = 2.00, CHC13) (ht. [a]0 - 38.3 (c = 2.73, CHC13); Vmax (film)/cm : 2833, 
2936, 2984 (aliphatic C-H stretch) 3547 (br, 0-H stretch); 41 (CDCh, 400 MHz, 
gCOSY) 1.31 (d, 3H, H-6, 1s,6 6.7 Hz), 1.35, 1.56 (2 x s, 2 x 3H, (CH3)2C), 2.32 (s, 
br, 1H, OH), 3.38 (s, 3H, CH30), 3.53 (d, 1H, H-4, 13,4 4.7 Hz), 3.80 (q, 1H, H-5, 1s,6 
6.7 Hz), 4.00 (d, 1H, H-2, 12,3 6.4 Hz), 4.18 (dd, 1H, H-3, 13,4 5.2 Hz, h_3 6.2 Hz,), 
4.90 (s, 1H, H-1). 4: (CDCh, 100.6 MHz, DEPT) 16.8 (q, C-6), 25.3, 25.9 (2 x s, 
(CH3)2C), 55.2 (q, CH3Q), 64.4, 66.9, 73.0, 73.3 (4 x d, C-2, C-3, C-4, C-5), 98.5 (d, 
C-1), 109.3 (s, (CH3)2C). 
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Methyl 4-azido-4-deoxy-2, 3-0-isopropylidene-a-L-rhamnopyranoside (3.11): 
Methyl 6-deoxy-2,3-0-isopropylidene-a-L-talopyranoside (3.10) (1.0 eq., 39.6 mmol, 
8.65 g) was dissolved in dry DCM (300 mL). Pyridine (3.1 eq., 121 mmol, 9.54 g, 
9.75 mL) was added and the solution stirred at -20 °C under nitrogen. 
Trifluoromethanesulfonic anhydride (1.42 eq., 56.0 mmol, 15.8 g, 9.43 mL) was 
added slowly. After 7 h TLC indicated complete conversion of starting material into 
product. The reaction mixture was diluted with DCM (1 L), washed with dilute 
hydrochloric acid (3 M, 100 mL), saturated aqueous sodium bicarbonate (200 mL), 
brine (satd., 200 mL), then the organic layer dried (MgS04), filtered and the solvent 
removed in vacuo. The residue was immediately dissolved in dry DMF (300 mL) and 
sodium azide added (1.8 eq., 71.1 mmol, 4.62 g). The reaction mixture was stirred 
vigorously under nitrogen at room temperature for 26 h. At the end of this time TLC 
indicated the complete consumption of starting material. The solvent was removed 
and the residue dissolved in DCM (500 mL). The DCM solution was washed 
consecutively with distilled water (100 mL), brine (satd., 200 mL) and dried 
(MgS04), filtered and the solvent removed in vacuo. The residue was purified by flash 
chromatography (1 : 19, ethyl acetate : hexane eluent) to yield methyl 4-azido-4-
deoxy-2,3-0-isopropylidene-a-L-rhamnopyranoside (3.11) (5.59 g, 58 % over 2 
steps) as a colourless oil: [a]n25 ·0 - 8.9 (c = 1.0, CHCh); 4I (CDCh, 500 MHz, 
gCOSY, gHSQC) 1.24 (d, 3H, H-6, H-6', H-6", J5,6 6.2 Hz), 1.31, 1.50 (2 x s, 2 x 
3H, (CH3)2C), 3.12 (dd, 1H, H-4, J3,4 8.2 Hz, J4,5 10.3 Hz), 3.31 (s, 3H, CH30), 3.47 
(dq, 1H, H-5, Js,6 6.2 Hz, J4,5 10.3 Hz), 4.03 (d, 1H, H-2, h,3 5.5 Hz), 4.09 (dd, 1H, H-
3, h,3 5.5 Hz, h,4 8.2 Hz), 4.83 (s, 1H, H-1); &:; (CDCh, 125.7 MHz, DEPT, gHSQC) 
18.0 (q, C-6), 26.2, 28.2 (2 X q, ~H3)2C), 54.9 (d, CH30), 64.2 (d, C-5), 66.7 (d, C-
4), 75.0 (d, C-2), 76.6 (d, C-3), 98.0 (d, H-1), 109.8 (s, (CH3)2Q. 
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4-Azido-4-deoxy-a,/)-L-rhamnopyranose (3.08) (Ref 99): 
Methyl 4-azido-4-deoxy-2,3-0-isopropylidene-a-L-rhamnopyranoside (3.11) (1.0 eq., 
4.93 mmol, 1.20 g) was dissolved in 1,4-dioxane (12 mL), and aqueous trifluoroacetic 
acid (50 mL, 1 : 1 v/v) slowly added. The resulting solution was degassed by purging 
with nitrogen gas for 5 minutes. The mixture was stirred under nitrogen at 80 °C for 
48 h, after which time TLC showed complete consumption of the starting material. 
The reaction mixture was cooled imd the solvent removed in vacuo. The residue was 
purified by flash chromatography (1 : 1, ethyl acetate: hexane eluent) to give 4-azido-
4-deoxy-a,,B-L-rhamnopyranose (3.08) (780 mg, 84 %) as a white crystalline solid: 
m.p. 119-120 °C (ethyl acetatelhexane); [a]0
26
.
0
- 52.2 (equlibrium) (c = 1.00, H20) 
(lit.99 [a]0
26
.
0
- 57.6 (equlibrium)(c = 1.07 in MeOH); Vmax (film)/cm-1: 2119 (azide 
stretch), 2920, 2979 (aliphatic C-H stretch), 3431 (br, 0-H stretch); m/z 212.4 (ES, 
MeOH, [M+Nat, 100 %); ~ (D-6 DMSO, 500 MHz, gCOSY, gHSQC, ' denotes 
minor anomer) 1.17 (d, 2.1H, H-6, H-6', H-6", J5,6 6.3 Hz), 1.19 (d, 0.9 H, H-6', H-
6'', H-6'", Js·,6· 6.0 Hz), 3.13 (dq, 0.3H, H-5', !s-,6· 6.0 Hz, h,s· 10.1 Hz), 3.17-3.21 
(m, 0.6H, H-2', H-4'), 3.25 (t, 0.7H, H-4, !),4 10.0 Hz, J4,s 10.0 Hz), 3.52 (H-3', 
obscured by solvent signal), 3.55-3.61 (m, 1.4H, H-2, H-5), 3.68 (ddd, 0.7H, H-3, JHH 
3.2 Hz, JHH 6.8 Hz, J3,4 10.0 Hz), 4.55 (d, 0.3H, H-1 ', J1,2 8.0 Hz), 4.80 (0.3H, d, OH', 
JH'H' 4.9 Hz), 4.85 (d, 0.7H, H-1, J1,2 3.5 Hz), 4.96 (d, 0.7H, OH, JHH 4.4 Hz), 5.18 (d, 
0.7H, OH, JHH 7.1 Hz), 5.23 (d, 0.3H, OH', JH'H' 7.3 Hz), 6.32 (d, 0.3H, OH', JH'H' 7.8 
Hz), 6.43 (d, 0.7H, OH, JHH 4.2 Hz); &:; (DMSO, 125.7 MHz, DEPT, gHSQC, ' 
denotes minor anomer) 19.56 (q, C-6'), 19.62 (q, C-6), 66.0, 72.3, 73.6 (3 x d, C-2', 
C-3', C-4'), 66.6, 66.7, 71.9 (3 x d, C-2, C-4, C-5), 70.4 (d, C-3), 70.5 (d, C-5'), 95.0 
(d, C-1 '), 95.1 (d, C-1). 
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Ally/2,3-0-isopropylidene-a-L-rhamnopyranoside (3.12) (Ref 1 10): 
L-Rhamnose monohydrate (3.07) (1.0 eq., 0.274 mol, 50.0 g), and allyl alcohol (400 
mL) were stirred under nitrogen and HzS04 added (4.0 mL, 98 %). The mixture was 
heated to reflux for 3 h, after which time TLC showed consumption of starting 
material. The reaction was cooled, and neutralised by addition of K2C03 (0.77 eq., 
0.210 mol, 29 g) with stirring. The mixture was concentrated in vacuo and the residue 
eo-evaporated with toluene (2 x 100 mL). The residue was diluted with ethyl acetate 
and then dried (MgS04), filtered, and concentrated in vacuo. The resultant crude allyl 
a-L-rhamnopyranoside was dissolved in dry acetone (300 mL), and 2,2-
dimethoxypropane (2.96 eq., 0.81 mol, 84.7 g, 100 mL) and HzS04 (4.0 mL, 98 %) 
were added. TLC showed complete consumption of starting material after 2 h, and 
the reaction was adjusted to pH ~ 7 by portion-wise addition of NH3 (aq., satd.). The 
resultant mixture was concentrated, and the residue dissolved in DCM (750 mL) then 
washed with water (3 x 500 mL). Aqueous washings were extracted with DCM (200 
mL), and all organic washings combined and dried (MgS04), filtered and 
concentrated to give an orange oil. The oil was purified by flash chromatography 
through a silica plug (3 : 7, ethyl acetate : hexane eluent) to give allyl 2,3-0-
isopropylidene-,8-L-rhamnopyranoside (3.09 g, 5.1 %), and allyl 2,3-0-
isopropylidene-a-L-rhamnopyranoside (3.12) (52.6 g, 88 %) as a colourless oil. A 
portion of allyl 2,3-0-isopropylidene-a-L-rhamnopyranoside (3.12) was purified 
further by flash chromatography on silica (1 : 3 ethyl acetate : hexane eluent) giving 
the desired product as a colourless oil: [a]0 25 ·8 - 35.0 (c = 0.50, CHCh) (lit. 110 [a]0 20 
- 35.0 (c = 1, CHCh)); m/z 267.1 (ES, MeOH, [M+Nat, 100 %), 299.1 
([M+MeOH+Nat, 3 %); Vmax (film)/cm-1: 1648 (C=C stretch), 2909, 2936, 2985 
(aliphatic C-H stretch), 3470 (br, 0-H stretch); c\i (CDCh, 400 MHz, gCOSY, 
gHSQC) 1.26 (d, 3H, H-6, H-6', H-6", 15,6 6.3 Hz), 1.32, 1.50 (2 x s, 2 x 3H, 
(CH3)2C), 3.13 (s, br, 1H, OH), 3.34 (dd, 1H, H-4, 13,4 7.3 Hz, J4,s 9.3 Hz), 3.66 (dq, 
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1H, H-5, Is,6 6.3 Hz, J4,5 9.3 Hz), 3.97 (m, 1H, 1 ofOCfuCHCH2), 4.07 (dd, 1H, H-3, 
J2,3 5.7 Hz, h,4 7.2 Hz), 4.15 (m, 2H, H-2, 1 ofOCfuCHCH2), 4.98 (s, 1H, H-1), 5.22 
(m, 2H, OCH2CHCfu), 5.87 (m, 1H, OCH2CHCH2); c\: (CDCh, 100.6 MHz, DEPT) 
17.6 (q, C-6), 26.3, 28.1 (2 X q, (CH3)2C), 66.1, 74.6, 76.0, 78.5 (4 X d, C-2, C-3, C-4, 
C-5), 68.1 (t, OCH2CHCH2), 96.4 (d, C-1), 109.7 (s, (CH3)2C), 118.0 (t, 
OCH2CHCH2), 133.7 (d, OCH2CHCH2). 
Allyl 6-deoxy-2,3-0-isopropylidene-a-L-talopyranoside (3.13) (Ref 111): 
A mixture of allyl 2,3-0-isopropylidene-a-L-rhamnopyranoside (3.12) (1.0 eq., 0.201 
mol, 49.02 g) dissolved in dry DCM, sieves (lOOg, 4A, powdered) and PCC (2.5 eq., 
0.494 mol, 106.5 g), and the mixture stirred under argon. After 18 h, TLC indicated 
complete consumption of starting material and formation of a new product. The 
mixture was triturated with diethyl ether (700 mL), and filtered through a silica plug 
topped with celite (diethyl ether eluent). The resultant solution was concentrated to 
give crude allyl 2,3-0-isopropylidene-a-L-rhamnopyran-4-uloside (3.22), a portion of 
which was purified by flash chromatography on silica (3 : 20, ethyl acetate : hexane 
eluent) giving the desired product as a colourless oil: [a] 0 26·5 - 79.1 (c = 1.00, 
CHCh) (lit. 111 optical rotation not quoted); mlz 297.1 (ES, MeOH, [M+MeOH+Na]+, 
100 %), 265.1 ([M+Nat, 10 %); Vmax (film)/cm-1: 1647 (C=C stretch), 1743 (C=O 
stretch), 2884, 2937, 2988 (aliphatic C-H stretch); 4r (CDCh, 400 MHz, gCOSY) 
1.37, 1.49 (2 x s, 2 x 3H, (CH3)2C), 1.39 (d, 3H, H-6, H-6', H-6", Is,6 6.8 Hz), 4.08 
(m, 1H, 1.37, 1 ofOCfuCHCH2), 4.24 (m, 1H, 1 ofOCfuCHCH2), 4.28 (q, 1H, H-5, 
J5,6 6.8 Hz), 4.46 (m, 2H, H-2, H-3), 5.00 (s, 1H, H-1), 5.22-5.34 (m, 2H, 
OCH2CHCfu), 5.90 (m, 1H, OCH2CHCH2); c\: (CDCh, 100.6 MHz, DEPT) 16.0 (q, 
C-6), 25.6, 26.9 (2 X q, (CH3)2C), 68.9 (t, OCH2CHCH2), 70.2, 76.1' 78.9, (3 X d, C-2, 
C-3, C-5), 96.1 (d, C-1), 111.6 (s, (CH3)2C), 118.5 (t, OCH2CHCH2), 133.1 (d, 
OCH2CHCH2), 204.8 (s, C-4); HRMS found 265.1043 (C12HisOsNa requires 
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265.1 052). The resultant oil was dissolved in ethanol : water (9 : 1 ), and cooled to 0 
°C, before careful, portion-wise addition of sodium borohydride (2.0 eq., 0.399 mol, 
15.1 g), with stirring. After 2 h stirring at 0 °C TLC showed consumption of starting 
material and formation of a new product. The reaction was stopped by careful 
(exotherrnic) portion-wise, addition of NH.tCl (s), until effervescence ceased. The 
resultant mixture was concentrated and diluted with DCM (1.25 L) and washed with 
water (2 x 250 rnL). The organic layer was dried (Na2S04), filtered and concentrated 
in vacuo to give allyl 2,3-0-isopropylidene-a-L-talopyranoside (3.13) ( 45.45 g, 93 % 
crude yield), a sample of which was purified by flash chromatography on silica (1 : 3, 
ethyl acetate : hexane eluent): [a]0 25·9 -58.1 (c = 2.00, CHCl3); mlz 267.1 (ES, 
MeQH, [M+Nat, 100 %), 299.1 ([M+MeOH+Nat, 3 %); Vmax (film)/cm-1: 1650 
(C=C stretch), 2936, 2985 (aliphatic C-H stretch), 3524 (br, 0-H stretch); bH (CDCh, 
400 MHz, gCOSY) 1.31 (d, 3H, H-6, H-6', H-6", Js,6 6.6 Hz), 1.37, 1.57 (2 x s, 2 x 
3H, (CH3)2C), 2.19 (d, br, 1H, OH, JHH 6.8 Hz), 3.54 (t, 1H, H-4, JHH 5.6 Hz), 3.85 (q, 
1H, H-5, Js,6 6.6 Hz), 3.99-4.07 (m, 2H, H-2, 1 of OCfuCHCH2), 4.16-4.23 (m, 2H, 
H-3, 1 ofOCfuCHCH2), 5.07 (s, 1H, H-1), 5.25 (m, 2H, OCH2CHCfu), 5.91 (m, 1H, 
OCH2CHCH2); ~ (CDCh, 100.6 MHz, DEPT) 16.8 (q, C-6), 25.4, 26.0 (2 x q, 
~H3)2C), 64.5, 67.0, 73.1, 73.4 (4 x d, C-2, C-3, C-4, C-5), 96.8 (d, C-1), 109.4 (s, 
(CH3)2C), 117.9 (t, OCH2CHCH2), 133.8 (d, OCH2CHCH2); HRMS found 267.1229 
(C12H2oOsNa requires 267.1232). 
Allyl 4-azido-4-deoxy-2, 3-0-isopropylidene-a-L-talopyranoside (3.14): 
0~ 
Allyl 6-deoxy-2,3-0-isopropylidene-a-L-talopyranoside (1.0 eq., 0.186 mol, 45.35 g) 
was dissolved in dry DCM (1.0 L) and dry pyridine added (3.17 eq., 0.589 mol, 46.6 
g, 47.6 rnL). The mixture was stirred under argon at -18 °C. 
Trifluoromethanesulfonic anhydride (1.41 eq., 0.262 rnrnol, 73.8 g, 44.0 rnL) was 
added slowly, and the mixture stirred until TLC showed complete consumption of 
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starting material. After 150 minutes the mixture was diluted with DCM (500 mL) and 
washed with HCl (aq, 0.5 M, 2 x 200 mL) then NaHC03 (aq, satd, 400 mL), then 
brine (satd., 400 mL), and dried (Na2S04), filtered, and evaporated. The crude oil was 
dissolved in dry DMF (1 L), and and sodium azide added (2.0 eq., 0.372 mol, 24.2 g). 
The mixture was stirred under argon. After 18.5 h TLC showed consumption of 
starting material, and the mixture was concentrated and the residue dissolved in DCM 
(1.25 L) and washed with water (2 x 400 mL), then brine (satd., 200 mL), and the 
organic layer dried (Na2S04), filtered, and concentrated to give an orange oil, which 
was purified by flash chromatography (1 : 49 ethyl acetate : hexane to 1 : 20 ethyl 
acetate : hexane eluent) to give allyl 4-azido-4-deoxy-2,3-0-isopropylidene-a-L-
talopyranoside (3.14) as a colourless oil (16.9 g, 37 %); [a]0 24·0 - 28.4 (c = 1.00, 
CHCh); m/z 292.3 (ES, MeOH, [M+Nat, 100 %); Vmax (film)/cm-1: 1647 (C=C 
stretch), 2933, 2986 (aliphatic C-H stretch); 4I (CDCh, 400 MHz, gCOSY) 1.39 (d, 
3H, H-6, H-6', H-6", J5,6 6.3 Hz), 1.36, 1.56 (2 x s, 2 x 3H, (CH3)2C), 3.17 (dd, 1H, 
H-4, h,4 7.9 Hz, J4,5 10.4 Hz), 3.58 (dq, IH, H-5, Js,6 6.3 Hz), 3.98 (m, 1H 1 x OCH-
2CHCH2),4.09-4.19 (m, 2H, H-2, H-3), 4.32 (m, IH, 1 of OCfuCHCH2), 5.04 (s, 1H, 
H-1) 5.18-5.37 (m, 2H, OCH2CHCfu), 5.89 (m, 1H, OCH2CHCH2); <\:: (CDCh, 100.6 
MHz, DEPT) 18.1 (q, C-6), 26.4, 28.3 (2 X q, (CH3)2C), 64.6, 66.9, 75.2, 76.7 (4 X d, 
C-2, C-3, C-4, C-5), 68.3 (t, OCH2CHCH2), 96.2 (d, C-1), 110.0 (s, (CH3)2C), 118.1 
(t, OCH2CHCH2), 133.6 (d, OCH2CHCH2). 
4-Azido-4-deoxy-2, 3 -0-isopropylidene-a, {3-L-rharnnopyranose (3. 01): 
Method 1 
4-Azido-4-deoxy-a,,B-L-rhamnopyranose (3.08) (1.0 eq., 4.23 mmol, 800 mg), 
powdered molecular sieves (1.78 g), anhydrous copper (II) sulfate (2.4 eq., 10.2 
mmol, 1.62 g) and H2S04 (0.2 mL, 98 %) were stirred in dry acetone (80 mL) under 
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nitrogen at room temperature. After 40 h TLC indicated complete consumption of 
starting material. The reaction mixture was neutralised with concentrated aqueous 
ammonia solution and silica (5 g) added. The resultant mixture was evaporated to 
dryness in vacuo. The resultant powder was deposited on a silica column and eluted 
with 1 : 3, ethyl acetate : hexane to give 4-azido-4-deoxy-2,3-0-isopropylidene-a,,B-
L-rhamnopyranose (3.01) (911.1 mg, 94 %) as a white crystalline solid. 
Method 2: 
Allyl 4-azido-4-deoxy-2,3-0-isopropylidene-a-L-talopyranoside (3.14) (1.0 eq., 
0.438 mmol, 118 mg) was dissolved in dry THF (2 mL) under nitrogen and heated to 
reflux. In a separate vessel Wilkinson's catalyst (0.1 eq., 0.044 mmol, 41 mg) was 
dissolved in dry THF (1 mL) under nitrogen and n-butyllithium (0.2 eq., 0.090 mmol, 
56 )lL, 1.6 M solution in hexanes) added. The mixture was stirred for 15 minutes 
befre addition to the solution of (3.14) at reflux. The mixture was heated at reflux for 
3 h, after which time TLC indicated complete consumption of starting material. The 
reaction was concentrated in vacuo then the residue dissolved in THF (3.0 mL) and 
iodine (1.2 eq, 133 mg) added followed by water (0.2 mL). The mixture was stirred 
for 2 h after which time TLC indicated complete consumption of starting material. 
The reaction was stopped by dilution with water (20 mL), and the aqueous layer 
extracted with DCM (2 x 30 mL). The organic extracts were dried (MgS04) filtered, 
and concentrated in vacuo. The residue was purified by flash chromatography (1 : 3, 
ethyl acetate : hexane eluent) giving 4-azido-4-deoxy-2,3-0-isopropylidene-a,,B-L-
rhamnopyranose (3.01) (76 mg, 76 %) as a white crystalline solid: [a]0 24·1 (eq.) + 14.0 
(c = 2.00, CHC13); m/z 252.4 (ES, MeOH, [M+Nat, 100 %), 284.4 
([M+MeOH+Nat, 83 %); Vmax (film)/cm-1: 2112 (azide stretch), 2936, 2987 (aliphatic 
C-H stretch), 3450 (br, 0-H stretch); ~ (CDCh, 400MHz, gCOSY) 1.29 (d, 3H, H-6, 
H-6', H-6", 15,6 6.3Hz), 1.38, 1.56 (2 x s, 2 x 3H, (CH3)2C), 2.75 (s, br, 1H, OH), 
3.18 (dd, lH, H-4, 13,4 8.2 Hz, 14,5 10.3 Hz), 3.80 (dq, 1H, H-5, 1s,6 6.3 Hz, 14,5 10.3 
Hz), 4.14 (d, 1H, H-2, 12,3 5.5 Hz), 4.21 (dd, 1H, H-3, h,3 5.5 Hz, hA 8.2 Hz), 5.42 (s, 
1H, H-1); 8c (CDCh, 100.6 MHz, DEPT, 'denotes minor anomer) 18.2 (q, C-6), 18.6 
(q, C-6'), 26.4, 28.3 (2 X q, (CH3)2C), 26.5, 28.2 (2 X q, (C'H3)2C'), 64.7, 66.8, 75.1, 
76.8 (4 X d, C-2, C-3, C-4, C-5), 66.5, 70.1, 74.4, 78.3 (4 X d, C-2', C-3', C-4', C-5'), 
92.0 (d, C-1), 92.8 (d, C-1 '), 110.1 (s, (CH3)2C), 111.0 (s, (C'H3)2C'). 
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1,N-Dehydro-1,4-dideoxy-1,4-imino-2,3-0-isopropylidene-L-rhamnitol (3.02): 
~H 
A() 
... : ':. 
>< 
4-Azido-4-deoxy-2,3-0-isopropylidene-a,,B-L-rhamnopyranose (1.0 eq., 0.870 mmol, 
200 mg) was stirred in dry DCM (2 mL) under nitrogen. Triphenylphosophine (1.1 
eq., 0.954 mmol, 250 mg) was added and the reaction followed by TLC. After 20 h 
the reaction mixture was concentrated and purified by flash column chromatography 
(ethyl acetate eluent) to give 1 ,N-dehydro-1 ,4-dideoxy-1 ,4-imino-2,3-0-
isopropylidene-L-rhamnitol (3.02) (154 mg, 96 % ), as a white crystalline solid: mp 
98-100 °C (ethyl acetate/hexane): [a]0 24·0 - 6.3 (c = 1.00, CHCh); mlz 186.1 (Cl+, 
[M+Ht, 60 %, NH3), 94 (48 %), 76 (69 %), 68 (100 %); Vmax (KBr disc)/cm-1: 1622 
cm-1 (C=N stretch), 2873, 2901, 2932, 2959, 2987 (aliphatic C-H stretch), 3249 cm-1 
(br, 0-H stretch); ~ (CDCh, 300 MHz) 1.48 (d, 3H, H-6, H-6', H-6", 15,6 6.3 Hz) 
1.53, 1.36 (2 x s, 2 x 3H, (CH3)2C), 2.6 (s, br, 1H, OH), 3.75 (ddd, 1H, H-4, 11,4 3.1 
Hz, 13,4 4.5 Hz, hs 8.2 Hz), 4.00 (dq, 1H, H-5, 1s,6 6.4 Hz, 14,5 8.1 Hz), 4.83 (dd, 1H, 
H-3, h,4 4.8 Hz, 1z,3 5.7 Hz), 5.07 (d, 1H, H-2, ]z,3 5.7 Hz), 7.60 (d, 1H, H-1, 11,4 3.1 
Hz); &: (CDCh, 75.4 MHz) 21.0 (C-6), 25.7, 26.8 ((CH3)2C), 67.8, 76.7, 80.1, 87.0 
(C-2, C-3, C-4, C-5), 112.5 ((CH3)zg, 165.5 (C-1); HRMS found 186.1125 
(C9H16N03 requires 186.1130). 
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5-0-tert-Butyldimethylsilyl-1 ,N-dehydro-1, 4-dideoxy-1, 4-imino-2, 3-0-
isopropylidene-L-rhamnitol (3.03): 
~TBBMS 
: N /---Q 
~l ~ xt 
Method 1 
l,N-Dehydro-1,4-dideoxy-1,4-imino-2,3-0-isopropylidene-L-rhamnitol (3.02) (1.0 
eq., 2.66 mmol, 493 mg) was dissolved in dry DCM (10 mL) in a dry round-bottomed 
flask under nitrogen. Dry pyridine (3.2 eq., 8.40 mmol, 665 mg, 0.650 mL), then tert-
butyldimethylsilyl trifluoromethanesulfonate (1.5 eq., 4.02 mmol, 1.06 g, 0.923 mL) 
were added with stirring. After 10 h the mixture was diluted with DCM (30 mL), and 
the mixture washed with H20 (2 x 10 mL). The aqueous layers were combined and 
extracted with a further portion of DCM (10 mL). The organic extracts were 
combined and dried (MgS04), filtered, then the solvent removed in vacuo. The 
resultant oil was purified by flash column chromatography (15 : 85, ethyl acetate : 
hexane eluent) giving 5-0-tert-butyldimethylsilyl-1 ,N-dehydro-1 ,4-dideoxy-1 ,4-
imino-2,3-0-isopropylidene-L-rhamnitol (3.03) as a colourless oil (0.669 g, 84 %). 
Method 2 
1 ,N-Dehydro-1 ,4-dideoxy-1,4-imino-2,3-0-isopropylidene-L-rhamnitol (3.02) (1.0 
eq., 0.950 mmol, 176 mg) was dissolved in dry DCM (5 mL) in a dry round-bottomed 
flask under nitrogen. Imidazole (2.2 eq, 142 mg, 2.09 mmol) was added, followed by 
tert-butylchlorodimethylsilane (1.5 eq, 1.43 mmol, 215 mg). The mixture was stirred 
for 15 h when TLC indicated complete consumption of starting material and 
formation of a new product. The reaction was diluted with DCM (50 mL), and the 
resultant solution washed with HCl (0.3 M, 2 x 40 mL), then brine (1 x 30 mL). The 
organic layer was dried (Na2S04), filtered and concentrated, and the residue purified 
by flash chromatography on silica (15 : 85, ethyl acetate: hexane eluant). The desired 
product 5-0-tert-butyldimethylsilyl-1 ,N-dehydro-1 ,4-dideoxy-1 ,4-imino-2,3-0-
isopropylidene-L-rhamnitol (3.03) was obtained as a colourless oil (225 mg, 79 %): 
[a]0 21.o + 12.9 (c = 1.0, CHCb); mlz 354.5 (ES, [M+MeOH+Nar, 100 %, MeOH), 
332.5 ([M+MeOH+Ht, 82 %), 300.5 ([M+Ht, 10 %); Vmax (film)/cm-1: 1620 (C=N 
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stretch), 2857, 2930, 2956, 2985 cm·1 (aliphatic C-H stretch); 4I (CDCh, 500 MHz, 
gCOSY, gHSQC) 0.08, 0.07 (2 x s, 6H, (CH3)2Si), 0.896 (s, 9H, (CH3)3CSi), 1.34, 
1.32 (2 x s, 2 x 3H, (CH3)2C), 1.45 (d, 3H, H-6, H-6', H-6" J5,6 6.1 Hz), 3.63 (ddd, 
1H, H-4, JI,4 3.5 Hz), 3.98 (dq, 1H, H-5, J4,s 9.4 Hz, Js,6 6.1 Hz), 4.70 (dd, 1H, H-3, 
h,3 4.9 Hz, J3,4 4.1 Hz), 5.0 (d, 1H, H-2, h,3 5.0 Hz), 7.55 (d, H-1, J1,4 3.0 Hz); ~ 
(CDCh, 125.7 MHz, DEPT, gHSQC) -4.3, -5.1 (2 x q, 2 x (CH3)2Si), 18.0 (s, 
(CH3)3CSi), 22.5 (q, C-6), 25.8 (s, ~H3)3CSi), 27.1, 25.7 (2 x q, (CH3)2C), 66.9 (d, 
C-5), 77.3 (d, C-3), 81.1 (d, C-4), 86.7 (d, C-2), 111.5 (s, (CH3)2C), 166.6 (d, C-1); 
HRMS found 300.1990 (C1sH29N03SiH requires 300.1995). 
(1 S)-5-0-tert-Butyldimethylsilyl-1, 4-dideoxy-1, 4-imino-2, 3-0-isopropylidene-1-C-
phenyl-L-rhamnitol (3.16): 
Method 1 
5-0-tert-Butyldimethylsilyl-1 ,N-dehydro-1 ,4-dideoxy-1 ,4-imino-2,3-0-
isopropylidene-L-rhamnitol (3.02) (1.0 eq., 0.184 mmol, 50.0 mg) was dissolved in 
dry diethyl ether (2.0 mL). Phenyl magnesium bromide (1.0 eq., 0.184 mmol, 0.184 
mL, 1 M solution in diethyl ether) was added and the reaction mixture stirred under 
nitrogen for 3.5 h. The reaction was quenched with H20 after 3.5 h, then the mixture 
diluted with diethyl ether (20 mL), and washed with H20 (2 x 20 mL). The organic 
layer was isolated, dried (Na2S04), filtered, and the solvent removed. The residue 
was purified by flash column chromatography (1 : 4, ethyl acetate : hexane eluent) to 
give recovered starting material (23 mg, 37 %), and (1S)-5-0-tert-butyldimethylsilyl-
1 ,4-dideoxy-1 ,4-imino-2,3-0-isopropylidene-1-C-phenyl-L-rhamnitol (3.16) as a 
colourless oil (3 7 mg, 60 % ). 
Method 2 
5-0-tert-Butyldimethylsilyl-1 ,N-dehydro-1 ,4-dideoxy-1 ,4-imino-2,3-0-
isopropylidene-L-rhamnitol (3.03) (1.0 eq., 0.0668 mmol, 20.0 mg) was dissolved in 
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dry diethyl ether (1.6 mL) and added to a stirred solution of phenyl magnesium 
bromide (15.0 eq., 0.334 mmol, 0.334 mL, 3.0 M solution in diethyl ether), and the 
reaction mixture stirred under nitrogen. After 1.5 h TLC indicated that the reaction 
was incomplete, so mixture was stirred for a further 24.5 h before quenching by 
careful addition of water (1 mL). The mixture was diluted with diethyl ether (30 mL), 
and washed with water (1 x 20 mL), then brine (satd., 1x 20 mL). The organic phase 
was dried (Na2S04), filtered, and concentrated in vacuo. The resultant colourless oil 
was purified by flash chromatography (1 : 9 ethyl acetate : hexane eluent), to give 
1S)-5-0-tert-butyldimethylsilyl-1 ,4-dideoxy-1 ,4-imino-2,3-0-isopropylidene-1-C-
phenyl-L-rhamnitol (3.11.6) as a colourless oil (17.3 mg, 69 %). 
[a]0 19·0 + 12.3 (c = 1.00, CHCb); m/z 378 (ES, [M+Ht, 100%, MeOH); Vmax 
(film)/cm"1: 2856, 2930 (aliphatic C-H stretch), 3026, 3062, 3090 (aromatic C-H 
stretch), 3300 (br, N-H stretch); 4I (CDCh, 500 MHz, gCOSY, gHSQC, nOoesy) 
0.085, 0.087 (2 x s, 2 x 3H, (CH3)2Si), 0.88 (s, 9H, (CH3)3CSi), 1.33, 1.55 (2 x s, 2 x 
3H, (CH3)2C), 1.35 (d, 3H, H-6, H-6', H-6", Js,6 6.4 Hz), 2.92 (dd, 1H, H-4, J3,4 3.9 
Hz, J4,s 8.6 Hz), 4.02 (dq, 1H, H-5, J5,6 6.4 Hz, J4,5 8.6 Hz), 4.34 (s, 1H, H-1), 4.65 
(dd, 1H, H-3, J3,4 3.9 Hz, J2,3 5.4 Hz), 4.82 (d, 1H, H-2, J2,3 5.5 Hz), 7.20 (t, lH, 
aromatic CH, JHH 7.3 Hz), 7.33 (t, 2H, aromatic CH, JHH 7.9 Hz), 7.40 (pd, 2H, 
aromatic CH, JHH 7.6 Hz); ~ (CDCh, 125 MHz, DEPT, gHSQC) -5.10, -4.39 (2 x q, 
(CH3)2Si), 18.1 (s, (CH3)3CSi), 22.6 (q, C-6), 24.0, 26.2 (2 x q, ~H3)2C), 25.8 (q, 
(CH3)3CSi), 67.12 (d, C-1), 67.17 (d C-5), 68.4 (d, C-4), 81.5 (d, C-3), 88.4 (d, C-2), 
110.6 (s, (CH3)2C), 126.6, 126.7, 128.4 (3 x d, 3 x aromatic CH), 140.2 (s, 
quartemary aromatic); HRMS found 378.2458 (C21 H3sN03SiH requires 378.2464). 
85 
(I S)-5 -0-tert-Butyldimethylsilyl-1, 4-dideoxy-1-C-ethyl-1, 4-imino-2, 3-0-
isopropylidene-L-rhamnitol (3.17): 
QTBDMS 
~ 
X 
5-0-tert-Butyldimethylsilyl-1 ,N-dehydro-1 ,4-dideoxy-1 ,4-imino-2,3-0-
isopropylidene-L-rhamnitol (3.03) (1.0 eq., 0.0668 mmol, 20.0 mg) was dissolved in 
dry diethyl ether (1.6 mL) and added to a stirred solution of ethyl magnesium bromide 
(15.0 eq., 0.334 mmol, 0.334 mL, 3.0 M solution in diethyl ether) and the reaction 
mixture stirred under nitrogen. After 1.5 h TLC indicated complete consumption of 
starting material, and the reaction was stopped by careful addition of water (1 mL). 
The mixture was diluted with diethyl ether (30 mL), and washed with water (20 mL), 
then brine (satd., 20 mL). The organic phase was dried (Na2S04), filtered, and 
concentrated in vacuo. The resultant colourless oil was purified by flash 
chromatography (3 : 7, ethyl acetate : hexane eluent), to give (1S)-5-0-tert-
butyldimethylsilyl-1,4-dideoxy-1-C-ethyl-1,4-irnino-2,3-0-isopropylidene-L-
rhamnitol (3.17) (21.9 mg, 100 %) as a colourless oil: [a]0 24·6 + 33.0 (c = 1.00, 
CHCh); mlz 330.2 (ES, [M+Ht, 100%, MeOH); Vmax (film)/cm-1: 2857, 2931, 2958 
(aliphatic C-H stretch); bH (CDCh, 500 MHz, gCOSY, gHSQC, nOesy) 0.07 (s, 6H, 
(CH3)2Si), 0.88 (s, 9H, (CH3)3CSi), 0.94 (t, 3H, CH2Cfu), 1.24 (d, 3H, H-6, H-6', H-
6", 15,6 6.2 Hz), 1.28, 1.44 (2 x s, 2 x 3H, (CH3)2C), 1.30-1.36 (m, 2H, CfuCH3), 1.97 
(s, br, 1H, NH), 2.79 (dd, 1H, H-4, h,4 3.8 Hz, 14,5 8.6 Hz), 2.96 (t, 1H, H-1, 1HH 7.9 
Hz), 3.92 (dq, 1H, H-5, 1s,6 6.2 Hz, 14,5 8.6 Hz), 4.36 (d, 1H, H-2, 12,3 5.5 Hz), 4.60 
(dd, 1H, H-3, h,4 3.8 Hz, 12,3 5.5 Hz); ~ (CDCh, 125 MHz, DEPT, gHSQC) -4.90,-
4.27 (2 x q, (CH3)2Si), 11.3 (q, CH2CH3), 18.2 (s, (CH3)3CSi), 22.8 (q, C-6), 24.1, 
26.3 (2 X q, (QH3)2C), 24.8 (t, CH2CH3), 26.0 (q, (CH3)3CSi), 66.1 (d, C-1), 67.43, 
67.45 (2 x d, C-4, C-5), 81.0 (d, C-3), 85.5 (d, C-2), 110.4 (s, (CH3)2C); HRMS found 
330.2457 (C1sH35N03SiH requires 330.2459). 
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(1 S)-5-0-tert-Butyldimethylsilyl-1, 4-dideoxy-1, 4-imino-2, 3-0-isopropylidene-1-C-
methyl-L-rhamnitol (3.18): 
QTBS 
A(y 
i' \ 
X 
5-0-tert-Butyldimethylsilyl-1 ,N-dehydro-1 ,4-dideoxy-1 ,4-imino-2,3-0-
isopropylidene-L-rhamnitol (3.03) (1.0 eq., 0.0668 mmol, 20.0 mg) was dissolved in 
diethyl ether (1.6 mL) and the resultant solution added to a stirred solution of methyl 
magnesium bromide (15 eq., 0.999 mol, 0.333 mL, 3 M solution in diethyl ether) 
under nitrogen. The reaction mixture was stirred for 10 minutes. At the end of this 
time TLC indicated the complete consumption of starting material and the reaction 
was cautiously quenched with water (1 mL). The resultant mixture was diluted with 
diethyl ether (30 mL), and washed with water (2 x 10 mL). The organic layer was 
dried (MgS04), filtered, and concentrated to give a colourless oil which was purified 
by flash chromatography on silica (1 : 1, ethyl acetate : hexane eluent). (1S)-5-0-tert-
butyldimethylsilyl-1 ,4-dideoxy-1 ,4-imino-2,3-0-isopropylidene-1-C-methyl-L-
rhamnitol (3.18) was isolated as a colourless oil (14.0 mg, 66 %) together with a 
mixture of adduct (3.18) and a similar compound tentatively assigned as the C-1 
epimer ( 1 R)-5-0-tert-butyldimethylsilyl-1, 4-dideoxy-1, 4-imino-2, 3-0-
isopropylidene-1-C-methyl-L-rhamnitol (2.23) (4.2 mg of a 7.2 : 1 mixture (NMR)) 
giving a total conversion to adduct of 86 %, and 69 : 2 overall diastereoselectivity. 
(3.18): [a]o21 + 60.8 (c = 1.0, CHCb); mlz 316.2 (ES, MeOH, [M+Ht, 100 %); Vmax 
(film)/cm-1: 2857, 2931, 2958 (aliphatic C-H stretch); 4r (CDCh, 400 MHz, gCOSY, 
gHSQC, nOesy) 0.07 (s, 6H, (CH3)2Si), 0.87 (s, 9H, (CH3)3CSi), 1.04 (d, 3H, C1CH3, 
1HH 7.2 Hz), 1.25 (d, 3H, H-6, H-6', H-6", 15,6 6.2 Hz), 1.27, 1.44 (2 x s, 2 x 3H, 
(CH3)2C), 1.90 (s, br, IH, NH), 2.88 (dd, 1H, H-4, 13,4 3.8 Hz, 14,5 8.5 Hz), 3.26 (q, 
1H, H-1, 1HH 7.2 Hz), 3.93 (dq, 1H, H-5, 15,6 6.2 Hz, 14,5 8.4 Hz), 4.32 (d, 1H, H-2, h,3 
5.5 Hz), 4.62 (dd, 1H, H-3, 13,4 3.8 Hz, 12,3 5.5 Hz); &:; (CDCh, 100.6 MHz, DEPT, 
gHSQC)- 4.9,- 4.3 (2 X q, (CH3)zSi), 17.9 (q, C1CH3), 18.2 (s, (CH3)3CSi), 22.8 (q, 
C-6), 24.0, 26.2 (2 X q, C£H3)2C), 26.0 (q, (CH3)3CSi), 59.6 (d, C-1), 67.2 (d, C-5), 
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67.3 (d, C-4), 81.2 (d, C-3), 87.1 (d, C-2), 110.3 (s, (CH3)2C); HRMS found 316.2296 
(Ct6H34N03Si requires 316.2302). 
4-Azido-4-deoxy-2, 3 -0-isopropylidene-L-rhamno-1, 5-lactone (3. 06) (Ref I 00): 
0 
A mixture of 4-azido-4-deoxy-2,3-0-isopropylidene-a,,B-L-rhamnopyranose (1.0 eq., 
0.880 mmol, 200 mg) dissolved in dry DCE (5.0 mL), PCC (2.5 eq., 2.20 mmol, 474 
mg), and molecular sieves (300 mg, 4 A, powdered), was heated to reflux. The 
reaction was followed by TLC, which showed complete consumption of starting 
material after 16 h. The reaction was stopped by triturating with diethyl ether (30 
mL), and filtered through a celite plug. The resultant brown oil was purified by flash 
chromatography (15 : 85, ethyl acetate : hexane eluent). 4-Azido-4-deoxy-2,3-0-
isopropylidene-L-rhamno-1,5-lactone (3.06) was isolated as a white crystalline solid 
(151 mg, 76 %): mp 93-94 °C (ethyl acetatelhexane) (lit. 100 93-95 °C (ethyl 
acetate/Hexane); [a]n23·9 -114.7 (c = 1.00, CHCh) (lit. 100 [a]n23·0 -104.8 (c = 1.27, 
CHCh); mlz 282.0 (ES, MeOH, [M+MeOH+Nat, 100 %); Vmax (KBr disc)/cm"1: 
1759 (s, C=O stretch), 2111 (azide stretch), 2919, 2940, 2985, 3001 (aliphatic C-H 
stretch); 4I (CDCb, 400 MHz, gCOSY, gHSQC) 1.42, 1.52 (2 x s, 2 x 3H, (CH3)2C), 
1.48 (d, 3H, H-6, H-6', H-6" 15,6 6.2 Hz), 3.44 (dd, 1H, H-4, 13,4 7.1 Hz, 14,5 10.3 Hz), 
4.19 (dq, 1H, H-5, 15,6 6.2 Hz, 14,5 10.1 Hz), 4.50 (dd, 1H, H-3, 13,4 7.1 Hz, h,3 8.1 
Hz), 4.69 (d, 1H, H-2, h,3 8.2 Hz); &:: (CDCh, 100.6 Hz, DEPT, gHSQC) 18.1 (q, C-
6), 25.3, 26.8 (2 X q, (CH3)2C), 65.7 (d, C-4), 71.9 (d, C-3), 73.7 (d, C-5), 77.4 (d, C-
2), 112.7 (s, (CH3)2C), 168.4 (s, C-1). 
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4-Azido-4-deoxy-1-C-ethyl-2, 3 -0-isopropylidene-a; f3-L-rhamnopyranose (3.19): 
4-Azido-4-deoxy-2,3-0-isopropylidene-L-rharnno-1,5-lactone (3.06) (1.0 eq., 0.379 
mmo1, 86.0 mg) was dissolved in dry diethyl ether (5.0 mL) under nitrogen and ethyl 
magnesium bromide added (1.5 eq., 0.567 mmol, 189 JlL, 3.0 M solution in diethyl 
ether). The mixture was stirred under nitrogen for 15 minutes when TLC indicated 
complete consumption of starting material. The reaction was stopped by addition of 
water (1 mL), and the mixture diluted with diethyl ether (30 mL), and washed with 
water (2 x 20 mL) then brine (satd., 20 mL), and the organic layer dried (MgS04), 
filtered, and the solvent removed in vacuo. The resultant colourless oil (83 mg, 85 % 
crude yield) was purified by flash chromatography (1 0 : 90, ethyl acetate : hexane 
eluent). The adduct (3.19) was isolated as a mixture of anomers (15.1 mg, 17 %). 5-
0-tert-Butyldimethylsilyl-1 ,N-dehydro-1 ,4-dideoxy-1-C-ethyl-1 ,4-imino-2,3-0-
isopropylidene-L-rhamnitol (3.20) (18.3 mg, 26 %) was also isolated by flushing the 
column with ethyl acetate. (3.19): [a]o25·9 + 7.4 (c = 1.00, CHCh) Vmax(film)/cm"3: 
2110 (azide stretch), 2882, 2937, 2983 (aliphatic C-H stretch), 3441 (br, 0-H stretch); 
4I (CDCh, 400 MHz, gCOSY, · denotes minor anomer) 0.97 (t, 0.3H, CH'2CH'3, 
JH'H' 7.3 Hz), 1.00 (t, 3H, CH2Cfu, JHH 7.7 Hz), 1.26 (d, 3H, H-6, H-6', H-6", Js,6 6.3 
Hz), 1.34 (d, 0.3H, H-6', H-6'', H-6'", J5·,6· 6.3 Hz), 1.37, 1.55 (2 x s, 2 x 3H, 2 x 
(Cfu)2C), 1.40, 1.55 (2 x s, 2 x 0.3H, 2 x (Cfu)2C), 1.68 (dq, 1H, 1 ofCfuCH3, JHH 
7.6 Hz, JHH 14.3 Hz), 1.90 (dq, 1H, 1 of CH2CH3, JHH 7.6 Hz, JHH 14.3 Hz), 1.90 (s, 
1H, OH), 3.14 (dd, 1H, H-4, J3,4 8.6 Hz, J4,s 10.4 Hz), 3.31 (dq, 0.1H, H-5', Js·,6· 6.2 
Hz, h,s· 10.4 Hz), 3.48 (dd, O.lH, H-4', h,4' 8.3 Hz, h,s· 10.4 Hz), 3.77 (dq, 1H, H-5, 
Js,6 6.3 Hz, J4,s 10.4 Hz), 4.02 (d, 1H, H-2, h,3 5.1 Hz), 4.06 (d, 0.1H, H-2', h-,3· 6.3 
Hz), 4.12 (dd, O.IH, H-3', h,3' 6.4 Hz, h,4' 8.1 Hz), 4.20 (dd, 1H, H-3, h,3 5.1 Hz, J3,4 
8.5 Hz); &: (CDCh, 100.6 MHz, DEPT, minor anomer not observable) 7.0 (q, C-1), 
18.4 (q, C-8), 26.4, 28.5 (2 X q, 2 X (CH3)2C), 31.7 (t, C-2), 66.4, 66.9 (2 X d, C-6, C-
7), 75.4 (d, C-5), 77.1 (d, C-4), 97.8 (s, C-3), 109.9 (s, (CH3)2C). 
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5-0-tert-Butyldimethylsilyl-1, N-dehydro-1, 4-dideoxy-1-C-ethyl-1, 4-imino-2, 3-0-
isopropylidene-L-rhamnitol (3.20): 
~H 
~ 
.:' :. 
X 
4-Azido-4-deoxy-2,3-0-isopropylidene-L-rhamno-1 ,5-lactone (3.06) (1.0 eq., 0.110 
mmol, 25.0 mg) was dissolved in dry diethyl ether (1.0 mL). Ethyl magnesium 
bromide was added (1.5 eq., 0.165 mmol, 55 )lL, 3.0 M solution in diethyl ether), and 
the mixture stirred under nitrogen. The reaction was stopped after 30 minutes, when 
TLC showed complete consumption of starting material, by addition of NH4Cl (satd, 
1.0 mL), and diluted with diethyl ether (25 mL). The solution was washed with water 
(20 mL), then brine (satd., 20 mL) then the organic layer dried (MgS04) and filtered. 
The solvent was removed in vacuo to give a colourless oil (24 mg), which was 
dissolved in CDCh (0.6 mL), and triphenylphosphine added (1.1 eq., 0.121 mmol, 
31.7 m g), and the mixture agitated. NMR analysis showed formation of one major 
product after 24 h, and the reaction was stopped by removal of the solvent in vacuo. 
The resultant pale yellow waxy solid was dissolved in diethyl ether (1 mL) and 
hexane (10 mL) added. The solution was cooled to -18 °C until triphenylphosphine 
oxide was observed to precipitate. The solution was filtered and the filtrate 
concentrated, then purified by repeated flash chromatography (ethyl acetate eluent), to 
give 5-0-tert-butyldimethylsilyl-1-C-ethyl-1 ,N-dehydro-1 ,4-dideoxy-1 ,4-imino-2,3-
0-isopropylidene-L-rhamnitol (3.20) as a white crystalline solid (17 mg, 64 %): mp 
47.5-53.0 °C (ethyl acetate); [a]0 24·0 -18.1 (c = 1.00, CHCh); mlz 236.1 (ES, 
(M+Nat, 100 %, MeOH), 214.2 ([M+Ht, 30 %), 268.2 ([M+MeOH+Nat, 5 %); 
Vmax(KBr disc)/cm-3: 1643 (C=N stretch), 2880, 2936, 2983 (aliphatic C-H stretch), 
3406 (br, 0-H stetch); & (CDCh, 400 MHz, gCOSY) 1.18 (t, CH2Cfu, JHH 7.6 Hz), 
1.36 (s, 6H, (CH3)2C), 1.48 (d, 3H, H-6, H-6', H-6", Js,6 6.3 Hz), 2.34-2.56 (m, 2H, 
CfuCH3), 3.68 (m, 1H, H-4), 4.00 (dq, lH, H-5, J4,s 6.4 Hz, Js,6 14.1 Hz), 4.84 (t, 1H, 
H-3, h,3 5.1 Hz, J3,4 5.1 Hz), 4.98 (d, lH, H-2, J2,3 5.5 Hz); ~ (CDCh, 100.6 MHz, 
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DEPT) 10.5 (q, CH2CH3), 21.3, (q, C-6), 24.2 (t, CH2CH3), 26.0, 27.0 (2 x 
q,(QH3)2C), 68.4 (d, C-4), 78.2, 79.0, 86.7 (3 x d, C-2, C-3 C-5), 112.8 (s, (CH3)2C), 
178.1 (s, C-1); HRMS found 214.1447 (CnH2oN03 requires 214.1443). 
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Chapter 4. Aza-sugar Piperidines: Tetra-0-benzyl DNJ, and DINJ, 
and their Cyclic Imine Derivatives 
In this chapter we discuss the syntheses of cyclic imine derivatives with 1-
deoxyidonojirimycin (DINJ) and 1-deoxynojirimycin (DNJ) stereochemistry (Figure 
26, see also Chapter 1, Section 1.6.3), by both a chlorination/elimination procedure 
and by the use of the intramolecular Staudinger aza-Wittig reaction of azido-sugars 
(see Chapter 1, Section 1.5.2, and Chapter 3, Sections 3.3 and 3.5).74 
OH 
OH 
DNJ 
OH 
I H 
''''''····9N ,,,.· .. ,,, 
HO'''' 111'0H 
OH 
DINJ 
Figure 26. Naturally occurring aza-sugars DNJ and DINJ. 
Benzyl ethers were chosen as suitable 0-protecting groups due to the ease of 
introduction, their stability to the wide variety of reaction conditions employed 
throughout these syntheses, and their ease of removal by catalytic hydrogenation. 112 
General strategies for the synthesis of cyclic imines derived from 2,3,4,6-tetra-0-
benzyl-DINJ (TBDINJ) (4.01) and 2,3,4,6-tetra-0-benzyl-DNJ (TBDNJ) (4.02) are 
shown below (Scheme 53 to Scheme 55). 
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Scheme 53. Retrosynthetic analysis of protected cyclic sugar aldimine I ,N-dehydro-
TBDINJ ( 4.05). 
2,3,4,6-Tetra-0-benzyl-D-glucopyranose ( 4.03) is a convenient chiral pool starting 
material, which is commercially available or readily synthesised from D-glucose. 113 
Reduction of the hemi-acetal function of (4.03) would afford the protected tetra-0-
benzyl-D-glucitol ( 4.04). 114 We envisage the introduction of azide via an SN2 
displacement reaction at either the 1-, or 5-position allowing access to either the 
cyclic aldimine l,N-dehydro-TBDINJ (4.05) (Scheme 53) or the cyclic ketimine 5,N-
dehydro-TBDNJ (4.06) (Scheme 54). 
OBn OBn OBn 
Aza- N3 
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Scheme 54. Retrosynthetic analysis of cyclic sugar ketimine 5,N-dehydro-TBDNJ 
(4.06). 
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An alternative strategy involves the elimination of HCl from N-chloro-TBDNJ ( 4.07) 
and N-chloro-TBDINJ ( 4.08) (Scheme 39). Our goal wass successful regiocontrol of 
elimination, allowing selective formation of either the ketimine ( 4.06) or aldimine 
(4.07) by control of the reaction conditions. We expected regiocontrol of such 
eliminations to be governed by stereoelectronic and conformational factors (see 
Chapter 1, Section 1.5.1 ). However regiocontrol of elimination of HCl from such N-
chlorinated piperidines had not, to the best of the author's knowledge, been previously 
investigated. 
OBn 
..• ,,,;::~ 
OBn 
OBn 
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OBn 
R = BnOCH2, R' = H ( 4.09) 
R = H, R' = BnOCH2 ( 4.05) 
R 
.. ,,, 
''
110Bn 
.. ,,, 
''
110Bn 
OBn OBn 
R = BnOCH2, R' = H (4.07) R = BnOCH2, R' = H (4.01) 
R = H, R' = BnOCH2 (4.08) R = H, R' = BnOCH2 (4.02) 
Scheme 55. Retrosynthetic analysis of protected cyclic imines from N-chloro-TBDNJ 
( 4.07), and N-chloro-TBDINJ ( 4.08). 
TheN-chlorination methodology utilises fully 0-protected aza-sugars TBDNJ (4.01) 
and TBDINJ ( 4.02). A synthesis of TBDINJ ( 4.02) via a double SN2 displacement of 
di-0-methanesulfonyl glucitol derivative (4.10) is proposed (Scheme 56). This work 
follows from a similar literature synthesis of deprotected DINJ (see Section 4.4). 115 
TBDNJ (4.02) was provided by Oxford Glycosciences Ltd., and although we achieved 
a small-scale synthesis (see Section 4.6), a large-scale synthesis was not performed. 
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§cheme 56. Retrosynthetic analysis of TBDINJ ( 4.02) (cf. ref. 115). 
Following the successful synthesis of cyclic imines ( 4.05), ( 4.06), ( 4.09) we will 
investigate irreversible addition of organometallic reagents to give access to 1-, and 5-
substituted aza-sugars (Scheme 57) (see Section 4.6, and 4.7). This late-stage 
introduction of functionality would be a valuable tool to the synthetic chemist for the 
creation of libraries of aza-sugars with potential biological activity. We will also 
illustrate the synthetic utility of our cyclic imine-sugar methodology with the first 
synthesis of the enantiomer of the natural product (-)-adenophorine116 (4.11) ((lS)-
1,5-dideoxy-1-C-ethyl-1,5-imino-L-iditol) (see Sections 4.8, and 4.9) and its C-1 
epimer ((lR)-1,5-dideoxy-1-C-ethyl-1,5-imino-L-iditol) (4.12) (see Sections 4.8 and 
4.9). 
BnO 
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11110Bn 
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R = H, R' = Bn0CH2 ( 4.05) 
BnO 
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Scheme 57. Addition reactions of cyclic imine derivatives ofTBDNJ and TBDINJ. 
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The work in this Chapter can be separated into nine main sections: 
4.1 Synthesis of Cyclic Ketimine 5,N-Dehydro-TBDNJ ( 4.06) by a Staudinger Aza-
Wittig Reaction. 
4.2 Synthesis of TBDINJ (4.02), and its Cyclic Aldimine l,N-Dehydro-TBDINJ 
( 4.05) by a Staudinger Aza-Wittig Reaction. 
4.3 Synthesis of Cyclic Ketimine 5,N-dehydro-TBDNJ (4.06), and Cyclic Aldimine 
l,N-Dehydro-TBDNJ (4.09) from TBDNJ (4.01) via a Chlorination/Elimination 
Strategy 
4.4 Synthesis of TBDINJ ( 4.02) from Tetra-0-benzyl-D-glucitol ( 4.04) via a Double 
Displacement strategy 
4.5 Synthesis of Cyclic Aldimine l,N-Dehydro-TBDINJ (4.05) from TBDINJ (4.02) 
via a Chlorination/Elimination Strategy 
4.6 Irreversible Addition Reactions of Cyclic !mines 5,N-Dehydro-TBDNJ (4.06) and 
1 ,N-Dehydro-TBDNJ ( 4.09) 
4. 7 Synthesis of Protected (-)-1-epi-Adenophorine ( 4.37) by Nucleophilic Addition 
to l,N-Dehydro-TBDINJ (4.05) 
4.8 Synthesis of Protected (-)-Adenophorine ( 4.43) by Addition of Hydride to Cyclic 
Ketimine 1-C-Ethyl-1,N-dehydro-TBDINJ (4.13) 
4.9 Deprotection of Aza-Sugars ( 4.37), ( 4.43), ( 4.35) and ( 4.36) 
4.1 Synthesis of Cyclic Ketimine 5,N-dehydro-TBDNJ (4.06) by a Staudinger 
Azaa Wittig Reaction 
This strategy for the synthesis of the DNJ framework utilised the difference in 
reactivity of the two free hydroxyl groups in the known114 2,3,4,6-tetra-0-benzyl-D-
glucitol ( 4.04) (Scheme 59), conveniently prepared by the reduction of commercially 
available 2,3,4,6-tetra-0-benzyl-a,,B-D-glucose ( 4.03) (Scheme 58). 
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Scheme 58. Reduction of2,3,4,6-tetra-O-benzyl-a,fJ-D-glucopyranose (4.03). 
The previously unknown 1-mesyl-glucitol derivative (4.14) was obtained in 83 % 
yield by treatment of protected glucitol ( 4.04) with methanesulfonyl chloride at - 18 
°C. Temperature was shown to have an effect in controlling the reaction selectivity, 
the dimesylate (4.10) (10 %) being obtained at 0 °C, together with the monomesylate 
in 73 % yield. 
OBn 
OBn 
(4.04) 
OBn 
(i) 
(i) MsCl, Py,- 18 °C, 83 %. 
OBn 
(4.14) 
OMs 
· .. 
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~OBn 
Scheme 59. Synthesis of primary mesylate ( 4.14). 
Treatment of 1-mesyl-glucitol (4.14) with sodium azide in DMF at room temperature 
gave a mixture of 1,4-anhydro-sugar (4.15) (Scheme 60), and the desired azido-
glucitol (4.16), which was isolated in 18 %yield. The anhydro-sugar (4.15) formed 
due to intramolecular participation of the benzyl ether at C-4. The synthesis of such 
tetrahydrofurans by intramolecular substitutions involving benzyl ethers has 
previously been reported. 117 
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(i) 
OBn 
(4.14) (4.16) (4.15) 
(i) NaN3, DMF, rt, 18% of(4.16), 14% of(4.15) or TBAAZ, toluene, 21% of(4.16). 
Scheme 60. Unwanted cyclisation of 1-mesylate (4.14). 
It was anticipated that the intramolecular side reaction might be disfavoured by a non-
polar solvent, due to the polar nature of the transition-state, which presumably 
proceeds via a benzyl oxonium ion. In order to use the less polar solvent toluene, an 
organic-soluble azide source was necessary. One such source is tetra-n-
butylammonium azide (TBAAZ). 118 TBAAZ was made from tetra-n-butylammonium 
hydroxide and sodium azide following a literature preparation. 119 The use of TBAAZ 
(10 eq.) in toluene gave only a moderate increase in yield of 1-azido glucitol (4.16) 
(21 %). 
As the synthesis of 1-azido-tetra-0-benzyl-1-deoxy glucitol ( 4.16) was only achieved 
in very low yield (21 % ), subsequent experiments were performed on a micromole 
scale. 
OBn 
OBn 
(4.16) 
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Scheme 61. Oxidation of azido-glucitol ( 4.16) to give azido-sugar ( 4.17). 
Oxidation of the free secondary hydroxyl group of azido glucitol ( 4.16) with 
pyridinium chlorochromate (PCC) in DCM (Scheme 61) on a 14 J..Lmol scale gave the 
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previously unknown azido ketone ( 4.1 7) in 86 % yield. The structure of the ketone 
was tentatively assigned by its proton NMR. 
Aza-Wittig cyclisation of ( 4.17) with triphenylphosphine in DCM, gave the desired 
imine ( 4.06) as identified by proton NMR, together with decomposition products 
notably substituted pyridine (4.18) (Scheme 62). The imine formed by this method 
was found to be identical to that formed by theN-chlorination/elimination of TBDNJ 
(4.01) (see Section 4.3). 
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Scheme 62. Formation ofketimine (4.06) by a Staudinger aza-Wittig reaction. 
In order to repeat this synthesis, a higher yielding synthesis of azide (4.16) must be 
developed. This was not achieved due to time constraints. 
4.2 Synthesis of TBDINJ (4.02), and its Cyclic Aldimine 1,N-Dehydro-TBDINJ 
( 4.05) by a Staudinger Aza-Wittig Reaction 
Selective protection of the primary hydroxyl function in tetra-0-benzyl-D-glucitol 
( 4.04) (see Section 4.1) with tert-butylchlorodiphenylsilane (TBDPSCl) and 
imidazole, in DMF solution gave the previously unknown, orthogonally protected 
glucitol ( 4.19) in 99 % yield. The free secondary hydroxyl group, when treated with 
methanesulfonyl chloride in dry pyridine at room temperature, gave the previously 
unknown 5-mesyl-glucitol ( 4.20), in 95 %yield (Scheme 63). 
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Scheme 63. Synthesis of protected mesylate (4.20) from 2,3,4,6-tetra-0-benzyl-D-
glucitol ( 4.04). 
SN2 displacement of the secondary mesylate with azide to give the unknown protected 
5-azido-5-deoxy-glucitol derivative (4.21) was only achieved in low yield (35 %) due 
to a competing side reaction (Scheme 64) similar to that observed for 1-mesyl glucitol 
derivative (4.14) (Scheme 60, page 98). The intramolecular cyclisation reaction 
giving the 2,5-anhydro-sugar ( 4.22) (Scheme 64) was found to predominate in all 
cases. Variation of reaction conditions and reagents was performed to optimise the 
yield of this reaction and the results are shown in Table 1. 
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Scheme 64. Nucleophilic displacement of 5-mesylate ( 4.20) by azide, giving azido 
iditol ( 4.21 ), and unwanted 2,5-anhydro-sugar ( 4.22). 
In the polar solvent DMSO, the desired azide (4.21) was only isolated when the azide 
source TBAAZ was used at high concentrations (typically 260 mg of TBAAZ per 1 
mL solvent added) (Table 1 entry 11 ). 
The use of less polar solvents such as toluene and xylene, high temperatures, and high 
concentration of azide favoured the intramolecular reaction. The use of less polar 
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solvents required the use of TBAAZ119 (see Section 4.1), as a soluble source of azide. 
Optimum conditions on a 0.04 mmol scale were found to be refluxing xylene with 10 
equivalents of azide for 1 h, giving only 35 % of the desired product (Table 1, entry 
12). 
Table 1. Formation of azido iditol ( 4.21) by SN2 reaction with azide under varying 
reaction conditions (approx 0.04 mmol scale). 
Yield" Yield" 
Temperature Azide Equivalents 
Entry Solvent (4.22) (4.21) 
I°C Source of Azide 
1% 1% 
1 DMF 30 NaN3 3 64 0 
2 DMF 50 NaN3 3 75 0 
4 DMF 50 LiN3 3 79° 0 
5 DMF 130 NaN3 3 81 0 
6 DMF 130 NaN3 10 76 0 
7 Toluene 110 Bu4NN3 10 37 23 
8 DMSO 50 NaN3 3 61 0 
9 DMSO 130 NaN3 3 75 0 
10 DMSO 130 NaN3 10 78 0 
11 DMSO 130 Bli4NN3 10 69 11 
12 Xylene 165 Bli4NN3 10 58 35 
a) Isolated yields (flash chromatography) b) 10 % starting material ( 4.20) 
recovered. 
All exploratory reactions shown above were performed on a small scale of 
approximately 40 mg ( 45 Jlmol). Upon proportional scale-up of the optimum reaction 
conditions in toluene to 0.5 g (0.58 mmol) the proportion ofazido-iditol (4.21) formed 
was reduced (crude NMR). After repeated chromatography only 2 % of the desired 
azide (4.21) was isolated, together with 70 % of the unwanted 2,5-anhydro-sugar 
(4.22). 
In an attempt to isolate azide (4.21) in sufficient yield to continue the synthesis, the 
0.045 mmol scale reaction in xylene (entry 12, Table 1) was repeated twelve times in 
parallel using a Radley™ Reaction Carousel, and all reactions combined and purified. 
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This method gave an intractable mixture of the desired azido-iditol (4.21) and 
unidentified side products with proton NMR signals in the olefinic region, together 
with the unwanted 2,5-anhydro sugar (4.22) (53 %). The problems associated with 
the scale-up and parallel syntheses may be due to heat transfer through the reaction 
medium at larger scale, or in different vessels. 
As a new strategy it was decided at this stage to explore the use of a Mitsunobu-type 
substitution reaction with hydrazoic acid. 120• 121 
4.2.2 Synthesis of Protected Azido-Iditol (4.21) via a Mitsunobu Reaction 
The formation of alkyl azides via a Mitsunobu-type inversion using hydrazoic acid is 
well known, and a literature procedure for conversion of a secondary hydroxyl to 
azide was followed initially using diisopropylazodicarboxylate (DIAD) and 
triphenylphosphine. 120 Treatment of the protected glucitol derivative ( 4.19) with 
hydrazoic acid, DIAD and triphenylphosphine was expected to give the desired azido 
iditol (4.21) (Scheme 65). 
OBn 
OBn 
(4.19) 
OBn 
(i) 
... ,, 
'''
1osn Bno'''' '''1osn 
OBn 
(4.21) 
(i) HN3, DIAD, PPh3, toluene. 
Scheme 65. Proposed synthesis of protected azido iditol (4.21) via a Mitsunobu-type 
reaction. 
A solution ofhydrazoic acid122 in toluene was prepared from sodium azide according 
to a literature preparation, 123 and titrated against standard sodium hydroxide with 
phenolphthalein indicator. The standardised hydrazoic acid solution was then used 
directly. The Mitsunobu reaction with hydrazoic acid, DIAD, and triphenylphosphine 
gave clean conversion of glucitol (4.19) to the desired azide (4.21). The yield and 
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conversion, however, depended heavily upon the order of addition and quantities of 
reagents used. 
Following a literature procedure120 (Table 2, reaction type A, entry 1), DIAD (1.1 
eq.), was added dropwise to a pre-mixed solution of hydrazoic acid (1.5 eq.), PPh3 
(1.1 eq.), and glucitol (4.19) (1.0 eq.). Under these conditions, the reaction was 
observed to stop before full consumption of starting material. Only 46 % of the 
desired product (4.21) was obtained, together with starting material (38 %). 
Pleasingly none of the unwanted 2,5-anhydro-sugar ( 4.22) was observed. Increased 
reaction times did not improve the yield. 
Table 2. Optimisation ofMitsunobu reaction of glucitol (4.19). 
Yield 
HN3 DIAD PPh3 Reaction Yield Yield of 
Entry 
Eq. Eq. Type a 
(4.19) (4.21)b (4.22)b Eq. (SM)b 
1 1.5 1.1 1.1 A 38 46 0 
2 1.8 1.25 1.3 A 38 52 0 
3 2.5 1.25 1.1 A 19 58 7 
4 1.8 1.1 1.1 B 18c 73c gc 
5 2.5 2.5 2.2 c oc 95c se 
6 2.5 2.5 2.5 c 0 87 8 
a) Reaction procedures defined as: A) PPh3, hydrazoic acid, and glucitol (4.19) 
pre-mixed, DIAD added drop-wise; B) PPh3, and glucitol (4.19) pre-mixed, 
DIAD added drop-wise, then hydrazoic acid added drop-wise to activated 
alcohol; C) PPh3 stirred and DIAD added drop-wise, then premixed hydrazoic 
acid and glucitol ( 4.19) added drop-wise; b) Isolated yields (flash 
chromatography) unless otherwise stated; c) Yields determined by 1H-NMR 
integration of the crude reaction mixture. 
An array of experiments was performed (Table 2), and all reactions, unless complete 
by TLC, were allowed to run for 100 h before work up. In an attempt to increase 
conversion, the quantities of DIAD and hydrazoic acid were increased to 1.25 eq. and 
2.5 eq. respectively (Table 2, entry 3). The reaction was again observed to stop before 
completion, and a proportion of2,5-anhydro-sugar (4.22) was observed. 
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The order of addition of reagents was changed. DIAD (1.1 eq.), PPh3 (1.1 eq.) and 
glucitol ( 4.19) were premixed and stirred for 15 minutes (Table 2, entry 4, reaction 
type B). Hydrazoic acid solution (1.8 eq) was added drop-wise to this solution. 
Again the reaction did not go to completion, and a greater proportion of furan was 
observed (9 %). This may be expected as the activated alcohol is formed in solution 
in the absence of the nucleophile. 
During reaction type A (Table 2), as the DIAD is added last, the desired azido-iditol 
(4.21) is formed in solution with triphenylphosphine (Table 2, reaction type A), which 
could result in reduction of the desired product. 
In order to circumvent both of these problems, pre-m1xmg of the DIAD and 
triphenylphosphine in toluene solution was performed, and a pre-mixed solution of 
HN3 (2.5 eq) and glucitol (4.19) added drop-wise to the mixture (Table 2, reaction 
type C). Since equimolar quantities of DIAD and triphenylphosphine were used, their 
pre-mixing prevents in situ reduction of the desired product, and the use of an excess 
ofboth reagents was possible (2.5 eq.). 
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Scheme 66. Synthesis of azido-iditol (4.21) by a Mitsunobu-type reaction of glucitol 
derivative (4.19). 
On a small scale (0.06 mmol) the reaction proceeded to completion, and NMR 
analysis of the crude reaction mixture showed very little anhydro-sugar formation 
(Table 2, entry 5). Upon scale-up to 1.3 mmol, with the same procedure, column 
chromatography oft he product gave the desired azide ( 4.19) in 8 7 % yield with a 
small quantity (8 %) ofthe anhydro-sugar (4.22) (Scheme 66). 
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4.2.3 Synthesis of 5-Azido-tetra-0-benzyl-5-deoxy-idose (4.24) 
Treatment of protected azido-glucitol (4.21) with tetra-N-butyl ammonium fluoride 
(TBAF) in THF, afforded the 1-0-deprotected azido-glucitol (4.23) in quantitative 
yield (Scheme 67). Subsequent oxidation of the primary hydroxyl to the aldehyde 
was achieved with PCC in DCM, over 4A molecular sieves, in up to 88 % yield 
(Scheme 67). Although evidence for the formation of the subsequent cyclic imine 
was not observed, it is possible that the azido aldehyde decomposes on silica in a 
similar fashion to that observed for azido-sugar (3.19) (see Chapter 3, section 3.5, 
page 69), and therefore minimum contact with silica is recommended. 
~0 
(ii) 
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(i) TBAF, THF, 100 %; (ii) PCC, sieves, DCM, 88%. 
Scheme 67. Synthesis of5-azido idose (4.24) from protected azido iditol (4.21). 
4.2.4 Synthesis of 1,N-Dehydro-TBDINJ (4.05) via a Staudinger Aza-Wittig 
Reaction 
The treatment of 5-azido-idose (4.24) with triphenylphosphine was expected to give 
the desired cyclic imine-sugar ( 4.05) (Scheme 68). The reaction was performed in 
CDCb, and monitored by 1H-NMR using proton signals for the aldehyde (9.7 ppm), 
imine (4.05) (7.8 ppm), and a probable enamine tautomer (4.25) (6.0 ppm). It was 
found that the imine formed (as observed by NMR) but quickly tautomerised to the 
enamine, and further decomposed to the cyclic aza-diene ( 4.26) (Scheme 68). In fact 
treatment of azido idose ( 4.24) with triphenylphosphine in refluxing DCM gave direct 
conversion to aza-diene ( 4.26), which could be isolated by flash chromatography in 
28% yield. 
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In order assess the effect of pH on tautomerisation, the Staudinger reaction was 
performed in CDCh in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) 
(0.1 eq). Further N1\.1R experiments showed enolisation was indeed slowed by the 
presence of DBU, however, when performed with 1,4-diazabicyclo[2.2.2]octane 
(Dabco ™), a weaker tertiary amine base, the imine again rapidly decomposed. 
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Scheme 68. Staudinger aza-Wittig reaction of azide idose ( 4.24) to form 1 ,N-
dehydro-TBDINJ ( 4.05) and subsequent decomposition. 
Use of diethyl ether as the solvent for the Staudinger reaction was found to reduce the 
formation of enamine/aza-diene, and optimum conditions were found to be excess 
triphenylphosphine (3.0 eq) in diethyl ether at room temperature, giving clean 
formation of the desired imine in 90 minutes (1H-Nl\.1R). 
N1\.1R studies showed the imine synthesised by this methodology to be identical to 
that synthesised by the chorination/elimination protocol from TBDINJ (seeS ection 
4.5), and reductive trapping of the aza-Wittig product ( 4.05) with sodium borohydride 
in methanol, gave TBDINJ (4.02) in 50% yield (Scheme 69). Aldimine l,N-dehydro-
TBDINJ ( 4.05) was found to be unstable to silica, and was used without purification. 
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Scheme 69. Reductive cyclisation of azido-idose ( 4.24). 
4.3 Synthesis of Cyclic Ketimine 5,N-Dehydro-TBDNJ (4.06), and Cyclic 
Aldimine 1,N-Dehydro-TBDNJ (4.09) from TBDNJ (4.01) via a 
Chlorination/Elimination Strategy 
N-Chlorination of TBDNJ (4.01) with N-chlorosuccinimide (NCS) in DCM gave N-
chloro-TBDNJ (4.07) in up to 97% yield (Scheme 70). N-Chloro-TBDNJ (4.07) was 
found to be stable at - 18 °C, and could be stored conveniently for several months 
without decomposition. 
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Scheme 70. N-Chlorination ofTBDNJ (4.01). 
Treatment of N-chloro-TBDNJ (4.07) with DBU in diethyl ether at room temperature 
gave elimination of HCl to form only ketimine (4.06) (Scheme 73). In diethyl ether 
and THF the DBU hydrochloride salt was found to precipitate from solution, and was 
conveniently removed by filtration. Ketimine 5,N-dehydro-TBDNJ (4.06) was found 
to be unstable to silica, eliminating benzyl alcohol to yield functionalised pyridine 
(4.18). It was therefore used without purification. The addition of nucleophiles to 
ketimine (4.06) is discussed in Section 4.6. 
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Scheme 71. Elimination of HCl from N-chloro-TBDNJ ( 4.07) at room temperature, 
and subsequent decomposition to pyridine (4.18). 
Decomposition of imine ( 4.06) to the pyridine ( 4.18) is similar to the decomposition 
ofnojirimycin (NJ) observed under acidic conditions (Scheme 72).4 Indeed it has been 
observed that piperidinoses of 5-arnino sugars are generally dehydrated in acidic 
media to give the 3-hydroxypyridine derivatives. 124 
OH 
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Scheme 72. Decomposition ofnojirimycin (NJ) under acidic conditions.4 
Treatment of N-chloro-TBDNJ (4.07) with the stong base lithium 2,2,6,6-
tetramethylpiperidide (LiTMP) at - 78 °C gave elimination of HCl to form 
exclusively the aldimine 1,N-dehydro-TBDNJ (4.09) (Scheme 73). Aldimine (4.09) 
was found to be slightly unstable, decomposing upon silica chromatography and 
storage at - 18 °C. The imine was identified by its characteristic spectroscopic data 
(HC=N, 4I (CDCb) 7.60 ppm (s, H-1); C=N, &:: (CDCb) 162.3 ppm (d, C-1); C=N 
stretch, vmaJcm-1 (film) 1654). 
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Scheme 73. Elimination ofHCl from N-chloro-TBDNJ at- 78 °C giving 1,N-
dehydro-TBDNJ ( 4.09). 
Elimination of HCl from N-chloro-TBDNJ ( 4.07) by an E2 mechanism, as would be 
expected in this case,66'67 would require periplanar geometry of the N-Cl and C-H 
bonds being broken (see Section 1.5.1).68 It is well known that amines undergo 
pyramidal inversion,71 '72 which is slowed in chloramines, due to the presence of 
unshared electrons on chlorine.72 The all-equatorial configuration of N-chloro-TBDNJ 
( 4.07) favours not only the 4C1 conformation, but also a pseudoequatorial position for 
chlorine, giving the proposed favoured structure A (Figure 27). 
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Figure 27. Simple conformational analysis of N-chloro-TBDNJ ( 4.07), and its 
relation to the formation ofketimine (4.06). 
In adopting a axial configuration ( NClax) by p yramidal inversion, as in structure B 
(Figure 27), the chlorine atom gains an anti-periplanar relationship to the ,8-hydrogen 
atoms at C-1, and C-5, allowing formation of the more stable ketimine in a Zaitzev-
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type elimination (see Chapter 1, Section 1.5.1). We speculate that the NClax structure 
B is not accessible at- 78 °C, but is readily accessible at room temperature. 
In general, elimination of HCl from N-chloro compounds in acyclic systems follows 
Zaitzev's rule in that the more substituted, imine is the expected product (see Chapter 
1, section 1. 5.1). This suggests that the reaction is product dependent or has a late 
product-like transition-state. 
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Figure 28. VT 13C-NMR studies on N-chloro-TBDNJ (4.07) (TfC). 
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Figure 28. VT 13C-NMR studies onN-chloro-TBDNJ (4.07) (TfC). 
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The slow inversion of stereochemistry at nitrogen is observable by its effect on the 
room temperature 13C-NMR oftetra-0-benzyl-N-chloro DNJ, causing a broadening of 
the carbon peaks adjacent to nitrogen in the ring. Preliminary variable temperature 
13C-NMR studies (Figure 28) have allowed us to observe the temperature dependence 
of this inversion. 
In the case of TBDNJ ( 4.01) we can assume a preferential 4C 1 conformation, with all 
benzyl ethers adopting an equatorial position. This is supported by the large proton-
proton NMR coupling constants eJHH) in the ring, and is analogous to the 4Cl 
conformation observed in similar D-glucose systems. 125 Pyrimidal inversion at 
nitrogen can be observed to slow upon cooling, by increased resolution in the 13C-
NMR spectrum, beginning around- 35 °C (Figure 28). 
Once locked in the lowest energy NCleq orientation, anti-elimination of HCl to form 
the ketimine is not possible (Figure 27). 
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Figure 29. Conformations allowing anti-periplanar elimination ofHCl in N-chloro-
TNDNJ ( 4.07) at low temperatures. 
We speculate that, at such low temperatures, only a few anti-periplanar conformers 
are accessible involving either of the two more stable boat forms of the system, 
conformations c e,4B), and D CBN,3) as shown in Figure 29, above. Ring flip to the 
alternative 1C4 chair with all substituents axial, which is unfavourable due to 1,3-
diax:ial interactions, also allows antiperiplanar alignment ofH-1, and N-Cl. 
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Upon treatment of N-chloro-TBDNJ ( 4.07) with lithium tetramethylpiperidide 
(LiTMP) at - 78 °C, elimination to form exclusively the aldimine is observed, 
consistent with the rationalisation above (Scheme 73). 
The other competing reaction in this case is a metal-halogen exchange, which we 
observed under certain conditions such as in the presence of Grignard reagents, with 
the use of LDA at low and elevated temperatures, and the use of LiTMP at room 
temperature. In such cases, reduction of the chloramines to the amine is observed, 
probably via metal/halogen exchange. 
The low temperature elimination was also attempted with the strong phosphazene 
base P4-t-butyl phosphazene ( 4.29), 126 however no elimination was observed. 
Formation of TBDNJ ( 4.01 ), possibly through halogen exchange, occurred. 
(4.29) 
Figure 30. P4-t-butyl phosphazene (4.29). 126 
These stereochemical rationalisations are based on simple modelling studies, and are 
intended to explain the experimental data. Another possibility, in the case of stronger 
bases, is a more ElcB-like mechanism, with the partial formation of an anion at the 
more stable C-2 position, giving the aldimine ( 4.09) upon elimination of chloride. In 
order to assess the mechanism fully kinetic isotope and isotope exchange experiments 
would be required. 66•67 
These studies have allowed us access to both cyclic imines (4.06) and (4.09) derived 
from TBDNJ ( 4.01 ), and these have been screened with organometallic nucleophiles 
(see Section 4.6). 
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4.4 Synthesis of TBDINJ (4.02) from Tetra-0-benzyl-D-glucitol (4.04) via a 
Double Displacement Strategy 
In this case, synthesis ofTBDINJ (4.02) is based around a known strategy towards the 
synthesis of fully deprotected DINJ via a double displacement of two methanesulfonyl 
groups by a suitable 'bidentate' nitrogen nucleophile. Haines et a!Y 5 used 
benzylamine as the nucleophile, giving the intermediate N-benzyl-TBDINJ (4.31), 
and cleaved all 0-benzyl ethers and the N-benzyl group in one step, giving fully 
deprotected DINJ (Scheme 74). 
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Scheme 74. Synthesis of2-deoxy idonojirimycin via a double displacement 
reaction. 115 
Since we require the tetra-0-benzyl derivative of DINJ, we initially attempted 
introducing protecting groups orthogonally by use of aminodiphenylmethane as the 
amine source, giving the N-diphenylmethane derivative. 
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Scheme 75. Synthesis of dimesyl glucitol derivative ( 4.1 0). 
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Treatment of glucitol (4.04) (Scheme 75) with methanesulfonyl chloride gave the 
protected 1,5-dimesyl-glucitol (4.10) in 71 % yield. The previously unknown double 
displacement of this dimesylate by aminodiphenylmethane, without solvent, 
proceeded in low yield ( 4 % isolated), as may be expected for such a bulky 
nucleophile. Problems were also encountered m removmg the 
aminodiphenylmethane, which has a high boiling point. Due to the low recovery, the 
product ( 4.32) was only identified by its mass spectrum. This strategy was abandoned 
due to the problems encountered during purification. 
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Scheme 76. Synthesis of N-benzyl-TBDINJ (4.31), and N-diphenylmethyl-TBDINJ 
(4.32) from dimesylate (4.10). 
In order to assess the double displacement reaction of dimesylate (4.10), benzyl amine 
was used, following the method of Haines et al., 115 and pleasingly the protected N-
benzyl-TBDINJ (4.31) could be isolated in 72 % yield after distillation of the excess 
benzylamine (Scheme 76). Subsequent selective deprotection of the N-benzyl group 
should be possible, 127 but was not attempted. A n alternative synthesis ofT BDINJ 
(4.02) was devised instead. 
The low yields obtained with aminodiphenylmethane in this synthesis prompted us to 
investigate an alternative, novel strategy. The lower reactivity of the secondary 
mesylate in dimesyl-glucitol derivative (4.10) to nucleophilic addition of azide 
allowed selective formation the 1-azido-5-mesyl-glucitol (4.33) (Scheme 77). 
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Scheme 77. Formation ofazido-mesyl-glucitol (4.33). 
Treatment of the dimesyl glucitol (4.10) with sodium azide in DMF at room 
temperature gave the 1-azido-5-mesyl-glucitol ( 4.33) in 48 % yield (78 % based on 
the recovery of the starting dimesylate (4.10)). However, the reaction did not proceed 
to completion even with extended reaction times. Elevated reaction temperatures 
improved this yield. 
Optimum conditions were found to be sodium azide in DMF at 70 °C for 7 h, giving 
the desired azido mesylate in up to 79 % yield with 17 % of the unwanted 5-azido-
1,4-anhydro-sugar (4.34) (Scheme 77). Cyclisation of the azido mesylate with 
triphenylphosphine in THF with dilute aqueous NaOH gave TBDINJ (4.02) in 92% 
yield after purification by cationic ion exchange (Scheme 77). 
OBn OBn 
I H 
'lt11, 
9
N 
'·· 
""o'" •.. :: .... ,,,OBo 
(i) 
OBn OBn 
(4.33) (4.02) 
(i) PPh3, Et20, then THF, NaOH (aq.), 92 %. 
Scheme 78. Synthesis ofTBDINJ (4.02). 
As an alternative large-scale approach to this synthesis of TBDINJ (4.02), the above 
reaction was performed in one pot (Scheme 79). Addition of triphenylphosphine and 
sodium hydroxide solution to the reaction mixture after formation of the azido 
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mesylate (4.33) gave TBDINJ in 61 %yield from dimesylate (4.10), an overall yield 
of 43% from tetra-0-benzyl-D-glucose (4.03) over 4 steps. 
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Scheme 79. One-pot synthesis ofTBDINJ (4.02) from dimesylate (4.10). 
4.5 Synthesis of Cyclic Aldimine l,N-Dehydro-TBDINJ (4.05) from TBDINJ 
( 4.02) via a Chlorination/Elimination Strategy 
TBDINJ ( 4.02) (Section 4.4) undergoes N-chlorination efficiently (Scheme 80), as 
was observed for the TBDNJ analogue (see Section 4.3). The desired N-chloro-
TBDINJ (4.08) was formed in up to 87 % yield by treatment of TBDINJ (4.02) with 
NCS in DCM, and could be stored at - 18 °C for several weeks without significant 
decomposition. 
OBn OBn Cl 
I H I I 
"'''''····9N (i) "''''•• ... 9N 
\,,,.· ·.,,,, ,,,,.. ·.,,,, 
Bno''\ 1110Bn sno''\ 1110Bn 
0~ 0~ 
(4.02) (4.08) 
(i) NCS, DCM, 87 %. 
Scheme 80. Chlorination ofTBDINJ (4.02). 
Studies of elimination reactions of N-chloro-TBDNJ ( 4.07) (Section 4.3) led us to 
expect that anti-elimination of HCl, via the 4C1 conformation NClax configuration, 
would be favoured at elevated temperatures (Figure 27, above). In the case of the 
analogous N-chloro-TBDINJ system (4.08) (the C-6 epimer of N-chloro-TBDNJ 
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(4.07)) elimination to form ketimine (4.06) via the 4C1, NClax structure (B, Figure 31) 
is not allowed. Using the same stereoelectronic considerations as applied to the DNJ 
system, only elimination to form the aldimine of TBDINJ can occur under such 
conditions (Figure 31, below). 
BnO H 
~H 
/'''''' BnO '··. 
., 
''''''
1oan 
OBn 
Figure 31. Conformational analysis of N-chloro-TBDINJ (4.08), and its relation to 
formation of 1 ,N-dehydro-TBDINJ ( 4.05). 
It was found that treatment of N-chloro-TBDINJ ( 4.08) with DBU at room 
temperature gave the aldimine (4.09) as expected. The reaction was, however, slower 
than for the analogous N-chloro-TBDNJ ( 4.07) (Section 4.3), and evidence for 
enolisation of the imine (crude NMR) was observed before total consumption of the 
chloramine (4.08). Total consumption of starting material (TLC) was only observed 
after> 48h. 
The reaction was performed in CDCh, and the progress monitored by 1H-NMR. Slow 
formation of the desired imine could be observed eH, s, 7.85 ppm; 13C, d, 164 ppm.) 
together with formation of another product, possibly the enamine eH, 5.56 ppm, 13C 
140.7, 126.3). 
In refluxing THF the reaction was found to proceed faster. However, enolisation was 
again observed at the end-point. Optimum conditions were found to be 1.1 eq. DBU 
in refluxing diethyl ether for 7 h. After formation of the imine the hydrochloride salt 
of DBU was removed by filtration and the resultant solution was used directly in 
addition reactions (see section 4.7), as degradation of the imine was observed if stored 
for any length of time, even at low temperatures. 
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Scheme 81. Formation of l,N-dehydroTBDINJ (4.05). 
The above observations are in agreement with the stereoelectronic factors discussed in 
Section 4.3 above with regard to elimination ofHCl from N-chloro-TBDNJ (4.07). 
4.6 Irreversible Addition Reactions of Cyclic lmines S,N-Dehydro-TBDNJ (4.06) 
and l,N-Dehydro-TBDNJ (4.09) 
Ketimine (4.09) formed by the room temperature elimination of HCl from N-chloro-
TBDNJ (see Section 4.3), was treated with various commercial Grignard reagents 
(MeMgBr, PhMgBr, EtMgBr and BnMgCl). Addition of the Grignard reagent to the 
imine in diethyl ether solution at room temperature led to decomposition of the imine, 
and no addition product was isolated for any of the Grignard reagents used. Addition 
of the nucleophile at low temperature (- 78 °C), followed by warming to room 
temperature gave isolable addition products in the case of methyl, and benzyl 
Grigards (see Table 3). In the case of phenyl and ethyl Grignards, only trace 
quantities of products arising from addition were isolated. Their identities were 
confirmed by mass spectroscopy. 
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A = BnOCH2,B = Bn, ( 4.36) 
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Scheme 82. Irreversible addiditon to ketimine 5.N-dehydro-TBDNJ (4.06). 
In a 11 cases significant decomposition o f the imine was observed, and by-products, 
such as benzyl alcohol and the functionalised pyridine (4.18), were isolated. 
Treatment of the imine with 5 eq. of the desired Grignard reagent at- 78 °C for 1.5 h 
followed by warming to room temperature for a further 12 hand quenching with aq. 
N}4Cl gave best yields of adducts, up to 19 % from N-chloro-TBDNJ (4.07) for 
benzylmagnesium chloride (Table 3). 
Stereocontrol of addition to the cyclic ketimine ( 4.06) can be rationalised by accepted 
stereo electronic and steric influences associated with such systems (see Chapter 1, 
Section 1.4).58 The addition of a nucleophile to a 6-membered cyclic sp2 system, in 
the absence of steric approach effects, should afford preferentially the product 
corresponding to the lower energy transition-state. The conformation of the 
transition-state is defined by the requirement for the reactive electron pair of the 
nucleophile to maintain orbital alignment with the breaking double bond, and the 
change in stereochemistry forced by the sp2 to sp3 transition. For example, Figure 32 
shows the approach of a nucleophile to ketimine (4.06). Path a (Nuc-ax) leads to a 
chair-like 4C1 transition-state (conformation A, Figure 32), and Path b (Nuc-eq) to a 
higher energy boat-like transition-state (conformation B, Figure 32). 
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Figure 32. Proposed transition-states in addition to cyclic ketimine 1 ,N-dehydro-
TBDNJ (4.06). 
Path a reactions are generally observed to be favoured, and products corresponding to 
such pseudo-axial attack are generally isolated in such cases (see Chapter 1, Section 
1.4). In our case the less bulky Grignard reagent, methyl, approached in a Path a type 
reaction, whereas the larger benzyl Grignard gave only the product corresponding to 
equatorial addition. In the case of benzyl Grignard we must therefore assume that the 
size of the nucleophile is introducing a new controlling factor to the addition. Simple 
steric approach control analysis of the imine shows that, when steric approach factors 
dominate, the preferred approach of the nucleophile is from the least hindered face, 
equating to Path b by our nomenclature (Figure 33). 
Path a Path b 
8-
Nuc· 
BnO 
I + 
'V\f\JV 
0 H 
BnO 
OBn 
Figure 33. Steric approach control analysis of addition to ketimine ( 4.06). 
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In order to probe further the stereochemistry of addition to the cyclic ketimine ( 4.06), 
nucleophilic addition of hydride was attempted in diethyl ether, with Li~ as the 
hydride source. Reduction gave only the DNJ diasteroisomer (87 % from N-chloro-
TBDNJ (4.07)). 128 The observations are consistent with axial attack of hydride, as 
might be expected for a small nucleophile. The results are also consistent with the 
reduction of S,N-dehydro-1-C-ethyl-TBDINJ (4.38) (Section 4.9) in the synthesis of 
the (-)-adenophorine skeleton. 
Table 3. Optimised results of addtition reactions to DNJ ketimine ( 4.06). 
Nucleophile Yieldb 
Conditions Product 
1% 
MeMgBr EhO, - 78 °C- rt ~'" (4.35) 10 OBo 
PhMgBr Et20, - 78 °C - rt - - -
BnMgCl EtzO, - 78 °C - rt ~ -~· ..... ,.. (4.36) 19 
""" 
H 
LiAl~ Et20, rt, 10 min -~"- (4.01) 87 
o .. 
Et2Mg -78 °C- rt, 2h -
- -
EtMgBr rt, reverse addition - - a 
a) Isolated yields over two steps from N-chloro-TBDNJ ( 4.07). 
Addition reactions were attempted with aldimine ( 4.09), as synthesised by the low 
temperature elimination of N-chloro-TBDNJ (4.07) (see Section 4.3). Screening with 
methyl, phenyl, benzyl Grignards at - 78 °C, then warming to room temperature 
before quenching gave no isolable adducts. In some cases formation of TBDNJ ( 4.01) 
was observed, possibly due to metal/halogen exchange of unreacted N-chloro-TBDNJ 
( 4.07), together with intractable mixtures of degradation products. 
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4.7 Synthesis of (-)-1-epi-Adenopll:aoll'ine (4.12) by Nucleophilic Addition to l,N-
Dehydro-TBDINJ (4.05) 
Nucleophilic addition to l,N-dehydro-TBDINJ (4.05) as formed by the 
chlorination/elimination of TBDINJ (see section 4.5) was attempted with the aim of 
synthesising the natural product adenophorine. Attempts at additions were therefore 
based around ethyl nucleophiles. Simple addition of ethylmagnesium bromide at 
room temperature led to decomposition of the imine and formation of the elimination 
product (4.26), through loss of benzyl alcohol (Scheme 83). Interestingly, complete 
elimination to form the pyridine was not observed, unlike the case of the formation of 
pyridine (4.18) from 5,N-dehydro-TBDNJ (4.06) ketimine under similar conditions 
(see Section 4.6). Performing the reactions at low temperature (- 78 °C), as was 
successful for 5,N-dehydro-TBDNJ (4.06) (Section 4.6), gave no isolable adducts in 
this system. 
/lt,,,,, 
BnO/ ··. 
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(i) DBU, Et20, reflux, 7h; (ii) EtMgBr, rt, Et20. 
Scheme 83. Decomposition of l,N-dehydro-TBDINJ (4.05) in the presence of 
Grignard reagents. 
It is possible that the basicity of the nucleophile contributed to the elimination. 
However, the same product was observed by the spontaneous decomposition of the 
imine in solution as formed either by the Staudinger approach or by the 
chlorination/elimination method (Sections 4.2, and 4.5 respectively). In order to 
change the properties of the nucleophile several factors were employed. 
Initially, use of catalytic copper(!) iodide was attempted in order to 'soften' the 
nucleophile, possibly making it more compatible with the azomethine electrophile,49 
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however, no incorporation of the ethyl nucleophile was observed under the conditions 
used. 
Dialkyl zincs have been observed to add to imines with and without activators such as 
amino-alcohols or Lewis acids. 56 Treatment of imine ( 4.05) with diethyl zinc at room 
temperature in diethyl ether gave no incorporation of the nucleophile. 
Use of the less basic dialkylmagnesium reagent in diethyl ether solution at - 78 °C 
was attempted by use of 1 ,4-dioxane to displace the Schlenk equilibrium in favour of 
the dialkyl nucleophiles. 89 Pleasingly addition to the imine was observed under these 
conditions, and up 35 %of desired adduct (4.37) was isolated (Scheme 84). Varying 
quantities of TBDINJ, were also formed during such reactions, probably formed by 
halogen exchange of N-chloro-TBDINJ ( 4.08) during the elimination or residual N-
chloro-TBDINJ (4.08) after the addition of the Grignard reagent. Decomposition of 
the imine was also observed, with aza-diene ( 4.26) being formed. 
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BnO/ '·· /'''''' (ii) BnO '··· 
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(i) DBU, Et20, reflux, 7 h; (ii) EtMgBr, I ,4-dioxan , - 78 °C, Et20, 35 % from ( 4.08). 
Scheme 84. Addition to 1,N-dehydro-TBDINJ (4.05). 
The addition product was found to have broad room temperature 1H- and 13C-NMR 
spectra, suggesting that m ore than one conformational state was readily accessible. 
The equatorial nature of the majority of substituents in the desired product 
adenophorine would suggest that the 4C1 chair form would be favoured as this allows 
four pseudoequatorial substituents, reducing diaxial interactions. 129 
Proton-proton coupling constants for ( 4.37) were not observable, and the relative 
stereochemistry at C-1 could not be determined by this means. NOe interactions were 
observed but were inconclusive, possibly due to the conformationallability. In order 
to assign the C-1 stereochemistry of adduct ( 4.3 7) it was decided to remove the benzyl 
123 
protecting groups and compare the sample to an authentic sample o fa denophorine 
supplied by Assano et al. 116 
Deprotection of (4.37) by hydrogenation over with palladium(ll) chloride gave the 
hydrochloride salt of the fully deprotected aza-sugar, which could be converted into 
the free base by ion exchange (see Section 4.9). The NMR spectrum of the 
deprotected aza-sugar showed it to be different to the authentic sample of 
adenophorine, indicating that the C-1 epimer had been formed, and the 
stereochemistry of ( 4.37) was assigned accordingly. NOe experiments showed 
through-space interactions between H-1, and H-5 (Figure 34) suggesting that the 
preferred conformation of the deprotected sugar in water was the opposite 1C4 chair, 
with three axial hydroxyl groups. 
OH OH 
(4.12) 
Figure 34. NOesy interactions of deprotected aza-sugar (4.12) in D20. 
The conformational analysis of the deprotected sugar allowed analysis of the 
stereochemistry of addition to the cyclic imine ( 4.05), with axial attack of the 
nucleophile, as might have been expected under stereoelectronic consideration of the 
transition state (see Section 4.6). Under our nomenclature, addition could occur by 
one of two paths, Path a or Path b (Figure 35). 
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Figure 35. Proposed transition-states for addition to cyclic imine ( 4.05). 
As we reasoned earlier (see Section 4.6), addition of a small nucleophile such as 
diethylmagnesium, to such an imine system should preclude formation of a favourable 
chair-like transition-state (l?ath a, Figure 26). Steric-approach-controlled additions, 
such as may be expected with large nucleophiles, should proceed by Path b. 
Retrospective analysis of the transition-state allows us to rationalise the observed 
addition via Path a, and propose another synthesis of the desired natural product by 
reduction of the cyclic ethyl ketimine (4.13) with a small hydride source (see Section 
4.8). 
4.8 Synthesis of (-)-Adenophorine by Addition of Hydride to Cyclic Ketimine 1-
Ethyl-1 ,N-dehydro-TBDINJ ( 4.13). 
Ethyl ketimine 1 ,N-dehydro-1-C-ethyl-TBDINJ ( 4.13) was our target molecule, and 
retrosynthetic analysis gave a convenient synthesis from the azido-sugar ( 4.24), 
synthesised earlier (see Section 4.2). Nucleophilic addition to the aldehyde function 
was achieved with ethylmagnesium bromide in diethyl ether at room temperature, 
giving an inseparable mixture of diastereoisomers ( 4.39), and ( 4.40) ( dr 1 : 3) in up to 
70 % yield (Scheme 85). 
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Scheme 85. Nucleophilic addition to azido-sugar ( 4.24). 
The resultant mixture of azido alcohols ( 4.39), and ( 4.40), was treated with PCC in 
DCM, giving the azido ketone (4.41) in up to 72 % yield (Scheme 86). The azido 
ketone is a direct precursor to the desired ketimine (4.13) via a Staudinger aza-Wittig 
cyclisation. 74 
OBn 
I OH 
,,,, N3 
'''··· 
OBn 
( 4.39) ( 4.40) 
OBn 
(4.41) 
(i) PCC, DCM, sieves, 72 %. 
Scheme 86. Oxidation of azido-alcohols ( 4.39), and ( 4.40). 
The Staudinger reaction of ketone (4.41) was performed initially in DCM with 
triphenylphosphine. It was found that considerable decomposition of the imine 
occurred in DCM or CDCh, similar to that observed during the formation of aldimine 
l,.N-dehydro-TBDINJ (4.05) by a Staudinger reaction (see Section 4.2). Imine (4.05) 
decomposed by elimination of benzyl alcohol, and the aza-diene ( 4.42) (Scheme 87) 
could be isolated after extended reaction times. This decomposition was less 
pronounced in diethyl ether solution, and optimium conditions for the formation of 
ketimine (4.13) were found to be treatment with excess triphenylphosphine (3.0 eq.) 
in diethyl ether for 3 hat room temperature. Ketimine (4.13) could not be purified by 
flash chromatography, and was therefore used immediately in all subsequent 
reactions. 
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Scheme 87. Formation of1,N-dehydro-1-C-ethyl-TBDINJ (4.13) and subsequent 
decomposition with extended reaction times. 
Treatment of ketimine ( 4.13) with a suitable nucleophilic hydride source was 
expected to give the desired adenophorine stereochemistry, by analogy with 
nucleophilic addition to the similar 1 ,N-dehydro-TBDINJ ( 4.06) (Section 4. 7). 
Formation of the proposed lower energy chair-like transition-state (conformation A, 
Figure 36), by pseudo-axial attack of hydride (Path a), should be favoured over the 
more strained boat-like transition-state (conformation B, Figure 36) formed by 
pseudo-equatorial attack ofthe nucleophile (Path b). 
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Figure 36. Proposed transition states for nucleophilic addition of hydride to ketimine 
(4.13). 
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Steric approach control analysis of the addition (Figure 37) shows the least hindered 
approach for the nucleophile to be pseudo-equatorial (Ireq), and as such would lead to 
the 1-epi-adenophorine. In this model, however, no consideration is given to the 
energetic barriers associated with change of conformation in the ring. Again, the 
stereochemistry may be defined by the size of the nucleophile, larger nucleophiles 
being directed by steric approach control. 
_..,..,...,,,,,,, 
BnO/ '•. 
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lFigure 37. Steric approach control analysis of addition to the cyclic ketimine (4.13). 
Initially methanolic sodium borohydride was chosen as the hydride source. The 
ketirnine (4.13) was synthesised by the Staudinger reaction of azido-sugar (4.41) in 
diethyl ether. The reaction mixture was immediately concentrated and redissolved in 
methanol with sodium borohydride (5.0 eq.). The borohydride reduction led to 
formation of a mixture of the desired (1S) isomer, tetra-0-benzyl-adenophorine ( 4.43) 
(16 %), and the (1R) isomer (4.37) (32 %), (dr 1 : 2). 
As an alternative approach, diethyl ether was used as the solvent, consistent with 
additions to the corresponding l,N-dehydro-TBDINJ (4.05) (see Section 4.7). 
Lithium aluminium hydride (LAH) was chosen as a nucleophilic hydride source. 
Addition of LAH to the Staudinger reaction mixture after imine formation gave only 
the adenophorine isomer ( 4.43), isolated in 68 % yield, together with the unsaturated 
piperidine (4.42) (13 %) (Scheme 88). None of the epi-adenophorine isomer was 
observed. 
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Scheme 88. Reduction ofketimine (4.13). 
In order to assess the effect of the size ofthe hydride source in diethyl ether, reduction 
of the imine was attempted with K-selectride, however, no reduction at all was 
observed, and only the aza-diene ( 4.42) was isolated even with extended reaction 
times and excess reagent. 
4.9 Deprotection of Aza-Sugars (4.37), (4.43), (4.35) and! (4.36) 
In order to demonstrate the utility of the above methodology in the synthesis of 
potentially biologically active compounds, removal of protecting groups from 
protected aza-sugars adducts (4.37), (4.43), (4.35) and (4.36) was attempted by 
catalytic hydrogenation. 
OBn OH 
A= Me, B = BnOCH2, (4.35) A= Me, B = HOCH2, (4.45) 
A = BnOCH2,B = Bn, ( 4.36) A = HOCH2,B = Bn, ( 4.46) 
(i)H2, PdC12, methanol, 93% for (4.45), (4.46) not isolated. 
Scheme 89. Hydrogenation of protected aza-sugars (4.35), and (4.36). 
Treatment of ( 4.35) with hydrogen in the presence of palladium(ll) chloride in 
methanolic solution gave the desired aza-sugar ( 4.45) in 93 % yield. Under similar 
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conditions, however, decomposition of (4.36) was observed, and no isolable product 
was obtained. 
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(i)H2, PdCI2, ethanol, 87% for (4.12), 100% for (4.11). 
Scheme 90. Synthesis of(-)-adenophorine (4.11), and (-)-1-epi-adenophorine (4.12). 
Hydrogenation of ( 4.37) in the presence of p alladium(II) chloride gave the desired 
(-)-1-epi-adenophorine ( 4.12) in 87 % yield. The stereochemistry was assigned by 
nOesy interactions (see Section 4.7, Figure 34, p 124). Similarly, removal of 
protecting groups from ( 4.43) gave the desired (-)-adenophorine ( 4.11) in quantitative 
yield. The sample was found to be identical in all respects to the authentic (+)-
adenophorine supplied by Assano et al., 116 except for the sense of its optical rotation 
((4.11): [a]0 22·0 =- 52.3 (c = 0.20, H20); (+)-adenophorine: [[a]o = + 59.7 (c = 1.0, 
H20)). It was by this means we were able to assign the absolute configuration of(+)-
adenophorine. 
4.10 Summary and Conclusions 
In this chapter we have investigated the formation and reactivity of several 
functionalised cyclic piperidine imines. Such imines have been shown to be versatile 
intermediates in the synthesis of novel aza-sugars as potential sugar-processing 
enzyme inhibitors via nucleophilic addition reactions. 
We have observed, and rationalised, good diastereoselectivity in such additions, and 
have used the methodology to acheive the first synthesis of the natural product 
enantiomer (-)-adenophorine (4.11), and its C-1 epimer (4.12). 
The use of such imines has allowed the late-stage introduction of functionality to aza-
sugar scaffolds a- to the ring nitrogen. Through careful control of reaction conditions 
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we have also controlled the regiochemistry of formation of imines from their N-chloro 
precursors. 
In order to mcrease the utility of this methodology, commercially available 
nucleophiles have been used throughout, with a particular emphasis on Grignard 
reagents, also found to be very successful in the case of rhamnopyrrolidine imine 
(3.03) (Chapter 3, Section 3.4). Future work in this field may concentrate on other 
carbon nucleophiles (see Chapter 1, Section 1.4), which may help to increase further 
the yields of additions to such systems. 
We have achieved good yields and excellent diastereoselectivites in the reduction of 
cyclic ketimine (4.13) (Section 4.8), and as such have developed methodology 
allowing potential access to a wide variety of aza-sugars with late-stage introduction 
of functionality and conveniently defined stereochemistry. 
4.11 Experimental Section 
2,3,4,6-Tetra-0-benzyl-D-g/ucito/ (4.04) (Ref 114): 
BnO 
OBn 
2,3,4,6-Tetra-0-benzyl-D-glucose (4.03) (1.0 eq, 9.24 mmol, 5.00 g) was dissolved in 
THF (70 mL). Distilled water (35 mL) was added, and nitrogen bubbled through the 
solution for 30 seconds. Sodium borohydride was added (10 eq, 0.0924 mol, 3.50 g) 
in one portion, and the reaction stirred under nitrogen for 24 h. At the end of this time 
TLC analysis (5 : 4, ethyl acetate: hexane) revealed complete consumption of starting 
material. The reaction was stopped after 24 h by addition of~Cl (aq, satd.) until 
effervescence ceased. The THF was removed in vacuo, diethyl ether (150 mL) was 
added, and the organic layer washed with H20 (3 x 50 mL). The organic layers were 
isolated, dried (MgS04), filtered, and the solvent removed to give a colourless oil 
which was purified by flash chromatography to yield 2,3,4,6-tetra-0-benzyl-D-
glucitol (4.04) as a colourless oil (4.98 g, 99.7 %)1: [a]0 26 + 11.8 (c = 1.00, CHCh) 
(lit. 114 [a] 0 19 + 10.3 ( c = 4 .54, CHCh); mlz 5 65.2 (ES, [M+Nat, 100 %, MeOH), 
1107 ([2M+Nat, 40 %); Vmax (film)/cm-1: 2867, 2923 (aliphatic C-H stretch), 3028, 
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3061 (aromatic C-H stretch), 3447 (br, 0-H stretch); ~ (CDCh, 500 MHz, gCOSY, 
gHSQC) 2.13 (t, 1H, CIOH, JHH 4.8 Hz), 2.97 (d, 1H, C50H, JHH 5.5 Hz), 3.57 (pdt, 
1H, H-1, JHH 5.0 Hz, JI,I' 11.4 Hz), 3.65 (m, 2H, H-6, H-6') 3.71-3.83 (m, 3H, H-1, H-
2, H-4), 3.90 (dd, 1H, H-3, JHH 3.70 Hz, JHH 6.4 Hz), 4.04 (m, 1H, H-5), 4.52 (d, 1H, 
1 x PhCfuO, JHH 11.8 Hz), 4.55 (d, 1H, 1 x PhCfuO, JHH 11.6 Hz), 4.56 (d, 1H, 1 x 
PhCfuO, JHH 11.8 Hz), 4.60 ( d, 1 H, 1 x PhCfuO, JHH 11.6 Hz), 4.64 ( d, 1 H, 1 x 
PhCfuO, JHH 1 1.6 H z), 4.67 ( d, 1 H, 1 x P hCfuO, JH H 1 1.3 H z), 4 .68 ( d, 1 H, 1 x 
PhCfuO, JHH 11.6 Hz), 4.73 (d, 1H, 1 x PhCfuO, JHH 11.3 Hz), 7.21-7.39 (m, 20H, 
aromatic CH); &::: (CDCh, 125.7 MHz, DEPT, gHSQC) 62.0 (t, C-1), 70.8, (d, C-5), 
71.2 (t, C-6), 73.2, 73.4, 73.6, 74.6 (4 X t, 4 X PhCH20), 77.4, 79.2 (2 X d, C-2, C-4), 
79.6 (d, C-3), 127.9, 127.98, 128.04, 128.07, 128.12, 128.3, 128.55, 128.57, 128.59, 
128.60, 128.61 (d, 11 of 20 aromatic CH, others coincident), 137.93, 137.97, 138.10, 
138.27 (4 x s, 4 x quaternary aromatic); HRMS found 565.2596 (C34H3s Na06 
([M+Nat) requires 565.2566). 
6-Azido-1, 3, 4, 5-tetra-0-benzyl-6-deoxy-L-sorbose ( 4.17): 
BnO 
1-Azido-2,3,4,6-tetra-O-benzy1-1-deoxy-D-glucitol (4.16) (1.0 eq, 14.4 ~-tmol, 8.2 mg) 
was dissolved in DCM (1.5 mL) with molecular sieves (4 A, powdered, 200 mg) and 
PCC (3.1 eq, 44.6 ~-tmol, 9.6 mg). The mixture was stirred under nitrogen for 3 days 
before filtering through a plug of silica (1 : 1, ethyl acetate : hexane eluent). The 
solvent was removed in vacuo to give 6-azido-1,3,4,5-tetra-0-benzyl-6-deoxy-L-
sorbose (4.17) as a colourless oil (7.0 mg, 86 %): ~ (CDCh, 300 MHz) 3.22 (dd, 1H, 
H-1, h2 6.7 Hz, hi· 13.1 Hz), 3.34 (dd, 1H, H-1 ', JI·,2 3.7 Hz, hi· 13.1 Hz), 3.75 
(ddd, 1H, H-2, lJ-,2 3.7 Hz, h3 6.0 Hz, h2 6.7 Hz), 3.94 (dd, 1H, H-3, h4 3.7 Hz, J2,3 
6.0 Hz), 4.09-4.21 (m, 3H, H-4, H-6, H-6'), 4.35-4.63 (m, 8H, 8 x PhCfuO), 7.17-
7.35 (m, 20 H, aromatic CH). 
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2, 3, 4, 6-Tetra-0-benzyl-1-0-tert-butyldiphenylsilyl-D-glucito/ ( 4.19): 
OTBDPS 
BnO 
OBn 
2,3,4,6-Tetra-0-benzyl-D-glucitol (4.04) (1.0 eq, 2.04 mmol, 1.11 g) was dissolved in 
dry DMF (3.0 mL), and imidazole (2.2 eq, 4.50 mmol, 306 mg) added with stirring 
under nitrogen. tert-Butylchlorodiphenylsilane (1.3 eq., 2.66 mmol, 0.689 mL) was 
added dropwise with stirring. The reaction was stirred under nitrogen for 24 h. At the 
end of this period TLC analysis (1 : 1, ethyl acetate : hexane eleunt) revealed 
complete conversion of starting material into product. The reaction was stopped after 
24 h by removal of the solvent in vacuo and the residue purified by flash 
chromatography (15 : 85, ethyl acetate : hexane eluent) to yield 2,3,4,6-tetra-0-
benzyl-1-0-tert-butyldiphenylsilyl-D-glucitol (4.19) as a colourless oil (1.58 g, 99 
%): [a]o20·0 + 19.5 (c = 1.00, CHCb); m/z 803.2 (ES, [M+Nat, 100 %, MeOH); Vmax 
(film)/cm-1: 3490 (br, 0-H stretch), 3806, 3065, 3029 (aromatic C-H stretch), 2929, 
2857 (aliphatic C-H stretch);~ ( CDCb, 400 MHz, gCOSY, gHSQC) 1.06 (s, 9H, 
(CH3)JCSi), 2.94 (d, 1H, OH, JHH 4.8 Hz), 3.60-3.63 (m, 2H, H-6, H-6'), 3.76-3.82 
(m, 2H, H-1, H-2), 3.85 (dd, 1H, JHH 4.9 Hz, JHH 9.6 Hz), 3.91 (dd, 1H, H-1, J 1,z 4.6 
Hz, J1,1• 10.1 Hz), 3.96 (dpt, 1H, H-5, JHH 4.4 Hz, JHH 10.7 Hz), 4.00 (t, 1H, JHH 4.4 
Hz), 4.47-4.56 (m, 5H, 5 x PhCfuO), 4.64-4.67 (m, 3H, 3 x PhCH20), 7.10-7.42 (m, 
26H, aromatic CH), 7.63-7.66 (m, 4H, aromatic CH); 4:: (CDCh, 100.6 MHz, DEPT, 
gHSQC) 19.2 (s, (CH3)3CSi), 27.0 (q, (CH3)3CSi), 63.2 (t, C-1), 71.1 (d, C-5), 71.3 (t, 
C-6), 73.1, 73.4, 73.5, 74.3 (4 x t, 4 x PhCH20), 77.5 (d, C-2), 78.0, 79.7 (2 x d, C-3, 
C-4), 127.7, 127.76, 127.81, 127.83, 127.9, 128.07, 128.37, 128.40, 128.42, 128.5, 
128.6, 129.80, 129.82, 135.8 (14 x d, 14 of25 aromatic CH, others coincident), 133.4, 
133.5 (2 x s, 2 x quaternary aromatic CSi), 138.20, 138.24, 138.3, 138.5 (4 x s, 4 x 
quaternary aromatic); HRMS found 798.4186 (C5oH6oN06Si ([M+~t) requires 
798.4190). 
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2, 3, 4, 6-Tetra-0-benzyl-1-0-tert-butyldiphenylsilyl-5-0-methanesulfonyl-D-glucitol 
(4.20): 
BnO 
2,3,4,6-Tetra-0-benzyl-1-0-tert-butyldiphenylsilyl-D-glucitol ( 4.19) (1.0 eq., 1.28 
mmol, 1.00 g) was dissolved in dry pyridine (20 mL) under nitrogen. 
Methanesulfonyl chloride (1.5 eq., 1.92 mmol, 0.149 mL) was added, and the mixture 
stirred under nitrogen for 72 h. No change in Rr by TLC (ethyl acetatelhexane eluent) 
was observed. The reaction mixture was diluted with CHCb (500 mL) and washed 
washed with water (2 x 250 mL) and the aqueous washings extracted with CHCb 
(100 mL). The organic layers were combined, dried (MgS04), filtered, and the 
solvent removed in vacuo. The resultant oil was purified by flash chromatography 
(15 : 85, ethyl acetate : hexane eluent) to yield 2,3,4,6-tetra-0-benzyl-1-0-tert-
butyldiphenylsilyl-5-0-methanesulfonyl-D-glucitol (4.20) as a colourless oil (1.08 g, 
97 %): [a]0 25 + 15.7 (c = 1.00, in CHCb); mlz 881.0 (ES, [M+Nat, 100%, MeOH); 
Vmax (film)/cm-1: 2857, 2929, 2953 (aliphatic C-H stretch), 3030, 3066 (aromatic C-H 
stretch); ~ (CDCb, 500 MHz, gHSQC) 1.06 (s, 9H, (CH3) 3CSi), 2.87 (s, 3H, 
CH3S03), 3.75-3.81 (m, 3H, H-1, H-2, H-6), 3.83 (t, 1H, JHH 5.2 Hz), 3.86 (dd, 1H, H-
6', Js,6· 2.5 Hz, h,6· 11.2 Hz), 3.89-3.94 (m, 1H, H-1 '), 4.04 (dd, 1H, H-4, hs 2.7 Hz, 
JHH 5.7 Hz), 4.41 (d, 1H, 1 x PhCfuO, JHH 11.7 Hz), 4.44 (d, 1H, 1 x PhCfuO, JHH 
11.7 Hz), 4.50 (d, 1H, 1 x PhCfuO, JHH 11.2 Hz), 4.57 (d, 1H, 1 x PhCfuO, JHH 11.6 
Hz), 4.60 (s, 2H, 2 x PhCfuO), 4.68 (m, 2H, 2 x PhCfuO, JHH 11.2 Hz), 4.98 (dpt, 
1H, H-5, J5,6· 2.6 Hz, JHH 7.9 Hz, JHH 7.9 Hz), 7.14-7.43 (m, 26H, aromatic CH), 7.65 
(t, 4H, aromatic CH, JHH 8.2 Hz); &:; (CDCb, 125.7 MHz, DEPT, gHSQC) 19.3 (s, 
(CH3)3CSi), 27.0 (q, ~H3)3CSi), 38.5 (q, CH3S03), 63.3 (t, C-1), 69.2 (t, C-6), 73.3, 
73.4, 74.7, 74.8 (4 X t, 4 X PhCH20), 78.7, 80.0, 80.1 (3 X d, C-2, C-3, C-4), 83.6 (d, 
C-5), 127.7, 127.79, 127.83, 127.9, 128.0, 128.1, 128.2, 128.41, 128.44, 128.45, 
128.5, 128.6, 129.8, 129.9, 135.78, 135.82 (16 x d, 16 of 30 aromatic CH, others 
coincident), 133.4, 133.5 (2 x s, 2 x quaternary aromatic CSi), 137.8, 137.9, 138.1, 
138.5 (4 x s, 4 x quaternary aromatic). 
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Tetra-n-butylammonium azide (Ref 119): 
Caution! 118 Sodium azide (1.0 eq., 15.4 mmol, 1.00 g) was dissolved in water (40 
mL), and tetra-N-butyl ammonium hydroxide (1.1 eq, 16.9 mmol, 11.0 g, 11.1 mL, 40 
% aq.) added. The resultant mixture was extracted with DCM (4 x 50 mL), and the 
organic layers dried (MgS04), filtered, and evaporated. Toluene was added to the 
residue and the solvent removed in vacuo at low bath temperature to give tetra-n-
butylammonium azide (TBAAZ) as a waxy solid (4.12 g, 95 %). 
Hydrazoic acid (Ref 123): 
Caution! 122 Sodium azide ( 1. 0 e q, 2 5.1 m mol, 1 .63 g) was p laced in a two-necked 
round-bottom flask with distilled water (1.6 mL). The slurry was cooled to 0 °C then 
98 % sulfuric acid (0.5 eq, 12.5 mmol, 1.23 g) added dropwise over 20 minutes 
(exothermic), maintaining the temperature between 5-10 °C throughout the addition. 
The mixture was stirred at 0 °C for a further 30 minutes then the organic layer dried 
(Na2S04) and filtered to give hydrazoic acid (1.30-1.79 M in toluene). The 
concentration of the solution was determined by titration in the following manner: 
Hydrazoic acid solution (2.0 mL) and phenolphthalein indicator (3 drops) were added 
to distilled water (20 mL) and mixed. The resultant solution was titrated agaist 
standard sodium hydroxide (approx 0.1 M). The procedure was repeated until 
consecutive consistent titres were obtained. 
5-Azido-2, 3, 4, 6-tetra-0-benzyl-1-0-tert-butyldiphenylsilyl-5-deoxy-L-iditol ( 4.21): 
OTBDPS ...,.......,,,,,,, 
BnO/ '·· 
OBn 
Method 1 
Caution! 118 2,3,4,6-Tetra-0-benzyl-1-0-tert-butyldiphenylsilyl-5-0-methanesulfonyl-
D-glucitol (4.20) (1.0 eq., 0.0439 mmol, 37.7 mg) was placed in dry flask under 
nitrogen and a solution of tetra-n-butylammonium azide (TBAAZ) (10 eq., 0.439 
mmol, 125 mg) in dry toluene (1.0 mL) was added and the mixture stirred briefly at 
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room temperature to dissolve all reactants. The mixture was then refluxed at 130 °C 
for 90 minutes until TLC indicated full consumption of starting material. The 
solution was cooled to room temperature, diluted with DCM (40 mL), washed with 
water (2 x 20 mL), and the organic phase dried (MgS04), filtered, and the solvent 
removed to give a pale yellow oil. R epeated flash column chromatography o f the 
crude mixture (5 : 95, ethyl acetate : hexane and 1 : 9, diethyl ether : hexane eluent) 
gave 5-azido-2,3 ,4,6-tetra-0-benzyl-1-0-tert-butyldiphenylsilyl-5-deoxy-L-iditol 
(4.21) (8.1 mg, 23 %). 
Method 2 
Caution! 122 1-0-tert-butyldiphenylsilyl-2,3,4,6-tetra-0-benzyl-D-glucitol ( 4.19) (1.0 
eq., 1.28 mmol, 1.00 g) was placed in a round bottomed flask with dry toluene (20 
mL), and freshly prepared HN3 solution added (2.5 eq., 3.21 mmol, 1.79 mL, 1.79 M 
solution in toluene) and the solution stirred under nitrogen for 10 minutes. In a 
separate flask triphenylphosphine (2.5 eq., 3.20 mmol, 840 mg) was dissolved in dry 
toluene (20 mL) under nitrogen. DIAD was added slowly (2.5 eq., 3.20 mmol, 647 
mg, 630 j..tl) and the resultant mixture stirred under nitrogen for 15 minutes. The pre-
prepared solution ofhydrazoic acid and 1-0-tert-butyldiphenylsilyl-2,3,4,6-0-benzyl-
D-glucitol (4.19) was added over 5 minutes. A white precipitate formed. The 
resultant mixture was stirred under nitrogen for 3 h after which time TLC indicated 
complete consumption of starting material. The reaction was stopped by addition of 
NaOH (aq., 3 M, 4 mL), then diluted with diethyl ether (250 mL) and washed with 
NaOH (aq.) (0.5 M, 2 x 150 mL). The organic extract was dried (MgS04), filtered, 
and the solvent removed to give a colourless oil which was purified by flash 
chromatography (5 : 95, diethyl ether: hexane). 2,5-Anhydro-3,4,6-tri-0-benzyl-1-0-
tert-butyldiphenylsilyl-L-iditol ( 4.22), ( 69 m g, 8 .0 %) was obtained as a colourless 
oil, and 5-azido-2,3,4,6-tetra-0-benzyl-1-0-tert-butyldiphenylsilyl-5-deoxy-L-iditol 
(4.21) as a colourless oil (894 mg, 87 %): [a]0 23·9 + 23.9 (c = 1.00, CHCh); m/z 828.4 
(ES, [M+Nat, 100 %, MeOH), 785.4 ([M-HN3+Nat, 15 %); Vmax (film)/cm-1: 2097 
(azide stretch), 2857, 2929, 2955 (aliphatic C-H stretch), 3030, 3066, 3088 (aromatic 
C-H stretch); ~ (CDCh, 500 MHz, gCOSY, gHSQC) 1.06 (s, 9H, (CH3)3CSi), 3.21 
(ddd, 1H, H-5, hs 3.0 Hz Js,6 4.6 Hz, Js,6' 7.7 Hz), 3.31 (dd, (1H, 1H, H-6, Js,6 4.7 Hz, 
J6,6' 9.5 Hz), 3.50-3.56 (m, 2H, H-2, H-6'), 3.79 (dd, 1H, H-4, J4,s 3.0 Hz, h4 7.7 Hz), 
3.84 (dd, 1H, H-1, ]],2 5.6 Hz, h1· 10.5 Hz), 3.91 (dd, 1H, H-1 ', J1·,2 6.5 Hz, 1J.1· 10.5 
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Hz), 4.00 (dd, 1H, H-3, h3 2.8 Hz, J3,4 7.7 Hz), 4.28 (d, 1H, 1 x PhCfuO, JHH 12.0 
Hz), 4.36 (d, 1H, 1 x PhCfuO, JHH 11.8 Hz), 4.39 (d, 1H, 1 x PhCfuO, JHH 11.8 
Hz), 4.51 (d, 1H, 1 x PhCfuO, JHH 11.5 Hz), 4.59 (d, 1H, 1 x PhCfuO, JHH 11.8 Hz), 
4.63 (d, 1H, 1 x PhCfuO, JHH 11.1 Hz), 4.74 (t, 2H, 2 x PhCfuO, JHH 11.8 Hz), 7.15-
7.24 (m, 26H, aromatic), 7.63-7.70 (m, 4H, aromatic);~ (CDCb, 125.7 MHz, DEPT, 
gHSQC) 19.3 (s, (CH3)3CSi), 27.0 (q, (CH3)3CSi), 61.4 (d, C-5), 62.4 (t, C-1), 70.0 (t, 
C-6), 72.5, 73.3, 75.0, 75.4 (4 X t, 4 X PhCH20), 77.9 (d, C-2), 78.5 (d, C-4), 79.1 (d, 
C-3), 127.7, 128.0, 128.1, 128.5, 129.9, 130.0, 135.7, 135.9 (8 x d, 8 of 30 aromatic 
CH, others coincident), 133.4 (s, aromatic CSi), 137.9, 138.0, 138.3, 138.4 (4 x s, 4 x 
quaternary aromatic); HRMS found 828.3877 (CsoHssNJOsNaSi ([M+Nat) requires 
828.3809). 
2, 5-Anhydro-3, 4, 6-tri-0-benzyl-1-0-tert-butyldiphenylsilyl-L-iditol ( 4.22): 
OBn OTBDPS 
I 
'''''''··· 
~ (CDCb, ppm, 499.8 MHz, gCOSY, gHSQC) 1.10 (s, 9H, (Cfu)JCSi), 3.73 (m, 2H, 
H-1, H-1'), 3.90 (dd, 1H, H-6, 15,6 5.3 Hz, h,6' 9.8 Hz), 4.01 (dd, 1H, H-6', Js,6' 8.3 
Hz, h,6' 9.8 Hz), 4.09 (d, 1H, H-4, J3,4 3.6 Hz), 4.12 (d, 1H, H-3, h,4 3.6 Hz), 4.37 (m, 
2H, H-2, H-5), 4.51-4.58 (m, 3H, 3 x PhCfuO), 4.60 (s, 2H, 2 x PhCfuO), 4.65 (d, 
1H, 1 x PhCfuO, JHH 12.1 Hz), 7.48-7.28 (m, 21H, aromatic), 7.71 (d, 4H, aromatic 
C-H); ~ (CDCb, 125.7 MHz, DEPT, gHSQC) 19.3 (s, (CH3)3CSiO), 27.0 (q, 
(Cfu)3CSiO), 61.6 (t, C-1), 68.8 (t, C-6), 72.4, 72.6, 73.5 (t, 3 X PhCH20), 79.1 (d, C-
2), 80.5 (d, C-5), 81.3 (d, C-3), 81.7 (d, C-4),127.69, 127.73, 127.9, 128.4, 128.50, 
128.6, 129.67, 129.72, 135.66, 135.72 (d, 10 of 25 aromatic CH, others coincident), 
133.7, 133.5 (s, 2 x quaternary aromatic CSi), 137.1, 138.2, 138.4 (3 x s, 3 x 
quaternary aromatic). 
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5-Azido-2,3,4,6-tetra-0-benzyl-5-deoxy-L-iditol (4.23): 
OH /11,,,,, 
BnO/ '·· 
·.,,, 
'''
1osn 
OBn 
5-Azido-2,3,4,6-0-benzyl-1-0-tert-butyldiphenyl-silyl-5-deoxy-L-iditol ( 4.21) (1.0 
eq., 0.689 mmol, 555 mg) was dissolved in THF (14 mL), and TBAF was added (1.5 
eq., 1.03 mmol, 1.03 mL of a 1 M solution in THF). The resultant solution was 
stirred under nitrogen for 3 h, after which time TLC showed complete consumption of 
starting material. The reaction mixture was concentrated and the residue dissolved in 
DCM (150 mL) and washed with water (2 x 50 mL). Then the organic layer dried 
(MgS04), filtered, and concentrated to give a colourless oil which was purified by 
flash chromatography (1 : 4, ethyl acetate : hexane eluent) to give 5-azido-2,3,4,6-0-
benzyl-5-deoxy-L-iditol (4.23) as a colourless oil (390 mg, 99 %): [a]0 25·7 + 18.3 (c, 
1.00, CHCh); mlz 590.0 (ES, [M+Nat, 100 %, MeOH); Vmaxlcm-1 (film): 2098 (azide 
stretch) 2866, 2926 (aliphatic C-H stretch) 3030, 3062, 3088 (aromatic C-H stretch) 
3440 (br, 0-H stretch); ~ (CDCh, 500 MHz, gCOSY, gHSQC) 1.91 (s, br, 1H, OH), 
3.46 (dd, 1H, H-6, Js,6 5.0 Hz, h,6' 9.3 Hz), 3.54 (dd, 1H, H-6', Js,6' 7.2 Hz, J6,6' 9.3 
Hz), 3.56-3.59 (m, 2H, H-2, H-5), 3.64 (m, 1H, H-1), 3.75 (m, 1H, H-1 '), 3.88 (dd, 
1H, H-3, J2,3 3.0 Hz, J3.4 7.0 Hz ), 3.86 (dd, 1H, H-4, J4,5 4.2 Hz, J3,4 7.0 Hz), 4.38 (d, 
1H, 1 x PhCfuO, JHH 11.9 Hz), 4.42 (d, 1H, 1 x PhCfuO, JHH 11.9 Hz), 4.54-4.60 (m, 
3H, 3 X PhCfuO), 4.62 (d, 1H, 1 X PhCfuO, JHH 11.3 Hz), 4.67 (d, 1H, 1 X 
PhCfuO, JHH 11.3 Hz), 4.47 (d, 1H, 1 x PhCfuO, JHH 11.6 Hz), 7.22-7.33 (m, 20H, 
aromatic CH); &:: (CDCh, 125.7 MHz, DEPT, gHSQC) 61.1 (d, C-5), 61.5 (t, C-1), 
69.6 (t, C-6), 72.5, 73.4, 74.8, 74.9 (4 X t, 4 X PhCH20), 78.0 (d, C-2), 78.1, 79.1 (2 X 
d, C-3, C-4), 127.8, 127.92, 127.93, 128.1, 128.4, 128.55, 128.57, 128.63, 128.64 (9 X 
d, 9 of 20 aromatic CH, others coincident), 137.8, 137.88, 137.90, 138.0 (4 x s, 4 x 
quaternary aromatic); HRMS found 568.2813 (C34H3sN30 5 ([M+Ht) requires 
568.2811). 
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5-Azido-2,3,4,6-tetra-0-benzyl-5-deoxy-D-idose (4.24): 
OBn 
5-Azido-2,3,4,6-0-benzyl-5-deoxy-L-iditol (4.23) (1.0 eq., 0.074 mmol, 42 mg) was 
placed in a round-bottom flask with dried powdered molecular sieves (4A, 100 mg) 
and PCC (4.0 eq., 0.297 mmol, 62 mg), and dry DCM added (3.0 mL). The mixture 
was stirred under nitrogen for 1.5 h. At the end of this period TLC indicated complete 
consumption o f starting material. T he reaction was stopped by addition of d iethyl 
ether (10 mL), and the mixture filtered through a celite plug, then concentrated, and 
the resultant brown/orange oil purified by flash chromatography (1 : 9, ethyl acetate : 
hexane eluent) to give 5-azido-2,3,4,6-0-benzyl-5-deoxy-L-idose (4.24) as a 
colourless oil (36 mg, 87 %): [a]0 23 + 20.7 (c = 1.00, in CHCh); m/z 588.3 (ES, 
[M+Nat, 100%, MeCN); Vmax (film)/cm-1: 1729 (C=O stretch), 2098 (azide stretch), 
2863, 2922 (aliphatic C-H stretch), 3031, 3063, 3088 (aromatic C-H stretch); bH 
(CDCh 400 MHz, gCOSY, gHSQC) 3.44- 3.57 (m, 3H, H-5, H-6, H-6'), 3.87 (t, 1H, 
H-4, J3,4 5.0 Hz, J4,5 5.0 Hz), 3.93 (d, 1H, H-2, h,3 4.8 Hz), 3.97 (t, 1H, H-3, J2,3 4.8 
Hz, hA 4.8 Hz), 4.42 (m, 2H, 2 x PhCfuO), 4.50 (d, 1H, 1 x PhCfuO, JHH 11.9 Hz), 
4.55 (m, 3H, 3 x PhCfuO), 4.64 (d, 1H, 1 x PhCfuO, JHH 11.2 Hz), 4.83 (d, 1H, 1 x 
PhCfuO, JHH 11.9 Hz), 7.18 (m, 2H, 2 x aromatic CH), 7.25-7.37 (m, 18H, 18 x 
aromatic CH), 9.67 (s, 1H, H-1); &: (100.6 MHz, CDCh, DEPT, gHSQC), 61.6 (d, C-
5), 69.3 (t, C-6), 73.2, 73.4, 74.2, 74.6 (4 x d, 4 x PhCH20), 77.4 (d, C-4), 79.3 (d, C-
3), 80.9 (d, C-2), 127.8, 127.95, 127.99, 128.3, 128.4, 128.46, 128.48, 128.52, 128.58, 
128.64, 128.75 (11 x d, 11 of20 aromatic CH, others coincident), 136.9, 137.2, 137.6, 
137.7 (4 x s, 4 x quaternary aromatic), 200.9 (d, C-1). 
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2, 3, 4, 6-Tetra-0-benzyl-1 ,N-dehydro-1, 5-dideo:xy-1, 5-imino-L-iditol ( 4. 05): 
OBn 
Method 1 
5-Azido-2,3,4,6-tetra-0-benzyl-5-deoxy-D-idose (4.24) (1.0 eq., 0.0725 mmol, 41.0 
mg) was dissolved in dry diethyl ether (1.5 mL) together with triphenylphosphine (3.0 
eq., 0.217 mmol, 57.0 mg). The mixture was stirred under nitrogen at room 
temperature for 90 minutes after which time TLC indicated complete consumption of 
starting material. The solvent was removed in vacuo to give 2,3,4,6-tetra-0-benzyl-
1 ,5-dideoxy-1 ,N-dehydro-1 ,5-imino-L-iditol ( 4.05), with residual phosphines, as a 
waxy white solid (97 mg) which was used directly. 
Method 2 
2,3,4,6-Tetra-0-benzyl-N-chloro-1,5-dideoxy-1 ,5-imino-L-iditol ( 4.08) (1.0 eq., 
0.0842 mmol, 47.0 mg) was dissolved in dry diethyl ether (2 mL) and DBU (1.1 eq., 
0.0926 mmol, 14.1 mg, 13.8 j..tL) added. The mixture was stirred at reflux for 7.5 h 
after which time TLC indicated complete consumption of starting material. The 
reaction was filtered under nitrogen and the filter washed with diethyl ether (1.0 mL). 
The solvent was removed in vacuo giving 2,3,4,6-tetra-O-benzyl-1,5-dideoxy-1,N-
dehydro-1,5-imino-L-iditol (4.05) (45 mg) as a pale yellow oil which was used 
directly: [a]o25 ·1 - 14.7 (c = 2, CHCh); Vmax (film)/cm-1: 1647 (C=N stretch), 2863, 
2921 (aliphatic C-H stretch), 3029, 3062, 3086 (aromatic C-H stretch); 8H (CDCh, 
400 MHz, gCOSY) 3.77-3.87 (m, 4H), 3.98 (dd, 1H, JHH 4.0 Hz, JHH 8.7 Hz), 4.00 (t, 
1H, JHH 5.3 Hz), 4.47-4.57 (m, 3H, 3 x PhCfuO), 4.60 (d, 1H, 1 x PhCfuO, JHH 11.5 
Hz), 4.62 (d, 1H, 1 x PhCfuO, JHH 11.8 Hz), 4.63 (d, 1H, 1 x PhCfuO, JHH 11.4 Hz), 
4.68 (d, 1H, 1 x PhCfuO, JHH 11.8 Hz), 4.70 (d, 1H, 1 x PhCfuO, JHH 11.5 Hz), 7.24-
7.37 (aromatic C-H), 7.80 (s, 1H, H-1); &:: (CDCh, 100.6 MHz, DEPT) 60.2 (d, C-5), 
69.6 (t, C-6), 74.4, 72.5, 72.8, 73.4 (4 x t, 4 x PhCH20), 75.0, 77.8, 78.6 (3 x d, C-2, 
C-3, C-4), 127.8-128.8 (aromatic CH), 137.8, 138.2, 138.4 (3 x s, 3 of 4 quaternary 
aromatic, 2 coincident), 164.0 (d, C-1). 
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2, 3,4, 6-Tetra-0-benzyl-1, 3, 5-trideoxy-1,N-dehydro-2, 3-dehydro-1, 5-imino-L-iditol, 
((2S,3S)2-benzyloxymethyl-3,5-dibenzyloxy-2,3-dihydro-pyridine) (4.26): 
/lt
11 QN BnO/ ''•·.. ~ 
~,,,,.· / 
BnO'~ OBn 
5-Azido-2,3,4,6-tetra-0-benzyl-5-deoxy-D-idose (4.24) (1.0 eq., 0.0716 mmol, 40.5 
mg) was dissolved in dry DCM (2.5 mL) with triphenylphosphine (3.0 eq., 0.215 
mmol, 56.3 mg), and the mixture heated to reflux for 12 h under nitrogen, after which 
time TLC indicated formation of a new product. The solvent was removed in vacuo, 
and the crude orange oil purified by flash chromatography (15 : 85, ethyl acetate : 
hexane eluent), to give 2,3,4,6-tetra-0-benzyl-1 ,3,5-trideoxy-1 ,N-dehydro-2,3-
dehydro-1,5-imino-L-iditol (4.26) as a colourless oil (11.3 mg, 28 %) as the only 
isolable product: [a]0 25·1 + 64.4 (c = 0.55, CHCh); m/z 436.1 (ES, [M+Nat, 100 %, 
MeOH), 306.2 ([M-BnOH+Ht, 20 %), 328.1 ([M-BnOH+Nat, 10 %); Vmax 
(film)/cm-1: 1603 (C=C stretch), 1654 (C=N stretch), 2855, 2919 (aliphatic C-H 
stretch), 3030, 3062, 3088 (aromatic C-H stretch); bH (CDCh, 500 MHz, gCOSY, 
gHSQC) 3.58 (m, 1H, H-5), 4.05-4.07 (m, 2H, H-6, H-6'), 4.21 (dd, 1H, H-4, J4,5 5.5 
Hz, J3,4 6.3 Hz), 4.41 (d, 1H, 1 x PhCfuO, JHH 11.9 Hz), 4.45 (d, 1H, 1 x PhCH20, 
JHH 11.9 Hz), 4.61 (d, 1H, 1 x PhCH20, JHH 11.9 Hz), 4.68 (d, 1H, 1 x PhCH20, JHH 
11.9 Hz), 4.80 (s, 2H, 2 x PhCH20), 5.37 (dd, 1H, H-3, J1,3 2.7 Hz, 1).4 6.3 Hz), 7.22-
7.40 (m, 15H, aromatic CH), 7.91 (dd, 1H, H-1, J1,3 2.7 Hz, hs 3.5 Hz); 8c (CDCh, 
125.7, DEPT, gHSQC) 61.7 (d, C-5), 67.9 (d, C-4), 69.4, 70.4, 73.6 (3 X t, 3 X 
PhCH20), 70.2 (t, C-6), 99.6 (d, C-3), 127.7, 127.76, 127.80, 128.0, 128.4, 128.5, 
128.8 (7 x d, 7 of 15 aromatic CH, others coincident), 135.9, 138.4, 138.8 (3 x s, 3 x 
quaternary aromatic), 149.6 (s, C-2), 156.4 (d, C-1); HRMS found 414.2080 
(C21H2sN03 ([M+Ht) requires 414.2069). 
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(1 R)-2, 3, 4, 6-Tetra-0-benzyl-1, 5-dideoxy-1-C-ethyl-1, 5-imino-L-iditol (4.3 7): 
_/lt,,,,, 
BnO/ '·· 
OBn 
2,3,4,6-Tetra-0-benzyl-N-chloro-1 ,5-dideoxy-1 ,5-imino-L-iditol ( 4.08) (1.0 eq., 0.111 
mmol, 62 mg) was placed in a round-bottom flask with dry diethyl ether (2.0 mL) and 
DBU added (1.1 eq., 0.122 mmol, 18.6 mg). The mixture was immediately heated to 
reflux under nitrogen for 7 h. At the end of this period TLC showed complete 
consumption of starting material. The mixture was then filtered under nitrogen to 
remove the white precipitate of DBU.HCl, and the flask and precipitate washed with 
dry ether (1 mL) under nitrogen. The combined colourless filtrate was used 
immediately. It was added dropwise to a freshly prepared, cooled (- 78 °C) solution 
of Et2Mg (see below). The mixture was stirred at- 78 °C for 2 h then allowed to 
warm to room temperature for 30 minutes before quenching with HCl (aq., 3.0 M, 1 
mL). The mixture was diluted with DCM (30 mL) and basified with NaOH (aq., 3.0 
M, to pH 13). The organic layer was washed with NaOH (aq., 0.1 M, 2 x 15 mL), 
dried (Na2S04), filtered and the solvent removed to give a colourless oil. Column 
chromatography (1 : 3, ethyl acetate : hexane) gave (1R)-2,3,4,6-tetra-0-benzyl-1,5-
dideoxy-1-C-ethyl-1,5-imino-L-iditol (4.37) as a colourless oil (21 mg, 34 %) together 
with recovered 2,3,4,6-tetra-0-benzyl-1 ,5-dideoxy-1,5-imino-L-iditol ( 4.02) (16 mg, 
27%). 
Preparation of Et2Mg reagent. 
Dry diethyl ether (5.0 mL) was placed in a dry round-bottomed flask under nitrogen, 
and ethylmagnesium bromide added (5.4 eq. based on N-chloro-2,3,4,6-tetra-0-
benzyl-1,5-dideoxy-1,5-imino-L-iditol (4.08), 0.60 mmol, 0.2 mL of a 3 M solution in 
diethyl ether). The mixture was stirred under nitrogen and dry 1,4-dioxane was added 
(5.4 eq., 53 mg, 51 JlL). A white precipitate formed immediately, and the mixture 
was stirred under nitrogen for 15 minutes at room temperature, before cooling to - 78 
oc. 
(4.37): [a] 0 24·6 + 2.33 (c = 0.67, in CHCh); m/z 552.3 (ES, [M+Ht, lOO%, MeOH), 
574.3 ([M+Nat, 15 %); Vmax (film)/cm-1: 2866, 2922, 2958 (aliphatic C-H stretch), 
3028, 3 062, 3 086 (aromatic C-H stretch); 5H ( CDCh, 5 00 MHz, gCOSY, gHSQC) 
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0.78 (t, 3H, CfuCH2, JI,2 7.5 Hz), 1.49-1.56 (m, 2H, CH3Cfu), 1.90 (s, br, 2H, NH), 
2.78 (m, br, 1H, H-1), 3.26 (t, br, 1H, H-5, JHH 6.5 Hz), 3.28 (s, br, 1H, H-2), 3.48 (t, 
1H, H-6, h,6' 8.6 Hz), 3.50 (s, br, 1H, H-4'), 3.60 (dd, 1H, H-6', Js,6· 7.3 Hz, J6,6' 8.6 
Hz), 3.74 (t, 1H, H-3, JHH 2.5 Hz), 4.32 (d, 1H, 1 x PhCfuO, JHH 12.0 Hz), 4.36 (d, 
1H, 1 x PhCfuO, JHH 12.2 Hz), 4.42 (d, 1H, 1 x PhCfuO, JHH 12.3 Hz), 4.45 (d, 1H, 
1 x PhCfuO, JHH 12.3 Hz), 4.47 (d, 1H, 1 x PhCfuO, JHH 11.8 Hz), 4.50-4.54 (m, 2H, 
2 x PhCfuO), 4.56 (d, 1H, 1 x PhCfuO, JHH 12.0 Hz), 7.21-7.37 (m, 20H, 20 x 
aromatic CH); £:\: (CDCh 125.7 Hz, DEPT, gHSQC) 10.7 (q, CH3CH2), 24.7 (t, 
CH3CH2), 55.5 (d, C-5), 57.3 (d, C-1), 70.8 (t, br, C-6), 70.9 (d, C-3), 72.0, 72.1, 72.5, 
73.4 ( 4 x t, 4 x PhCH20), 7 2.9 ( d, C -4), 7 4.0 (d, br, C -2), 127.66, 127.73, 127.8, 
127.9, 128.0; 128.35, 128.37, 128.5, 128.6 (9 x d, 9 of 20 aromatic CH, others 
coincident), 138.3, 138.55, 138.60, 138.7 (4 x s, 4 x q uatemary aromatic); HRMS 
found 552.3192 (C36~2N04 ([M+Ht) requires 552.3114). 
1,4-Anhydro-2,3,6-tetra-0-benzyl-D-glucitol (4.15) (Ref 117): 
[a]0 I9 - 9.1 (c = 1.00, CHCb) (lit. 117 [a]0 I9 - 6 (c = 1.0, CHCh)); m/z 891.2 (ES, 
[2M+Nat, 100 %, MeOH), 457.1 ([M+Nat, 83 %); ~ (CDCh, 500 MHz, gCOSY, 
gHSQC) 2.75 (s, br, 1H, OH), 3.63 (dd, 1H, H-1, JI,2 6.3 Hz, hi· 9.7 Hz), 3.76 (dd, 
1H, H-1 ', h,2 3.2, hi· 9.7 Hz), 3.83 (dd, 1H, H-6, J5,6 1.5 Hz, J6,6' 9.8 Hz), 3.99 (dd, 
1H, H-4, J3,4 3.6 Hz, hs 8.2 Hz), 4.08 (m, lH, H-3), 4.13-4.19 (m, 3H, H-2, H-5, H-
6'), 4.47 (d, 1H, 1 X PhCfuO, JHH 12.0 Hz), 4.51 (d, 1H, 1 X PhCfuO, JHH 12.0 Hz), 
4.56 (d, 1H, 1 x PhCfuO, JHH 11.8 Hz), 4.57 (d, 1H, 1 x PhCfuO, JHH 11.8 Hz), 4.61 
(d, 1H, 1 x PhCfuO, JHH 11.8 Hz), 4.62 (d, 1H, 1 x PhCfuO, JHH 11.8 Hz), 7.28-7.39 
(m, 15H, 15 x aromatic); £:\: (CDCh, 125.7 MHz, DEPT, gHSQC) 68.5 (d, C-5), 71.8, 
(t, C-6), 72.21 (t, C-1), 71.3, 72.25, 73.5 (3 X t, 3 X PhCH20), 80.3(d, C-4), 81.9 (d, 
C-3), 82.0 (d, C-2), 127.6, 127.7, 127.8, 127.86, 127.87, 127.9, 128.4, 128.47, 128.51 
(9 x d, 9 of 15 aromatic CH, others coincident), 137.6, 138.1 (2 x s, 2 x quaternary 
aromatic, two coincident). 
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(1 R)-1, 5-dideoxy-1-C-ethyl-1,5-imino-L-iditol ( 4.11): 
/ll''''· HO/ ·· . 
Ho'''''' 
•.. 
OH 
(1R)-2,3,4,6-Tetra-0-benzyl-1 ,5-dideoxy-1-C-ethyl-1 ,5-imino-L-iditol ( 4.37) (1.0 eq., 
0.0254 mmol, 14.0 mg) was dissolved in ethanol (2.0 mL), and PdClz (2.2 eq., 0.0564 
mmol, 10.0 mg) added. The flask was evacuated and purged with hydrogen four 
times before stirring under hydrogen at atmospheric pressure for 1.5 h. At the end of 
this period all the starting material had been consumed and a single product was 
visible by TLC (ethyl acetate/hexane). The mixture was filtered through celite and 
the solvent removed in vacuo. The residue was purified by loading on to a column of 
Dowex ™ SOW acidic exchange resin, washing with methanol, then eluting the 
product with methanol : ammonia (aq., satd.) (9 : 1) The solvent was removed in 
vacuo to give (1R)-1,5-dideoxy-1-C-ethyl-1,5-imino-L-iditol (4.11) as a colourless oil 
(4.2 mg, 86 %); [a]0 25 ·8 - 26.4 (c = 0.18, H 20); mlz 214.2 (ES, [M+Nat, 100 %, 
MeOH), 1 92.2 ( [M+Ht, 4 0 % ); Vm ax ( film)/cm-1: 2 860, 2 934, 2 956 ( aliphatic C-H 
stretch), 3410 (br, 0-H stretch); 4r (D20, 500 MHz, nOesy) 0.83 (t, 3H, CfuCHz, hz 
7.5 Hz) 1.38-1.49 (m, 2H, CH3Cfu), 2.72 (dpt, 1H, H-3, J3,4 1.42 Hz, ]z,3 7.3 Hz), 
2.95 (dpt, 1H, H-7, J6,7 1.6 Hz, h,s 6.6 Hz), 3.54 (dd, 1H, H-8, J7,8 6.6 Hz, Js,s· 11.1), 
3.60 (dd, 1H, H-8', hs 6.7 Hz, Js,s· 11.1 Hz), 3.63 (m, 1H, H-4), 3.68 (m, 1H, H-6), 
3.94 (t, 1H, H-5, J4,s 3.1Hz, Js,6 3.1 Hz); &:: (D20, 125.7 MHz) 9.83 (C-1), 23.8 (C-2), 
55.4, 55,5, 62.2, 68.6, 69.0, 69.4 (C-3, C-4, C-5, C-6, C-7, C-8); HRMS found 
192.1253 (CsH18N04 ([M+Ht) requires 192.1236). 
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2, 3, 4, 6-Tetra-0-benzyl-1, 5-di-0-methanesulfonyl-D-glucitol ( 4.1 0) (Ref 13 0): 
BnO 
2,3,4,6-Tetra-0-benzyl-D-glucitol (4.03) (1.0 eq., 3.97 mmol, 2.15 g) was dissolved 
in dry pyridine (20 mL), under nitrogen and cooled to 0 °C. A cooled (0 °C) solution 
ofmethanesulfonyl chloride (2.45 eq., 9.70 mol, 1.11 g) in dry pyridine (10 mL) was 
added with stirring. The reaction was stirred at 0 °C for 72 h. TLC analysis then 
showed complete consumption of starting material and formation of a new product. 
The mixture was diluted with CHCh (50 mL), and washed with HCl (aq., 1 M, 20 
mL), water (20 mL) and NaHC03 (aq., satd., 20 mL). The organic layer was dried 
(Na2S04), filtered and concentrated in vacuo. The residue was purified by flash 
chromatography (4 : 5, ethyl acetate : hexane) to yield 2,3,4,6-tetra-0-benzyl-1,5-di-
0-methanesulfonyl-D-glucitol (4.10) as a pale yellow oil (1.95 g, 71 %): [a]0 23 .4 + 4.8 
(c = 1.00, CHCh) (lit. 130 + 7.6 (C = 0.91 CHCh); m/z 721.2 (ES, [M+Nat, 100 %, 
MeOH); Vmax (film)/cm-1: 1175, 1356 (S02 stretch) 2873, 2936 (aliphatic C-H 
stretch), 3031, 3063, 3094 (aromatic C-H stretch); bH (CDCh, 500 MHz, gCOSY, 
gHSQC) 2.83 (s, 3H, CfuS03), 2.95 (s, 3H, CfuS03), 3.72 (t, 1H, H-3, h3 5.0 Hz, 
h4 5.0 Hz), 3.78 (dd, 1H, H-6, Js,6 7.8 Hz, J6,6' 11.0 Hz), 3.87 (dd, 1H, H-6', Js,6 2.7 
Hz, h,6' 11.0 Hz), 3.93 (m, 1H, H-2), 4.05 (dd, 1H, H-4, J4,s 2.8 Hz, J3,4 4.9 Hz), 4.26 
(dd, 1H, H-1, hz 6.9 Hz, 1J,1· 10.7 Hz), 4.47 (s, 2H, 2 x PhCfuO), 4.49 (m, 1H, H-1 ') 
4.56 (s, 2H, 2 x PhCfuO), 4.53 (d, 1H, 1 x PhCfuO, JHH 11.6 Hz), 4.57 (d, 2H, 2 x 
PhCfuO, JHH 1 1.1 Hz), 4.71 ( d, 1 H, 1 x P hCfuO, JHH 11.6 Hz), 4.83 ( d, 1 x 1 H, 
PhCfuO, JHH 11.1 Hz), 5.05 (ddd, 1H, H-5, J5,6· 2.7 Hz, J4,s 2.8 Hz, J5,6 7.8 Hz), 7.21-
7.38 (m, 20H, aromatic CH); ~ (CDCh, 125.7 MHz, gHSQC, DEPT) 36.9, 38.3 (q, 2 
x CH3S03), 68.9 (t, C-6), 70.2 (t, C-1), 73.3, 73.5, 74.2, 74.6 (4 x t, 4 x PhCHzO), 
76.6 (d, C-2), 77.8 (d, C-3), 79.0 (d, C4), 82.9, (d, C-5), 127.7, 127.89, 127.94 128.0, 
128.09, 128.1, 128.2, 128.4, 128.5 (9 of 20 aromatic CH, others coincident), 137.2, 
137.32, 137.37, 137.44 (3 x quaternary aromatic); HRMS found 716.2564 
(C36~6SzN010 ([M+~t) requires 716.2563). 
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1-Azido-2, 3, 4, 6-tetra-0-benzyl-1-deoxy-5-0-methanesulfonyl-D-glucitol (4.33): 
BnO 
·.,,, 
'''
1oBn 
OBn 
2,3,4,6-Tetra-0-benzyl-1 ,5-dimethanesulfonyl-D-glucitol ( 4.1 0) (1.0 eq., 0.249 mmol, 
174 mg) was dissolved in dry DMF (4.0 mL). Sodium azide was added (1.8 eq., 
0.448 mmol, 29 mg) and the reaction stirred under nitrogen for 72 h after which time 
TLC showed partial conversion of starting material to product. The reaction mixture 
was concentrated in vacuo, and the residue dissolved in CHCh (50 mL) and washed 
with water (2 x 30 mL). The aqueous layers were combined and extracted with 
CHCh (30 mL). The organic extracts were combined, dried (MgS04), filtered, and 
the solvent removed in vacuo. The residue was purified by flash chromatography (15 
: 85, ethyl acetate : hexane) to give recovered 2,3,4,6-tetra-0-benzyl-1,5-di-0-
methanesulfonyl-D-glucitol (4.10) (75 mg, 43 %), and 1-azido-2,3,4,6-tetra-0-benzyl-
1-deoxy-5-0-methanesulfonyl-D-glucitol (4.33) (56 mg, 42 %) as a colourless oil: 
[a]0 23·5 + 25.2 (c = 1.00, CHCh); m/z 668.2 (ES, [M+Nat, 100 %, MeOH), 1313.5 
([2M+Nat, 5 %); Vmax (film)/cm-1: 2099 (azide stretch), 2854, 2922, 2952 (aliphatic 
C-H stretch), 3026, 3060, 3094 (aromatic C-H stretch); bH (CDCh, 500 MHz, 
gCOSY, gHSQC) 2.91 (s, 3H, CfuS02), 3.31 (dd, 1H, H-1, J1,2 7.4 Hz, lt.t· 13.1 Hz), 
3.35 (dd, 1H, H-1 ', lt-,2 3.4 Hz, J1,1· 13.1 Hz) 3.62 (t, 1H, H-3, h3 5.5 Hz, J3,4 5.5 Hz), 
3.68 (ddd, 1H, H-2, J1·,2 3.4 Hz, J2,3 5.4 Hz, J1,2 7.4 Hz), 3.75 (dd, 1H, H-6, Js,6 7.8 Hz 
J6,6' 11.1 Hz), 3.80 (dd, 1H, H-6', Js,6· 2.9 Hz, J6,6' 11.1 Hz), 3.95 (dd, 1H, H-4, J4,5 2.6 
Hz, J3,4 5.6 Hz), 4.40 (s, 2H, 2 x PhCfuO), 4.51-4.62 (m, 5H, 5 x PhCfuO), 4.72 (d, 
1H, 1 x PhCfuO), 5.00 (pdt, 1H, H-5, J4,5 2.9Hz, Js,6' 2.9 Hz, Js,6 7.8 Hz), 7.20-7.33 
(m, 20H, aromatic CH): ~ (CDCh, 125.7 MHz, DEPT, gHSQC) 38.6 (q, CfuS03), 
51.5 (t, C-1), 69.2 (t, C-6), 73.6, 73.7, 74.8, 74.9 (4 X t, 4 X PhCH20), 78.5 (d, C-3), 
78.6 (d, C-2), 79.8 (d, C-4), 83.4 (d, C-5), 128.0, 128.16, 128.22, 128.25, 128.30, 
128.4, 128.5, 128.65, 128.71, 128.73, 128.8 (11 x d, 11 of 20 aromatic CH, others 
coincident), 137.69, 137.73, 137.76 (3 x s, 3 of 4 quaternary aromatic, two 
coincident); HRMS found 663.2850 (C35~3SN407 ([M+~t) requires 663.2852). 
2, 5-Anhydro-1-azido-3, 4, 6-tetra-0-benzyl-1-deoxy-D-glucitol (4.34): 
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mlz 482.2 (ES, [M+Nat, 100 %, MeOH), 460.2 ([M+Ht, 15 %); Vmax (film)/cm-1: 
2099 (azide stretch), 2852, 2866, 2920 (aliphatic C-H stretch), 3028, 3064, 3088 
(aromatic C-H stretch); ~ (CDCh, 500 MHz, gCOSY, gHSQC) 3.45 (dd, 1H, H-1, 
It,2 6.6 Hz, hl' 12.4 Hz), 3.51 (dd, 1H, H-1 ', lt-,1 6.8 Hz, h1· 12.4 Hz), 3.68 (dd, 1H, 
H-6, Js,6 6.3 Hz, J6,6' 9.7 Hz) 3.72 (dd, 1H, H-6', Js,6· 6.2 Hz), 3.98 (dd, 1H, H-3, J3,4 
1.3 Hz, Jz.3 4.2 Hz), 4.04 (dd, 1H, H-4, J3,4 1.3 Hz, J4,s 3.9 Hz), 4.28 (dpt, 1H, H-2, lz,3 
4.2 Hz, hz 6.7 Hz, J1·,2 6.7 Hz), 4.36 (dpt, 1H, H-5, J4,5 3.9 Hz, Js,6 6.2 Hz, Js,6· 6.2 
Hz), 4.42 (d, 1H, 1 x PhCfuO, JHH 11.7 Hz), 4.47-4.45 (m, 4H, 4 x PhCfuO), 4.61 (d, 
1H, 1 x PhCfuO, JHH 11.7 Hz), 7.24-7.37 (m, 15H, 15 x aromatic CH); ~ (CDCh, 
125.7 Hz, DEPT, gHSQC) 50.2 (t, C-1), 68.4 (t, C-6), 72.2, 72.5, 73.6 (3 x t, 3 x 
PhCfuO), 78.9 (d, C-2), 79.4 (d, C-5), 81.2 (d, C-4), 81.4 (d, C-3), 127.78, 128.16, 
127.9, 128.0, 128.1, 128.2, 128.5, 128.7 (8 x d, 8 of 15 aromatic CH, others 
coincident), 137.6, 137.9, 138.3 (3 x s, 3 x quaternary aromatic). 
2,3,4, 6-Tetra-0-benzy/-1,5-dideoxy-1, 5-imino-L-idito/ (4. 02): 
/11,,,, 
BnO/ '• .. 
OBn 
Method 1 
1-azido-1-deoxy-2,3,4,6-tetra-0-benzyl-5-0-methanesulfonyl-D-glucitol ( 4.33) (1.0 
eq., 0.0542 mmol, 35.0 mg) was dissolved in dry diethyl ether (2.0 mL) under 
nitrogen. Triphenylphosphine was added (1.1 eq., 0.0595 mmol, 15.6 mg), and the 
reaction stirred. The reaction was monitored by TLC. After 18 h the mixture was 
diluted with diethyl ether (30 mL), washed with brine (20 mL). The organic layer was 
dried (NazS04), filtered and evaporated. The residue was dissolved in THF (3.0 mL), 
and NaOH (aq., 0.1 M, 1 mL) added. The mixture was refluxed for 18 h, then diluted 
with diethyl ether (30 mL). The solution was washed with brine (20 mL), then the 
organic layer dried (Na2S04), filtered and concentrated in vacuo. The residue was 
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purified by adsorbing onto Dowex 1M SOW acidic exchange resin (MeOH eluent), and 
eluting with methanol : ammonia (cone., aq.) (4 : 1). The solvent was removed in 
vacuo to give 2,3,4,6-tetra-O-benzyl-1,S-dideoxy-1,S-imino-L-iditol (4.02) as a 
colourless oil (26 mg, 92 %). 
Method 2 
2,3,4,6-Tetra-0-benzyl-1 ,S-di-0-methanesulfonyl-D-glucitol ( 4.1 0) (1.0 eq., 2.98 
mmol, 2.09 g), and sodium azide (3.0 eq, 8.97 mmol, S83 mg) were dissolved in dry 
DMF under nitrogen, and the mixture stirred at 80 °C. After S h the reaction mixture 
was cooled to room temperature and triphenylphosphine added (860 mg, 3.28 mmol, 
1.1 eq.). The mixture was heated to 80 °C for a further 17 h. The reaction mixture 
was diluted with diethyl ether (200 mL), washed with water (100 mL), dried 
(Na2S04), filtered, and the solvent removed in vacuo. The crude oil was passed 
through a column of DowexlM SOW acidic exchange resin (10 g) and washed with 
methanol ( 100 mL) then the desired product eluted with methanol: ammonia ( aq., 
satd.) ( 4 : 1 ), 100 mL, and the solvent removed in vacuo. The resultant oil was 
purified by flash chromatography (3 : 1, ethyl acetate: hexane eluent) to give 2,3,4,6-
tetra-O-benzyl-1,S-dideoxy-1,S-imino-L-iditol (4.02) as a colourless oil (9S8 mg, 61 
%): m/z S24.0 (ES, [M+Ht, 100%, MeOH), S46.0 ([M+Nat, 3S %); 41 (CDCh, SOO 
MHz, gCOSY, gHSQC) 2.47 (s, br, 1H, NH), 2.93 (dd, 1H, H-1, lt,z 6.6 Hz, hi' 12.8 
Hz), 3.07 (dd, 1H, H-1 ', lJ-,2 3.8 Hz, hi· 12.8 Hz), 3.45 (m, 1H, H-S), 3.S1 (m, 1H, H-
2), 3.61 (dd, H-6, 15,6 5.2 Hz, h,6· 9.S Hz), 3.67-3.71 (m, 2H, H-3, H-4), 3.74 (t, 1H, 
H-6', 1s,6 9.2 Hz, h,6• 9.2 Hz), 4.S6-4.73 (m, 8H, 8 x PhCfuO), 7.30-7.41 (m, 20H, 
aromatic CH); £\:: (100.6 MHz, CDCh, DEPT, gHSQC) 44.3, (t, C-1), S4.7 (d, C-S), 
67.2 (t, C-6), 72.1, 72.6, 73.4, 74.1 (4 x t, 4 x PhCH20), 76.9 (d, br, C-2), 77.4, 78.0 
(2 x d, br, C-3, C-4), 127.6, 127.68, 127.74, 127.8, 127.9, 128.0, 128.37, 128.41, 
128.S (9 x d, 9 of20 aromatic CH, others coincident), 138.34, 138.46, 138.S7, 138.63 
(4 x s, 4 x quaternary aromatic); HRMS found 524.2801 (C34H3sN04 ([M+H]l 
requires S24.2801). 
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N-Benzyl-2, 3, 4, 6-tetra-0-benzyl-1, 5-dideoxy-1, 5-imino-L-iditol ( 4.31): 
OBn 
2,3,4,6-Tetra-0-benzyl-1 ,5-di-0-methanesulfonyl-D-glucitol ( 4.1 0) (1.0 eq., 0.869 
mmol, 607 mg) was dissolved in benzylamine (5.0 mL), and the mixture heated to 80 
°C under nitrogen for 24 h. The benzylamine was removed in vacuo, and the residue 
purified by flash chromatography (1 : 9, ethyl acetate : hexane eluent) to give N-
benzyl-2,3,4,6-tetra-0-benzyl-1,5-dideoxy-1,5-imino-L-iditol (4.31) as a colourless 
oil (386 mg, 72 %): ~ (CDCh, 500 MHz, gCOSY, gHSQC) 2.63 (m, 1H, H-1), 2.88 
(m, 1H, H-1 '), 3.46 (m, 1H, H-5), 3.60 (m, 2H, H-2, H-3), 3.75-3.81 (m, 3H, H-4, H-
6', 1 x PhCH2N), 3.97 (dd, 1H, H-6, J5,6 7.2 Hz, J6,6· 10.0 Hz), 4.02 (d, 1H, 1 x PhCH-
zN, JHH 14.1 Hz), 4.53-4.69 (m, 6H, 6 x PhCfuO), 4.84 (d, 1H, JHH 10.9 Hz), 4.90 (d, 
1H, JHH 10.9 Hz), 7.24-7.42 (m, 25H, aromatic CH); ~ (100.6 MHz, CDCh, DEPT, 
gHSQC) 48.9 (t, C-1), 59.2 (t, C-6), 59.9 (d, C-5), 64.8 (t, PhCH2N), 72.6, 72.9, 73.4, 
75.6 (4 x t, 4 x PhCH20), 79.1, 83.2 (2 x d, C-2, C-3), 80.4 (d, C-4), 126.9, 127.5, 
127.61, 127.64, 127.7, 127.8, 128.0, 128.3, 128.35, 128.37, 128.41, 128.43, 128.5 (13 
x d, 13 of25 aromatic CH, others coincident), 138.62, 138.63, 138.65, 139.3, 139.8 (5 
x q, 5 x quaternary aromatic); HRMS found 614.3275 (C41H44N04 ([M+Ht) requires 
614.3270). 
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(1 S)-5-Azido-2, 3, 4, 6-tetra-0-benzyl-1, 5-dideoxy-1-C-ethyl-L-iditol ( 4.3 9), and 
(1 R)-5-azido-2, 3,4, 6-tetra-0-benzyl-1 ,5-dideoxy-1-C-ethyl-L-iditol (4.40) (mixture of 
isomers): 
Et 
/lt,,,,, 
BnO/ ··. OH 
OBn 
5-Azido-2,3,4,6-0-benzyl-5-deoxy-L-idose (4.24) (1.0 eq., 0.437 mmol, 247 mg) was 
dissolved in dry diethyl ether (10 mL), and ethylmagnesium bromide added (1.5 eq., 
0.655 mmol, 218!-lL, 3.0 M solution in THF). The reaction was stopped after 90 
minutes by addition of NH4Cl (aq., satd., 1 mL). The mixture was diluted with 
diethyl ether (50 mL), washed with water (30 mL), and brine (satd., 30 mL). The 
organic layer was dried (MgS04), filtered and concentrated. The resultant colourless 
oil was purified by flash chromatography (1 : 9, ethyl acetate : hexane eluent) to give 
as an intractable mixture of isomers (1S)-5-azido-2,3,4,6-tetra-O-benzyl-1,5-dideoxy-
1-C-ethyl-L-iditol ( 4.39) and (1R)-5-azido-2,3,4,6-tetra-0-benzyl-1 ,5-dideoxy-1-C-
ethyl-L-iditol (4.40) (dr = 1 : 3 (NMR)) (183 mg, 70 %): m/z 618.3 (ES, [M+Nat, 
100%, MeOH); Vmax (film)/cm-1: 2098 (azide stretch), 2869, 2925, 2959 (aliphatic C-H 
stretch), 3030, 3063, 3090 (aromatic C-H stretch), 3436 (br, 0-H stretch); HRMS 
found 596.3122 (C36H42N305 ([M+Ht) requires 596.3124). 
5-Azido-2, 3, 4, 6-tetra-0-benzyl-1, 5-dideoxy-1-C-ethyl-L-idose ( 4.41): 
Et 
0 
/lit,,,, 
BnO/ •.. 
,,,. 
Bno'''' 
OBn 
( 1S)-5-Azido-2,3 ,4,6-tetra-0-benzyl-1 ,5-dideoxy-1-C-ethyl-L-iditol ( 4.39) and (1R)-
5-azido-2,3,4,6-tetra-O-benzyl-1 ,5-dideoxy-1-C-ethyl-L-iditol ( 4.40) (mixture of 
isomers) (1.0 eq., 0.307 mmol, 183 mg), PCC (2.5 eq., 0.766 mmol, 165.2 mg), and 
molecular sieves (4 A, powdered, 200 mg), were dissolved in dry DCM (6.0 mL) and 
stirred under nitrogen. The reaction was stopped after 2 h by triturating with diethyl 
ether ( 30 mL), and filtering through celite. The mixture was concentrated and the 
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resultant brown oil purified by flash chromatography (7.5 : 93.5, ethyl acetate : 
hexane eluent) to give 5 -azido-2,3,4,6-tetra-0-benzyl-1,5-dideoxy-1-C-ethyl-L-idose 
(4.41) (132 mg, 72 %): [a] 0 21.6 + 33.8 (c = 1.00, in CHCh); mlz 616.2 (ES [M+Nat, 
100 %, MeOH), 1209.7 ([2M+Nat, 40 %); Vmaxlcm-1(film), 1713 (C=O stretch), 2098 
(azide stretch), 2852, 2920 (aliphatic C-H stretch), 3030, 3064, 3088 (aromatic C-H 
stretch); 4! (CDCh, 500 MHz, gCOSY, gHSQC) 0.85 (t, 3H, CfuCH2, JHH 7.2 Hz), 
2.40 (dq, lH, 1 x CH3Cfu, JHH 7.2 Hz, JHH 18.8 Hz), 2.47 (dq, lH, 1 x CH3Cfu, 1HH 
7.2 Hz, JHH 18.8 Hz), 3.23 (ddd, lH, H-5, hs 3.6 Hz, 1s,6 5.1 Hz, 15,6· 7.4 Hz), 3.38 
(dd, lH, H-6, 1s,6 5.1 Hz, 16,6· 9.7 Hz), 3.47 (dd, lH, H-6', 1s,6' 7.4 Hz, h,6' 9.6 Hz), 
3.78 (dd, 1H, H-4, 14,5 3.6 Hz, 13,4 7.2 Hz), 3.89 (d, lH, H-2, 12,3 3.5 Hz), 3.97 (dd, lH, 
H-3, 12,3 3.5 Hz, h4 7.2 Hz), 4.26 (d, 1 x PhCfuO, 1HH 11.8 Hz), 4.31 (d, 1H, 1 x 
PhCfuO, 1HH 1 1.9 H z), 4.35 ( d, 1 H, 1 x P hCfuO, 1H H 1 1.9 H z), 4 .38 ( d, 1 H, 1 x 
PhCfuO, 1HH 11.2 Hz), 4.47 ( d, 1 H, 1 x PhCfuO, JHH 11.5 Hz), 4.58 ( d, 1 H, 1 x 
PhCfuO, 1HH 11.2 Hz), 4.64 (m, 2H, 2 x PhCfuO, 1HH 11.8 Hz), 7.10-7.28 (m, 20H, 
aromatic CH); c\: (CDCh, 125.7 MHz, DEPT, gHSQC) 7.16 (q, CH3CH2), 33.6 (t, 
CH3CH2), 61.1 (d, C-5), 69.5 (t, C-6), 73.3, 73.4, 75.0, 75.1 (4 X t, 4 X PhCH20), 78.1 
(d, C-4), 80.7 (d, C-3), 82.9 (d, C-2), 127.8, 127.9, 128.0, 128.10, 128.4, 128.45, 
128.49, 128.52, 128.56, 128.59, 128.7 (11 x d, 11 of 20 aromatic CH, others 
coincident), 136.8, 137.7, 137.8, 138.0 (4 x s, 4 x quaternary aromatic), 211.5 (s, C-
l); HRMS found 611.3237 (C36H43N405 ([M+~t) requires 611.3233). 
(1 R)-2,3,4, 6-Tetra-0-benzyl-1,5-dideoxy-1-C-ethyl-1,5-imino-L-iditol (4.37), and 
(1 S)-2, 3, 4, 6-tetra-0-benzyl-1, 5-dideoxy-1-C-ethyl-1, 5-imino-L-iditol ( 4.43): 
/11,,,,, 
BnO/ '·· 
/lt,,,,, 
BnO/ '·· 
OBn OBn 
5-azido-2,3,4,6-tetra-0-benzyl-1 ,5-dideoxy-1-C-ethyl-L-idose ( 4.41) (1.0 eq., 0.033 7 
mmol, 20.0 mg) and triphenylphosphine (1.5 eq., 0.0507 mmol, 13.3 mg) were 
dissolved in dry diethyl ether (1.0 mL) and stirred under nitrogen. The reaction was 
followed by TLC, and stopped after 6 h, after which time complete consumption of 
starting material was observed. The mixture was concentrated in vacuo and the 
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residue dissolved in methanol (2.5 mL). Sodium borohydride was added (5.0 eq., 
0.167 mmol, 6.3 mg) and the mixture stirred. After a further 16 h the reaction mixture 
was concentrated in vacuo. The residue was dissolved in DCM (30 mL), washed with 
NaOH (aq., pH 13) (2 x 20 mL), then brine (satd., 20 mL). The organic layer was 
dried (Na2S04), filtered and concentrated in vacuo. The residue was purified by flash 
chromatography (1 :3, ethyl acetate : hexane eluent) to give (1S)-2,3,4,6-tetra-O-
benzyl-1,5-dideoxy-1-C-ethyl-1,5-imino-L-iditol (4.43) (3.0 mg, 16 %), (1R)-2,3,4,6-
tetra-O-benzyl-1,5-dideoxy-1-C-ethyl-1,5-imino-L-iditol (4.37) (5.9 mg, 32 %), and 
2,3,4,6-Tetra-0-benzyl-1 ,3,5-trideoxy-1 ,N-dehydro-2,3-dehydro-1-C-ethyl-1 ,5-imino-
L-iditol ( 4.42) (3.1 mg, 20 %), together with other intractable decomposition 
products. 
(1 S)-2, 3, 4, 6-Tetra-0-benzyl-1, 5-dideoxy-1-C-ethyl-1, 5-imino-L-iditol ( 4.43): 
5-Azido-2,3,4,6-tetra-0-benzyl-1,5-dideoxy-1-C-ethyl-L-idose (4.41) (1.0 eq., 0.0185 
mmol, 11.0 mg), was dissolved in dry diethyl ether (1.5 ml) and triphenylphosphine 
added (3.5 eq., 0.0656 mmol, 17.2 mg). The mixture was stirred under nitrogen for 3 
h after which time TLC showed consumption of starting material. Lithium aluminium 
hydride was added (4.0 eq., 0.074 mmol 74 !J.L, 1.0 M solution in THF). The mixture 
was stirred for 30 minutes before quenching with ~Cl (satd., aq., 1 mL). The 
mixture was diluted with diethyl ether (30 mL), and washed with water (2 x 10 mL). 
The organic layer was dried (Na2S04), filtered, and the solvent removed in vacuo. 
The resultant colourless oil was purified by flash column chromatography (15 : 85, 
ethyl acetate : hexane eluent) to yield (18)-2,4,6-tri-0-benzyl-1 ,3,5-trideoxy-2,3-
dehydro-1-C-ethyl-1,5-imino-L-iditol (4.44) (1.1 mg, 13 %) and, as the only 
diastereoisomer (1S)-2,3,4,6-tetra-O-benzyl-1 ,5-dideoxy-1-C-ethyl-1 ,5-imino-L-iditol 
(4.43) (7.0 mg, 68 %): [a] 0 25·1 - 34.1 (c = 1.00, in CHCh); mlz 552.3 (ES, [M+Ht, 
100 %, MeOH), 574.5 ([M+Nat, 20 %); vmax/cm-1(film), 2856, 2919, 2959 (aliphatic 
C-H stretch), 3030, 3063, 3088 (aromatic C-H stretch); bH (CDCh, 500 MHz, 
gCOSY, gHSQC) 0.85 (t, 3H, CfuCH2), 1.18-1.29 (m, 1H, 1 x CH3Cfu), 1.79-1.88 
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(m, 1H, 1 x CH3Cfu), 2.60 (dpt, 1H, H-1, JHH 2.6 Hz, J1,2 9.1 Hz), 3.07 (t, 1H, H-2, 
h2 9.1 Hz, J2,3 9.1 Hz), 3.46-3.59 (m, 3H, H-3, H-5, H-6) 3.69 (t, 1H, H-4, h4 10.0 
Hz,J4,s 10.0 Hz), 3.72(dd, 1H, H-6', Js,6· 5.8Hz,J6,6' 9.6 Hz); &:: (CDCh, 125.7 
MHz, DEPT, gHSQC) 10.3 (q, CH3CH2), 29.8 (t, CH3CH2), 54.0, 54.2 (2 x d, C-1, C-
5), 65.4 (t, C-6), 72.8, 73.7, 75.6, 75.7 (4 X t, 4 X PhCfuO), 80.8, 83.9 (2 X d, C-3, C-
4), 83.5 (d, C-2), 127.7, 127.9, 128.49, 128.54, 128.57, 128.63 (6 x d, 6 of 20 
aromatic C-H, others coincident), 138.3, 138.4, 138.6, 139.0 (4 x s, 4 x quaternary 
aromatic); HRMS found 552.3151 (C36~2N04 ([M+Ht) requires 552.3114). 
2, 4, 6-Tri-0-benzyl-1, 3, 5-trideoxy-1 ,N-dehydro-2, 3 -dehydro-1-C-ethyl-1, 5-imino-L-
iditol, ( (2S, 3S) 1-benzyloxymethyl-3, 5-dibenzyloxy-2, 3-dihydro-6-ethyl-pyridine) 
(4.44): 
~ (CDCh, 500 MHz, gCOSY, gHSQC) 1.14 (t, 3H, CH3CH2, JHH 7.7 Hz), 2.52-2.59 
(m, 2H, CH3Cfu), 3.51 (m, 1H, H-5), 4.04 (d, 2H, H-6, H-6', J5,6 8.0 Hz), 4.21 (dd, 
1H, H-4, J4,5 5.1 Hz, J3,4 6.5 Hz), 4.62 (d, 1H, 1 x PhCfuO, JHH 12.0 Hz), 4.66 (d, 1H, 
1 x PhCfuO, JHH 12.0 Hz), 4.71 (s, 2H, 2 x PhCH20), 4.78 (s, 2H, PhCfuO), 5.36 (d, 
1H, H-3, J3,4 6.5 Hz), 7.19-7.37 (m, 15H, aromatic CH); &:: (CDCh, 125.7 MHz, 
DEPT, gHSQC) 11.3 (q, CH3CH2), 27.9 (t, CH3CH2), 60.9 (d, C-5), 68.5 (d, C-4), 
69.2, 70.3, 73.7 (3 X t, 3 X PhCH20), 70.8 (t, C-6), 100.1 (d, C-3), 127.3, 127.4, 
127.7, 127.8, 127.9, 128.1, 128.3, 128.5, 128.6, 128.8 (10 x d, 10 x aromatic CH), 
136.5, 138.7, 139.3 (3 x s, 3 x quaternary aromatic), 150.6 (s, C-2), 165.8 (s, C-1). 
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(1 S)-1, 5 -dideoxy-1-C-ethyl-1, 5-imino-L-iditol, ( -)-adenophorine ( 4.11) (Ref 116): 
OH 
(1S)-2,3,4,6-Tetra-0-benzyl-1,5-dideoxy-1-C-ethyl-1 ,5-imino-L-iditol ( 4.43) (1.0 eq., 
0.014 mmol, 7.9 mg) was dissolved in absolute ethanol (2.0 mL) which had been 
degassed by boiling under reduced pressure, and PdCh (2 eq., 0.028 mmol, 5 mg) and 
HCl (aq., 3.0 M, 0.25 mL) added. The mixture was stirred under an atmosphere of 
hydrogen at atmospheric pressure for 1.5 h before filtering through celite. The 
resultant solution was passed through a plug of Dowex TM 550A anionic exchange 
resin, and eluted with methanol. T he eluent was then p assed over D owex ™ 5 OW 
acidic echange resin, and the resin washed with methanol (25 ml). The desired 
product was eluted with methanol : ammonia (cone., aq.) (4 : 1) (10 mL) and the 
solvent removed in vacuo to give as a colourless oil (18)-1,5-dideoxy-1-C-ethyl-1,5-
imino-L-iditol (4.11) (2.7 mg, 100 %). [a]n22·0 - 52.3 (c = 0.2, H20) (lit. 116 for 
enantiomer [a]n19 + 59.7 (c = 1, H20); Vmax (film)/cm-1: 2860, 2935, 2957 (aliphatic 
C-H stretch), 3405 (br, 0-H stretch); m/z 192.1 (ES, [M+Ht, 100%, MeOH), 214.1 
([M+Nat, 5 %); ~ (DzO, 500 MHz, gCOSY) 0.94 (t, 3H, CH3CHz), 1.30-1.39 (m, 
1H, 1 x CH3Cfu), 1.80-1.89 (m, 1H, 1 x CH3Cfu), 2.64 (dpt, 1H, H-1, JHH 3.0 Hz, 
JHH 8.9 Hz, hz 8.9 Hz), 3.11 (t, 1H, H-2, hz 9.5 Hz, hs 9.5 Hz), 3.23-3.28 (m, 1H, 
H-5), 3.45 (t, 1H, H-3, Jz,3 9.4 Hz, h4 9.4 Hz), 3.75 (dd, 1H, H-4, J4,s 6.0 Hz, lJ,4 10.0 
Hz), 3.77-3.84 (m, 2H, H-6, H-6'); &: (D20, 125.7 MHz, DEPT) 11.7 (q, CH3CHz), 
26.8 (t, CH3CH2), 56.2 (d, C-1), 59.1 (t, C-6), 59.7 (d, C-5), 74.4 (d, C-4), 77.2 (d, C-
3), 77.6 (d, C-2); HRMS found 192.1229 (C8H18N04 ([M+Ht) requires192.1236. 
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2, 3, 4, 6-Tetra-0-benzyl-N-chloro-1 ,5-dideoxy-1, 5-imino-L-iditol (4. 08): 
/'''''' BnO '··· 
·.,,,, 
111osn 
OBn 
2,3,4,6-Tetra-0-benzyl-1,5-dideoxy-1,5-imino-L-iditol (4.02) (1.0 eq., 1.91 mmol, 
1.00 g) was placed in a round-bottomed flask with dry DCM (20 mL), and N-
chlorosuccinimide added (1.2 eq., 2.30 mmol, 311 mg). The mixture was stirred 
under nitrogen and followed by TLC until complete conversion of starting material 
into product had occurred. After 16 h the reaction mixture was diluted with DCM (80 
mL), and washed with water (2 x 50 mL), then the organic layer dried (Na2S04), 
filtered, and the solvent removed to give a pale yellow oil which was purified by 
passing through a plug of silica (1 : 4, ethyl actetate : hexane eluent). Removal of the 
solvent in vacuo gave 2,3,4,6-tetra-0-benzyl-N-chloro-1 ,5-dideoxy-1 ,5-imino-L-iditol 
(4.08) as a colourless oil (987 mg) (93 %): [a]0 25·3 + 9.9 (c = 1.00, CHCh); m/z 580.0 
(ES, [M+Nat,35Cl, 100 %, MeOH), 524.0 ([M-C1+2Ht, 90 %), 582 ([M+Nat, 37Cl, 
24 %); Vmax (film)/cm-1: 2865 (br, aliphatic C-H stretch), 3029, 3062, 3090 (aromatic 
C-H stretch); ~ (CDCh, 500 MHz, COSY) 3.35-3.45 (m, 2H, H-1, H-1 '), 3.54 (pdd, 
1H, H-5, 14,5 4.8 Hz, 1s,6 9.6 Hz, 15,6' 9.6 Hz), 3.75 (t, 1H, H-3, h,3 8.0 Hz, 13,4 8.0 Hz), 
3.81 (m, 2H, H-2, H-6), 3.91 (dd, 1H, H-6', 15,6· 4.4 Hz, 16,6· 10.1 Hz), 4.0 (dd, 1H, H-
4, 14,5 5.3 Hz h4 7.8 Hz,), 4.57 (s, 2H, 2 x PhCfuO), 4.59-4.73 (m, 5H, 5 x PhCfuO), 
4.76 (d, 1H, 1 x PhCH20, 1HH 11.3 Hz), 7.27-7.37 (m, 20H, aromatic CH); ~ (125.7 
MHz, CDCh, DEPT, gHSQC) 59.3 (t, br, C-1), 67.3 (t, C-6), 68.2 (d, C-5), 73.0, 73.4, 
73.5, 74.9 (4 x t, 4 x PhCH20), 76.9 (d, C-2), 77.7 (d, C-4), 80.1 (d, br, C-3), 127.7, 
127.8, 127.87, 127.93, 128.08, 128.10, 128.49, 128.51, 128.54 (9 x d, 9 of 20 
aromatic CH, others coincident), 138.17, 138.24, 138.3, 138.7 (4 x s, 4 x quaternary 
aromatic); HRMS found 558.2416, (C34H37ClN04 ([M+Ht) requires 558.2411). 
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2,3,4,6-Tetra-0-benzyl-N-chloro-1,5-dideoxy-1,5-imino-D-glucitol (4.07): 
BnO 
·.,,, 
'''
1oBn 
OBn 
2,3,4,6-Tetra-0-benzyl-1,5-dideoxy-1,5-imino-D-glucitol (4.01) (1.0 eq., 0.573 mmol, 
300 mg) was placed in a dry round bottomed flask with dry DCM (5.0 mL) under 
nitrogen with stirring. NCS (1.1 eq., 0.632 mmol, 84.4 mg) was added. The reaction 
was followed by T LC, revealing consumption of starting material after 2 2 h. T he 
reaction mixture was diluted with DCM (20 mL) and washed with distilled water (2 x 
30 mL). The organic layer was dried (Na2S04), filtered, and the solvent removed in 
vacuo to give a colourless oil, which was flushed though a silica plug (1 : 1, ethyl 
acetate : hexane eluent) and the solvent removed in vacuo to give 2,3,4,6-tetra-0-
benzyl-N-chloro-1 ,5-dideoxy-1 ,5-imino-D-glucitol ( 4.07) as a colourless oil which 
forms a white crystalline solid on standing (310 mg, 97 %); mp 168-169 °C (dec., 
ethyl acetatelhexane): [a] 0 253 + 8.0 (c = 1.00, CHCh); mlz 558 (ES, [M+Ht,35Cl, 12 
%, MeOH), 580 ([M+Nat, 20 %, 35Cl), 582 ([M+Nat, 7 %, 37Cl), 524 ([M-Cl+2Ht, 
100 %); Vmax (KBr disc)/cm-1: 2900- 2930 (aliphatic C-H stretch), 3027 (aromatic C-
H stretch); OH (CDCh, 500 MHz, gCOSY) 2.75 (d, br, 1H, JHH 8.0 Hz), 2.9 (t, 1H, JHH 
11.7 Hz), 3.55 (t, 1H, JHH 9.1 Hz), 3.75 (m, 4H), 3.85 (dd, 1H, JHH 2.0 Hz JHH 10.6 
Hz), 4.4-4.95 (m, 8H, 8 x PhCfuO), 7.1 (m, 2H, 2 x aromatic CH), 7.3 (m, 18H, 18 
x aromatic CH); ~ (CDCh, 100.5 MHz, DEPT) 64 (t, br, C-1), 66.3 (t, C-6), 72 (d, 
br, C-5), 73.1, 73.5, 75.5, 75.6 (4 x t, 4 x PhCH20), 76.9, 77.0, 86.3 (3 x d, C-2, C-3, 
C-4), 127.6, 127.7, 127.8, 127.9, 127.95, 127.98, 128.1, 128.35, 128.36, 128.41, 128.5 
(11 x d, 11 of 20 aromatic CH, others coincident), 137.81, 137.84, 138.0, 138.5 (4 x 
s, 4 x quartemary aromatic); HRMS found 580.2224 (C34H36NaClN04 ([M+Na]l 
requires 580.2231); Found: C, 72.93; H, 6.45; N, 2.46 % (C34H36C1N04 requires C, 
73.17; H, 6.50; N, 2.51 %). 
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2, 3, 4, 6-Tetra-0-benzyl-1, 5-dideoxy-1, 5-imino-D-glucitol ( 4. 01): 
BnO 
OBn 
2,3,4,6-Tetra-0-benzyl-N-chloro-1 ,5-dideoxy-1,5-imino-D-glucitol ( 4.07) (1.0 eq., 
0.0896 mmol, 50 mg), was placed in a dry round-bottomed flask. Dry diethyl ether 
(2.0 mL) was added under nitrogen with stirring, followed by DBU (4.2 eq., 0.375 
mmol, 57.1 mg) was added. After 2 h the reaction mixture was filtered through a 
glass sinter under nitrogen and concentrated in vacuo to give crude 2,3,4,6-tetra-O-
benzyl-1,5-dideoxy-5,N-dehydro-1,5-imino-D-glucitol (4.06), with residual DBU as a 
pale orange oil (98 mg). The residue was dissolved in dry CDCh, and analysed by 
NMR. Analysis confirmed the identity of ( 4.06) and showed no remaining starting 
material ( 4.07). The sample was concentrated in vacuo and the residue dissolved in 
dry ether (2.0 mL). LiAIHt was added (5.0 eq., 0.448 mmol, 0.448 mL, 1.0 M 
solution in THF). The reaction was stopped after 10 minutes by addition of NI4Cl 
(aq., satd., 1 mL), and the mixture diluted with diethyl ether (30 mL), washed with 
water (20 mL). The organic layer was dried (Na2S04), filtered and the solvent 
removed in vacuo to give a colourless oil. Column chromatography of the crude 
product (3 : 7 ethyl acetate : hexane) gave 2,3,4,6-tetra-0-benzyl-1,5-dideoxy-1,5-
imino-D-glucitol (4.01) as a colourless oil (41 mg, 87 %) which could be 
recrystallised to give white needles from ethyl acetate/hexane; mp 64.0 - 65.0 °C 
(ethyl acetatelhexane); mlz 524.2 (ES, [M+Ht, 100 %, MeOH), 546.2 ([M+Nat, 35 
%), 1069.7 ([2M+Nat, 15 %); Vmax (KBr disc)/cm-1: 2848, 2902, 2948 (aliphatic C-H 
stretch), 3028, 3062, 3086 (aromatic C-H stretch), 3320 (N-H stretch) bH (CDCb, 400 
MHz, gCOSY) 1.86 (br, 1H, NH), 2.51 (dd, 1H, H-1, J1,2 10.2 Hz, 1J,1· 12.1 Hz), 2.73 
(ddd, 1H, H-5, Js,6· 2.7 Hz, Js,6 6.3 Hz, J4,5 9.4 Hz), 3.25 (dd, 1H, H-1 ', J1·.2 4.88 Hz, 
1J.1· 12.1 Hz), 3.36 (dd, lH, H-4, J3,4 8.8 Hz, J4,s 9.5 Hz), 3.47-3.55 (m, 2H, H-2, H-6), 
3.56 (t, lH, H-3, h3 9.0 Hz, h4 9.0 Hz), 3.68 (dd, 1H, H-6', J5,6· 2.5 Hz, J6,6' 8.9 Hz), 
4.43 (d, 1H, 1 x PhCfuO, JHH 11.8 Hz), 4.47 (d, 1H, 1 x PhCfuO, JHH 11.8 Hz), 4.50 
(d, 1H, 1 x PhCfuO, JHH 11.1 Hz), 4.67 (d, 1H, 1 x PhCfuO, JHH 11.6 Hz), 4.71 (d, 
1H, 1 x PhCfuO, JHH 11.6 Hz), 4.86 (t, 2H, 2 x PhCfuO, JHH 10.5 Hz), 4.99 (d, 1H, 1 
x PhCfuO, JHH 10.9 Hz), 7.19-7.22 (m, 2H, 2 x aromatic CH), 7.27-7.38 (m, 18H, 18 
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x aromatic);~ (CDCh, 125.7 MHz, DEPT) 48.1 (t, C-1), 59.7 (d, C-5), 70.2 (t, C-6), 
72.8, 73.3, 75.2, 75.7 (4 x t, 4 x PhCH20), 80.0, 80.6, 87.3 (3 x d, C-2, C-3, C-4), 
127.5, 127.6, 127.65, 127.72, 127.74, 127.8, 127.9, 127.99, 128.3, 128.35, 128.37, 
128.38 (12 x d, 12 of 20 aromatic CH, others coincident), 137.9, 18.3, 138.4, 138.8 (4 
x s, 4 x quaternary aromatic). 
2, 3, 4, 6-Tetra-0-benzyl-1 ,5-dideoxy-5,N-dehydro-1,5-imino-D-glucitol (4. 06): 
BnO 
OBn 
2,3,4,6-Tetra-0-benzyl-N-chloro-1 ,5-dideoxy-1 ,5-imino-D-glucitol ( 4.07) (1.0 eq., 
0.179 mmol, 1 00 mg), was placed in a dry round-bottomed flask with dry diethyl 
ether (4 mL) under nitrogen with stirring. DBU (1.05 eq., 0.188 mmol, 28.5 mg, 28 
j.tl) was added, and the reaction followed by TLC, which revealed consumtion of 
starting material and formation of a new product. A white precipitate of DBU.HCl 
was seen to form quickly. After 135 minutes, the reaction mixture was filtered 
through a glass sinter under nitrogen and concentrated in vacuo to give 2,3,4,6-tetra-
O-benzyl-1,5-dideoxy-5,N-dehydro-1,5-imino-D-glucitol (4.06) as a pale orange oil 
(97 mg, 95 %); Vmax (film)/cm-1: 1667 (C=N stretch), 2953, 2850 (aliphatic C-H 
stretch), 3030, 3088 (aromatic C-H stretch); 4r (CDCh, 400 MHz, gCOSY, gHSQC) 
3.60 (ddd, 1H, H-1, J1.4 1.4 Hz, hz 8.4 Hz, h1· 16.8 Hz,), 3.70 (ddd, 1H, H-2, h.z 4.6 
Hz, J1,2 8.4 Hz, J2,3 8.4 Hz), 3.90 (dd, 1H, H-3, J3,4 7.1 Hz, Jz,3 8.6 Hz), 4.05 (dd, 1H, 
H-1 ', h,z 4.6 Hz, J1,1' 16.8 Hz), 4.10 (d, 1H, H-6, J6,6" 13.1 Hz), 4.13 (dd, 1H, H-4, JI,4 
1.4 Hz, h4 7.1 Hz), 4.40 (d, 1H H-6', J6,6" 13.1 Hz), 4.5-4.9 (m, 8H, 8 x PhCfuO), 
7.23-7.40 (m, 20H, 20 x aromatic CH); ~ (CDCh, 75 MHz, DEPT, gHSQC) 53.2 (t, 
C-1), 71.9 (t, C-6), 72.4, 73.0, 74.3, 74.9 (4 x t, 4 x PhCHzO), 75.7 (d, C-2), 78.5 (d, 
C-4), 81.7 (d, C-3), 127.65, 127.66, 127.68, 127.76, 127.78, 127.84, 127.87, 128.0, 
128.1, 128.16, 128.24, 128.27, 128.32, 128.34, 128.5 (15 x d, 15 of20 aromatic CH, 
others coincident), 137.6, 137.8, 138.0, 138.2 (4 x s, 4 x quaternary aromatic), 168.5 
(s, C-6). 
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(5R)-2, 3, 4, 6-Tetra-0-benzyl-1, 5-dideoxy-1, 5-imino-5-C-methyl-D-glucitol (4.35): 
BnO 
To a cooled (- 78 °C) freshly prepared solution of 2,3,4,6-tetra-0-benzyl-1,5-
dideoxy-5,N-dehydro-1,5-imino-D-glucitol (4.06) (1.0 eq., 0.112 mmol, 3.33 mL, 
0.0340 M solution in dry diethyl ether) under nitrogen, was added methylmagnesium 
bromide (3.0 eq., 0.112 mmol, 0.112 mL, 3.0 M solution in diethyl ether) with 
stirring. After 2 h at - 78 °C the mixture was warmed to room temperature and stirred 
for a further 12 h. The reaction was stopped by the addition of water (5 mL), then 
diluted with diethyl ether (10 mL), and washed with water (2 x 20 mL). The organic 
layer was dried (Na2S04), filtered, and the solvent removed in vacuo. The resultant 
oil was separated by flash column chromatography (1 : 4, ethyl acetate : hexane 
eluent) to yield (5R)-2,3,4,6-tetra-O-benzyl-1 ,5-dideoxy-1 ,5-imino-5-C-methyl-D-
glucitol (4.35) (6.0 mg, 10 %): [a]n2u + 22.2 (c = 0.65, CHCb); mlz 192.1 (ES, 
[M+Ht, 100 %, MeOH), 538.4 ([M+Ht, 100 %, MeOH), 560.3 ([M+Nat, 80%), 
1097.7 ([2M+Nat, 10%); Vmax (:film)/cm-1: 2854, 2918 (aliphatic C-H stretch), 3030, 
3062 (aromatic C-H stretch); ~ (CDCb, 500 MHz, gCOSY, gHSQC nOesy) 1.09 (s, 
3H, CH3), 1.96 (s, br, 1H, NH), 2.72 (1H, dd, H-1, h2 11.0 Hz, h1· 13.6 Hz), 3.09 
(dd, 1H, H-1 ', 1t,2 5.6 Hz, h 1• 13.6 Hz), 3.18 (d, 1H, H-6, 16,6' 8.8 Hz), 3.44 (ddd, 1H, 
H-2, 11·,2 5.5 H, 12,3 9.1 Hz, h2 10.8 Hz), 3.53 (d, 1H, H-6', 16,6' 8.7 Hz), 3.62 (d, 1H, 
H-4, h,4 9.6 Hz), 3.72 (t, 1H, H-3, h,3 9.2 Hz, h,4 9.2 Hz), 4.37 (d, 1H, 1 x PhCfuO, 
1HH 11.8 Hz), 4.44 (d, 1H, 1 x PhCfuO, 1HH 11.8 Hz), 4.51 (d, 1H, 1 x PhCfuO, 1HH 
11.2 Hz), 4.61 (d, 1H, 1 x PhCfuO, 1HH 11.6 Hz), 4.72 (d, 1H, 1 x PhCfuO, 1HH 11.6 
Hz), 4.81 (d, 1H, 1 x PhCfuO, 1HH 10.6 Hz), 4.90 (d, 1H, 1 x PhCfuO, 1HH 11.3 Hz), 
4.93 (d, 1H, 1 x PhCfuO, 1HH 10.7 Hz), 7.21-7.37 (m, 20H, aromatic); ~ (CDCb, 
125.7 MHz, DEPT, gHSQC) 15.4 (q, CH3), 43.3 (t, C-1), 57.7 (s, C-5), 73.1, 73.3, 
75.4, 75.9 (4 X t, 4 X PhCH20), 75.0 (t, C-6), 81.2 (d, C-4), 82.0 (d, C-2), 84.2 (d, C-
3), 127.5, 127.7, 127.8, 127.86, 127.92, 127.94, 128.1, 128.4, 128.50, 128.52, 128.6 
(11 x d, 11 x aromatic CH, others coincident), 138.1, 138.7, 139.1, 139.2 (4 x s, 4 x 
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quaternary aromatic); HRMS found 538.2959 (C35~oN04 ([M+H]l reqmres 
538.2957). 
(5S)-2,3,4,6-Tetra-O-benzyl-5-C-benzyl-1,5-dideoxy-1,5-imino-L-iditol (4.36): 
OBn 
To a cooled (- 78 °C) freshly prepared solution of 2,3,4,6-tetra-O-benzyl-1,5-
dideoxy-5,N-dehydro-1,5-imino-D-glucitol (4.06) (1.0 eq., 0.112 mmol, 3.33 mL, 
0.0340 M solution in dry diethyl ether) under nitrogen was added benzylmagnesium 
chloride (3.0 eq., 0.336 mmol, 0.336 mL, 1 M solution in diethyl ether) with stirring. 
After 2 h at - 78 °C the mixture was warmed to room temperature and stirred for a 
further 12 h. The reaction was stopped by the addition of water (5 mL). The solution 
was diluted with diethyl ether (10 mL), and washed with water (2 x 20 mL). The 
organic layer was isolated, dried (Na2S04), filtered, and the solvent removed in vacuo. 
The resultant oil was separated by flash column chromatography (1 : 4, ethyl acetate : 
hexane eluent) to yield ( 5S)-2,3,4,6-tetra-O-benzyl-5-C-benzyl-1 ,5-dideoxy-1 ,5-
imino-L-iditol (4.36) (13.2 mg, 19 %); [a] 0 20·0 + 14.6 (c = 1.00, CHCb); m/z 614 
(ES, [M+Ht,100 %, MeOH), 636 ([M+Nat, 10 %); Vmax (film)/cm-1: 2916 (aliphatic 
C-H stretch) 3029, 3062, 3090 (aromatic C-H stretch), 3348 (N-H stretch); ~ 
(CDCb, 500 MHz, gCOSY, nOesy) 2.74 (dd, 1H, H-1, J1,2 10.1 Hz, h 1· 12.0 Hz), 
2.90 (d, 1H, 1 x PhCfuC, JHH 13.6 Hz), 3.10 (d, 1H, PhCH2C, JHH 13.6 Hz), 3.12 (dd, 
1H, H-1 ', J1,2 5.4 Hz, h1· 12.0 Hz), 3.37 (d, 1H, H-4, J3,4 9.0 Hz), 3.43 (ddd, 1H, H-
2, h,2 5.4 Hz, h,3 8.9 Hz, J1,2 10.1 Hz), 3.61 (d, 1H, H-6, h,7 9.8 Hz), 3.83 (t, lH, H-3, 
J2,3 9.1 Hz, J3,4 9.1 Hz), 3.96 (d, 1H, H-6', J6,6' 9.6 Hz), 4.53 (d, 1H, 1 x PhCfuO, JHH 
11.9 Hz), 4.56 (d, 1H, 1 x PhCfuO, JHH 11.9 Hz), 4.63 (s, 2H, 2 x PhCfuO), 4.66 (d, 
1H, 1 x PhCfuO, JHH 11.9 Hz), 4.69 (d, 1H, 1 x PhCfuO, JHH 10.2 Hz), 4.95 (d, 1H, 
1 x PhCfuO, JHH 10.2 Hz), 5.02 (d, 1H, 1 x PhCfuO, JHH 11.9 Hz), 7.20-7.35 (m, 
25H, 25 x aromatic CH); &:; (CDCb, 125.7 MHz, DEPT, gHSQC) 42.1 (t, PhCH2C), 
43.4 (t, C-1), 60.6 (s, C-5), 69.4 (t, C-6), 72.5, 73.5, 74.8, 75.4 (4 x t, 4 x PhCH20), 
81.0 (d, C-2), 82.0 (d, C-4), 84.8 (d, C-3), 126.3, 126.8, 127.3, 127.6, 128.0, 128.3, 
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130.8(7x d, 7 of25aromaticCH,otherscoincident), 137.2, 138.4, 138.5, 138.6, 
139.3 (5 x s, 5 x quaternary aromatic); HRMS found 614.3269 (C41H43N04 ([M+HJl 
requires 614.3270). 
2, 3, 4, 6-Tetra-0-benzy/-1-0-methanesulfonyl-D-g/ucitol ( 4.14): 
BnO 
OBn 
2,3,4,6-Tetra-0-benzyl-D-glucitol (4.04) (1.0 eq., 0.111 mmol, 600 mg) was 
dissolved in dry pyridine (20 mL) under nitrogen at 0 °C. Methanesulfonyl chloride 
(1.1 eq, 1.22 mmol, 139 mg, 94.3 ~L) was added. The solution was stirred at 0 °C for 
24 h after which time TLC indicated almost complete consumption of starting 
material and formation of a major product. The solvent was removed in vacuo at low 
bath temperature. T her esidue was diluted with C HCb (50 m L), and washed with 
water (30 mL). The organic layer was dried (MgS04), filtered, and the solvent 
removed in vacuo. The resultant pale yellow oil was purified by repeated flash 
chromatography (3 : 7, ethyl acetate: hexane eluent) giving 2,3,4,6-tetra-0-benzyl-
1,5-0-di-0-methanesulfonyl-D-glucitol (4.10) (81 mg, 10 %), and 2,3,4,6-tetra-0-
benzyl-1-0-methanesulfonyl-D-glucitol (4.14) as a colourless oil (502 mg, 73 %): 
[a]0 2!.2 + 3.55 (c = 1.00, CHCh); m/z 457.2 (ES, [M-CH3SOrPhCHz+Nat,100 %, 
MeOH), 643.2 ([M+Nat, 95 %), 891.4 ([2(M-CH3S03-PhCHz)+Nat, 45 %); Vmax 
(film)/cm-1: 2867, 2932 (aliphatic C-H stretch), 3029, 3062, 3084 (aromatic C-H 
stretch); 4I (CDCl3, 400 MHz, gCOSY) 2.60 (s, br, 1H, OH), 2.63 (s, 3H, CH3S03), 
3.53-3.56 (m, 2H, H-1, H-1 '), 3.71 (dd, 1H, H-3, J3.4 3.2 Hz, J2,3 6.9 Hz), 3.79 (dd, 
1H, H-4, J3,4 3.2 Hz, J4,s 5.7 Hz), 3.87 (m, 1H, H-5), 3.93 (m, 1H, H-2), 4.13 (dd, 1H, 
H-6, J5,6 6.5 Hz, J6,6· 11.2 Hz), 4.25-4.69 (m, 9H, H-6, 8 x PhCfuO) 7.14-7.29 (m, 20 
H, aromatic CH); &:; (CDCb, 125.7 MHz, DEPT, gHSQC) 37.2 (q, CH3S03), 70.4 (d, 
C-2), 70.9 (t, C-6), 71.1 (t, C-1), 73.4, 73.6, 74.3 (3 x d, 3 of 4 PhCH20, two 
coincident), 77.1, 77.2 (2 x d, C-3, C-5), 77.7 (d, C-4), 128.00, 128.02, 128.07, 
128.08, 128.22, 128.30, 128.59, 128.62, 128.64, 128.7 (10 x d, 10 of20 aromatic CH, 
others coincident), 137.6, 137.8, 137.9, 137.9 (4 x s, 4 x quaternary aromatic). 
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1-Azido-2, 3,4, 6-tetra-0-benzyl-1-deoxy-D-glucitol (4.16): 
BnO 
·.,,,, 
''
1osn 
OBn 
2,3,4,6-Tetra-0-benzyl-1-0-methanesulfonyl-D-glucitol ( 4.14) (1.0 eq., 0.248 mmol, 
154 mg) was dissolved in DMF (6.0 mL) and sodium azide (1.8 eq., 0.45 mmol, 29 
mg) added. The mixture was stirred at room temperature under nitrogen. TLC 
anaysis after 20 h indicated the presence of starting material. The mixture was stirred 
for a total of 6 days. The solvent was removed in vacuo, and the residue dissolved in 
CHCh (50 mL) and washed with water (50 mL). The organic layer was dried 
(MgS04), filtered, and concentrated in vacuo. The mixture was purified by repeated 
column chromatography (1 : 4, ethyl acetate : hexane eluent, then 15 : 85, ethyl 
acetate: hexane eluent) giving 1,4-anhydro-2,3,6-tetra-0-benzyl-D-glucitol (4.15) (16 
mg, 14 %), and 1-azido-2,3,4,6-tetra-0-benzyl-1-deoxy-D-glucitol (4.16) (25.2 mg, 
18 %): [a]0 24·3 + 4.3 (c = 1.00, CHCh); m/z 590.2 (ES, [M+Nat,100 %, MeOH); Vmax 
(film)/cm-1: 2099 (azide stretch), 2864, 2924 (aliphatic C-H stretch), 3030, 3064, 3088 
{aromatic C-H stretch); bH (CDCh, 5 00 MHz, gCOSY) 2.83 ( d, 1 H, 0-H, JH,H 5.5 
Hz), 3.25 (dd, 1H, H-1, J1,z 6.0 Hz, hi' 13.0 Hz), 3.40 (dd, 1H, H-1 ', h,z 3.5 Hz, h1· 
13.0 Hz), 3.63 {m, 2H, H-6, H-6'), 3.71 {dd, 1H, H-4, JHH 3.0 Hz, JHH 7.0 Hz), 3.84 
(m, 2H, H-2, H-3), 4.00 (m, 1H, H-5) 4.50-4.59 (m, 4H, 4 x PhCfuO), 4.63-4.69 (m, 
4H, 4 x PhCH20), 7.22-7.36 (m, 20H, 20 x aromatic CH); &; (CDCh, 125.7 MHz, 
DEPT, gHSQC) 51.8 (t, C-1), 70.7 (d, C-5), 71.2 (t, C-6), 73.2, 73.61, 73.62, 74.7 (4 
x t, 4 x PhCH20), 77.2 (d, C-4), 78.4, 78.8 (2 x d, C-2, C-3), 128.0, 128.2, 128.3, 
128.6 (4 x d, 4 of 20 aromatic CH, others coincident), 137.87, 137.93, 138.0 (3 x s, 3 
of 4 quaternary aromatic, two coincident). 
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2, 3, 4, 6-Tetra-0-benzyl-1, 5 -dideoxy-1 ,N-dehydro-1, 5 -imino-D-glucitol ( 4. 09): 
BnO 
OBn 
2,3,4,6-Tetra-0-benzyl-N-chloro-1 ,5-dideoxy-1 ,5-imino-D-glucitol ( 4.07) (1.0 eq, 
0.104 mmol, 58.0 mg) was dissolved in dry THF (5.0 mL), and the mixture cooled to 
- 78 °C under nitrogen. LiTMP (1.1 eq, 0.11 mmol, 960 JlL, 0.12 M solution in THF) 
was added with stirring. After 1 h the reaction was stopped by the addition of water 
(5 mL), then the mixture wanned to room temperature. Diethyl ether was added (20 
mL) and the solution washed with water (10 mL). The organic layer was dried 
(Na2S04), filtered, and the solvent removed in vacuo. 2,3,4,6-Tetra-0-benzyl-1,5-
dideoxy-1,N-dehydro-1,5-imino-D-glucitol (4.09) was obtained as an orange oil (62 
mg). The imine was found to be unstable and was used immediately in any 
subsequent reactions. 
Preparation of LiTMP reagent. 
2,2,6,6-Tetramethylpiperidine (1.0 eq., 0.594 mmol, 100 JlL) was dissolved in THF 
(4.0 mL) under nitrogen. n-BuLi (1.0 eq., 0.59 mmol, 371 J.!L, 1.6 M solution in 
hexanes) was added dropwise with agitation. The resultant solution was made up to 
5.0 mL with dry THF, and agitated for 15 minutes under nitrogen before use. 
(4.09): Vmax (film)/cm"1: 1654 (C=N stretch); ~ (CDCb, 200 MHz) 7.60 (s, br, H-1), 
&: (CDCh, 50.3 Hz, DEPT) 162.3 (d, C-1). 
(5R)-1,5-Dideoxy-1,5-imino-5-C-methyl-D-glucitol (4.45): 
.,,, 
'''
1oH 
OH 
(5R)-2,3,4,6-Tetra-0-benzyl-1 ,5-dideoxy-1 ,5-imino-5-C-methyl-D-glucitol ( 4.35) (1.0 
eq., 0.0260 mmol, 14.0 mg) was stirred in methanol (1.0 mL) with palladium chloride 
(1.5 eq, 0.0395 mmol, 7 mg). The flask was purged with hydrogen, and the mixture 
stirred under hydrogen for 1 h after which time TLC indicated complete conversion of 
starting material into a single product. The reaction mixture was filtered through 
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celite and concentrated in vacuo to give a colourless oil ( 4.3 m g). The oil was 
dissolved in methanol (10 mL) and passed through a plug ofDowexTM 550A anionic 
exchange resin. The mixture was concentrated in vacuo to give (SR)-1,5-dideoxy-1,5-
imino-5-C-methyl-D-glucitol (4.45) as a colourless oil (4.3 mg, 93 %): [a]0 24·3 + 4.3 
(c = 0.52, MeOH); mlz 178.1 (ES, [M+Ht,100 %, MeOH), 200.1 ([M+Nat, 10%); 
& (D20, 400 MHz, gCOSY, gHSQC) 1.25 (s, 3H, CH3), 3.05 (dd, 1H, H-1, JI,2 11.5 
Hz, hi· 12.8 Hz), 3.35 (dd, 1H, H-1 ', h2 5.5 Hz, hi· 12.8 Hz), 3.55-3.59 (m, 2H, H-
4, H-6), 3.64 (t, 1H, H-3, h,3 9.3 Hz, J3,4 9.3 Hz), 3.73 (ddd, 1H, H-2, h.2 5.5 Hz, h,3 
9.3 Hz, JI,2 11.5 Hz), 3.79 (d, 1H, H-6', J6,6' 12.6 Hz); &: (D20, 100.6 MHz, DEPT, 
gHSQC) 11.7 (q, CH3), 41.8 (t C-1), 62.4 (s, C-5), 63.3 (t, C-6), 67.4 (d, C-2), 69.2 (d, 
C-3), 72.8 (d, C-4); HRMS found 178.1078 (C7HI6N04 ([M+Ht) requires 178.1079). 
(1 R)-1,5-dideoxy-1-C-ethyl-1,5-imino-L-iditol, ( -:)-1-epi-adenophorine (4.12): 
/lt,,,,, 
HO/ ... 
..,,, 
'''
1oH 
OH 
(lR)-2,3,4,6-tetra-0-benzyl-1 ,5-dideoxy-1-C-ethyl-1 ,5-imino-L-iditol ( 4.37) (1.0 eq., 
25.4 ~mol, 14.0 mg) was dissolved in ethanol (2.0 mL) and palladium(II) chloride 
(2.2 eq., 56.4 ~mol, 10 mg) added. The vessel was purged with hydrogen and the 
mixture stirred under an atmosphere of hydrogen for 1.5 h. The mixture was filtered 
through celite and the solvent removed in vacuo. The residue was dissolved in 
methanol and loaded on to Dowex TM SOW acidic exchange resin, washed with 
methanol, and the product eluted with methanol : ammonia (cone., aq.) (95 : 5). The 
solvent was removed in vacuo to give (1R)-1,5-dideoxy-1-C-ethyl-1,5-imino-L-iditol 
(4.12) (4.2 mg, 87 %): [a]0 24·3 - 26.4 (c = 0.18, H20); m/z 214.2 (ES, [M+Nat,100 
%, MeOH), 191.2 ([M+Ht, 40 %); Vmax (film)/cm-I: 2099 (azide stretch), 2864, 2924 
(aliphatic C-H stretch), 3030, 3064, 3088 (aromatic C-H stretch); & (D20, 400 MHz, 
gCOSY, gHSQC) 0.86 (t, 3 H, CfuCH2, JHH 7.5 Hz), 1.46 (m, 2H, CH3Cfu), 2.73 
(ddd, 1H, H-1, JHH 1.5 Hz, JHH 6.5 Hz, JHH 8.1 Hz), 2.98 (ddd, 1H, H-5, JHH 1.7 Hz, 
JHH 6.5 Hz, JHH 8.3 Hz), 3.57 (dd, 1H, H-6, J5,6 6.5 Hz, J6,6' 11.1 Hz), 3.63 (dd, 1H, H-
6', Js,6· 6.7 Hz, J6,6' 11.1 Hz), 3.65 (s, 1H, H-2), 3.70 (m, lH, H-4), 3.96 (t, 1H, H-3, 
h,3 3.2 Hz, J3,4 3.2 Hz); &: (D20, 125.7 MHz) 9.8 (CH3CH2), 23.8 (CH3CH2), 55.4, 
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55.5 (C-1, C-5), 62.2 (C-6), 68.6, 69.0, 69.4 (C-2, C-3, C-4); HRMS found 192.1253 
(CsH1sN04 ([M+Ht) requires 192.1236). 
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General Experimental. 
1H and 13C nuclear magnetic resonance (NMR) spectra were recorded on Varian 
Gemini 200, Unity 300, VXR 400, Bruker 400 or Varian Inova 500 NMR 
spectrometers at the frequencies indicated. Where indicated, NMR peak assignments 
were made using COSY, DEPT, gHSQC or nOesy experiments; all others are 
subjective. All chemical shifts are quoted on the o-scale and were referenced to 
residual solvent as an internal standard. Combinations of the following abbreviations 
are used to describe NMR spectra: s, singlet; d, doublet; t, triplet; q, quartet; m, 
multiplet; br, broad. Infra-red spectra were recorded on a Perkin-Elmer Fourier 
Transform spectrophotometer. The following abbreviations are used to describe infra-
red absortion bands: br, broad; s, strong. Mass spectra were recorded by the 
University of Durham mass spectrometry service using electron impact, chemical 
ionisation or electrospray ionisation techniques on a Micromass LCT time-of-flight 
mass spectrometer; high resolution electrospray spectra were recorded by the 
University of Durham mass spectrometry service or EPSRC mass spectrometry 
service at Swansea, UK. Microanalyses were performed by the University of Durham 
analytical service. Melting-point determination was performed on a Gallenkamp 
melting-point apparatus with a Zeal mercury-filled thermometer. 
Thin layer chromatography (TLC) was carried out on aluminium sheets coated with 
silica gel 60F254 (Merck, 1.05554). Plates were visualised under ultra-violet light or 
developed using an ethanolic phosphomolybdic acid or aqueous basic potassium 
permanganate dip. Flash column chromatography was performed using silica gel 
(Merck, 60A, 230-400 Mesh). Diethyl ether, tetrahydrofuran, and DCM were dried 
immediately prior to use according to standard procedures: diethyl ether and 
tetrahydrofuran were distilled under nitrogen from metallic sodium with 
benzophenone indicator. D CM was distilled under nitrogen from calcium hydride. 
Toluene was distilled under nitrogen from metallic sodium and stored over 4A 
molecular sieves under nitrogen. Methanol and ethanol were distilled from 
magnesium/iodine, and stored over 4A molecular sieves under nitrogen. Acetone was 
distilled from calcium sulfate immediately prior to use. Other dry solvents used were 
commercial, and stored and handled under dry nitrogen. All solvents were removed 
by evaporation under reduced pressure. 
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